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Being diagnosed with HIV/AIDS and commencement of lifelong antiretroviral therapy (ART) with 
the requirement of high adherence can exacerbate or trigger depressive disorders. Prevalence of 
major depression is substantially higher in people living with HIV/AIDS (PLWHA) than those in 
the general population. More than 50% of PLWHA are likely to meet one or more criteria for 
depression in their lifetime. However, access to interventions for depressive disorders remains 
limited in Low- and Middle-Income Countries (LMICs) where more than 90% of people with 
depressive disorders are not receiving formal treatment. The role of evidence-based 
psychological treatments has been fundamental in reducing the huge treatment gap in LMICs. 
Although brief, flexible and effective psychological treatments are emerging, issues in relation to 
their acceptability, feasibility and effectiveness in HIV populations remain unexplored. Therefore, 
this thesis aimed to adapt and pilot group interpersonal therapy (IPT) for treatment of depressive 
symptoms including its acceptability and feasibility for PLWHA.    
This thesis has been the first that attempted to adapt and pilot group IPT for treatment of 
depression in the HIV population in Ethiopia. The findings of this thesis can serve as a baseline 
for researchers interested in adapting or developing psychological treatments in the HIV 
population in Ethiopia. The findings contribute information on the process used in examining 
acceptability and feasibility of psychological interventions which provides indications for 
conducting future trials to test the effectiveness of group IPT.  
Methods  
First, a systematic review and meta-analysis of randomised controlled trials was conducted to 
identify the most effective psychological treatments for depressive symptoms for PLWHA in 
LMICs. Second, a survey of major depressive disorder (MDD) was conducted among PLWHA 
who were attending ART follow-up appointments at the Felege-Hiwot Referral Hospital (FHRH) 
in Northwest Ethiopia. The survey served as a baseline to identify cases for piloting of group IPT 
and helped to identify areas for intervention. Third, the intervention areas were further explored 
among stakeholders from the ART clinic including PLWHA and this was followed by a stepwise 
adaptation of the group IPT manual. Furthermore, a formative qualitative study was conducted to 
examine explanatory models of depression and to explore acceptable contexts for implementation 
of group IPT. A total of three focus groups were conducted with purposively selected case 
managers, adherence supporters and service users at the ART clinic. The qualitative data were 
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analysed based on a framework approach using predefined thematic concepts. Fourth, a pilot 
study of the group IPT intervention was conducted among PLWHA to evaluate the acceptability 
and feasibility of peer-administered group IPT for treatment of depressive symptoms for PLWHA 
in Ethiopia. A single-arm, pre-post, peer-administered, group IPT interventional study was 
conducted with 31 consecutively recruited participants. The participants were assigned to four 
IPT groups for the intervention. A post-intervention evaluation of depressive symptoms, perceived 
social support (PSS), functional disability and quality of life (QoL) was conducted using the same 
instruments used at the baseline. No control group was included in this pilot study.  
Results 
The findings of the systematic review and meta-analysis revealed that trials that used IPT have 
shown good effectiveness in treating depressive symptoms of PLWHA in LMICs. The baseline 
study found 32.5% prevalence of MDD among randomly selected PLWHA (N=393). MDD was 
positively associated with reduced adherence to ART, functional disability and negatively 
associated with overall QoL. Overall findings of the baseline and the qualitative study indicated 
that psychosocial problems are the most important factors that need intervention for depression 
for PLWHA. The main findings in relation to the adaptation of the WHO group IPT were: i) an IPT 
group that contains five to ten people was perceived to be acceptable and mixed gender groups 
were recommended; ii) sessions were recommended to be conducted in private rooms for 1.5 to 
2 hours, and on a weekly basis. Findings of the pilot study indicated that depression scores 
reduced significantly between baseline and post-intervention (mean difference (MD)=9.92; t=-
7.82; p<0.001). The mean PSS scores (MD=0.79; t=2.84; p=0.009) and the mean QoL scores 
(MD=0.39, t=4.58, p<0.001) improved significantly between baseline and post-intervention. 
All the IPT intervention areas (life change, disagreement, grief and loneliness) were found to be 
applicable to and important areas associated with depression in PLWHA in Ethiopia. Most 
importantly, disagreement within a family and life change due to HIV/AIDS, such as sickness and 
separation were faced by almost all PLWHA included in the study, followed by loneliness or social 
isolation as result of HIV stigma, and grief due to loss of loved ones including a spouse, a child, 
a mother or a father. 
Overall evaluation of the pilot indicated that the procedures and outcomes of group based IPT 
were perceived as acceptable. Participants of the intervention gained benefits in resolving 
psychosocial problems and reported high satisfaction with counsellors and intervention setting. 
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The eight weekly sessions that lasted around two hours were acceptable; however, additional 
sessions were recommended by some counsellors until everyone recovers from depression.  
Conclusion  
The overall findings of this thesis suggested that group IPT was found to be acceptable and 
feasible for PLWHA in Ethiopia. Future studies should focus on examining its effectiveness for 
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Chapter 1. Introduction 
This chapter reviews the global and local literature pertaining to the burden of depression and its 
health-related outcomes in people living with HIV/AIDS (PLWHA). It also summarises the current 
evidence on the treatment gap and the role of psychological treatments in reducing the burden of 
depression in low- and middle-income countries (LMICs), particularly in Ethiopia. The rationale 
for this thesis and research objectives are then described. Finally, the setting in which the present 
research took place is briefly described. 
1.1. Burden of depression  
Depressive disorders are the most common mental health problems affecting over 300 million 
people globally, accounting for 4.4% of the world’s population (1, 2). The total number of people 
with depressive disorders increased by 18.4% between 2005 and 2015 (1). Depressive disorders 
are the leading cause of the mental health-related disease burden (3) and contribute to more than 
800,000 suicide deaths per year globally (1). According to a study on the global burden of 
diseases in 2017, of all diseases and injuries, depressive disorders were the third leading cause 
of years lived with disability (YLD) (4). The World Health Organization (WHO) report on burden of 
mental disorders shows that depressive disorders accounted for 50 million YLD globally in 2015 
and more than 80% of the burden of depressive disorders occurred in LMICs, with more than 
seven million YLD occurring in Africa (1). Depressive disorders remain one of the barriers to 
achieving the sustainable development goals (5) and are associated with a high risk of all causes 
of mortality, including cardiovascular death and stroke (6). Reducing suicide by 10% in 2020 was 
one of the target goals of the WHO mental health action plan (7). Unfortunately, to date, 
depressive disorders continue to contribute to more than 68% of all suicide deaths (3). In addition, 
socio-economic adversities such as unemployment and poverty are also associated with 
depressive disorders (6, 8).  
In addition to shared risk factors between depression and HIV/AIDS (e.g. poverty), being 
diagnosed with HIV/AIDS, a life-threatening chronic illness necessitating lifelong antiretroviral 
therapy (ART) with a need for high adherence, can exacerbate or trigger depressive disorders. In 
association with declining death rates from HIV, depressive disorders are becoming more 
prevalent among PLWHA (9). More than 50% of PLWHA are likely to meet one or more criteria 
for depression in their lifetime (10, 11). Prevalence of major depression is nearly two times higher 
among PLWHA than those in the general population (12, 13). In low-income countries, the 
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prevalence of depressive disorders using diagnostic instruments can be as high as 63% among 
PLWHA (14). A meta-analysis of 74 observational studies found a 50.8% pooled prevalence of 
depression among PLWHA in China (10). A meta-analysis of studies from Africa found a 15.3% 
pooled prevalence of major depressive disorder (MDD) using a diagnostic interview (15). Table 1 
presents a range of systematic reviews and meta-analysis studies conducted in LMICs and their 
findings on the prevalence of depression among PLWHA. Several studies have reported a range 
of prevalence estimates for depression, which vary from 7.3% to 76.7% among PLWHA in 
Ethiopia (16, 17). A meta-analysis of studies conducted in Ethiopia has shown a 36.7% pooled 
prevalence of probable depression among PLWHA (18). However, the heterogeneity of studies 
in terms of measurement variation and study design limits our ability to draw conclusions on the 
prevalence of depressive disorders among PLWHA in Ethiopia. In addition, the timing of the 
depression assessment following receiving the diagnosis of HIV/AIDS influences the prevalence 
of depressive disorders (14). Measuring depression immediately after HIV diagnosis can 
artificially inflate estimates, where adjustment reactions may be mislabelled as depression.       
There is a large body of evidence that depression can lead to poor clinical outcomes and a high 
risk of mortality among PLWHA (6). A prospective cohort epidemiological study from the United 
States of America (USA) found that women with chronic depression had two times greater risk of 
mortality than women with limited or no depressive symptoms (19). A cohort study of seropositive 
men in San Francisco, USA demonstrated that men with depressive symptoms had 1.7 times 
greater risk of mortality than men without depressive symptoms (20). PLWHA who had comorbid 
mental illness including depression had three times increased risk of dying from all causes of 
death compared to those who had no history of mental illness in South Africa (21). Evidence 
shows that there is a relationship between depression and altered immunity, although the 
mechanism of association remains unclear (19). However, biological studies argue that a low 
lymphocyte response to mitogens occurs in people with depression and leads to low immune 
functioning and poor recovery (22). In turn, low immunological functioning hastens advanced 
stages of disease and mortality (22). 
Several studies provide a biological explanation to the relationship between depression and poor 
outcome of HIV/AIDS; however, vegetative symptoms of depression such as poor food intake, 
weight loss and insomnia can also contribute to the poor outcome of HIV/AIDS. For example, 
nutritional deficiency due to poor appetite and insomnia could also predict a poor prognosis of 
HIV/AIDS (23). Despite existing evidence, more interventional research is needed to manage 
depression and improve the outcomes of HIV/AIDS.            
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Table 1. Prevalence of depression among people living with HIV/AIDS in range of systematic review and meta-analysis studies in low- 
and middle-income countries. 
N Author & Year Setting Tool  Sample Pooled prevalence  Predictors  
1 Ayano G,  et al 
2018 (24) 
East Africa  Not described 19 articles  38% pooled prevalence of 
depression. It ranges from 12% 
to 46% depending on 
measurement. 
Having opportunistic infection, perceived 
stigma, hospitalisation in the past month, 
food insecurity, frequency of missed clinic 
visits, older age, low income, urban 
residence and being government employee  






66 articles 9% to 32%  Low socio-economy, female sex and low 
CD4  
3 Lofgren SM, 202 
(15) 
sub-Sahara Africa  Diagnostic 
interview and 
screening tools 
70 articles  15.3% prevalence of major 
depression and 25.5% 
prevalence of probable 
depression was reported  
Not described  
4 Nakimuli-Mpungu 
E, et al, 2012 (26) 
sub-Sahara Africa 12 studies used 
validated 
instruments  
23 articles  31.2% prevalence of mild to 
moderate depression and 18% 
major depression 
Adherence to ART medication 
5 Patel P, et al 
2018 (27) 
Low- and middle-
income countries   













24.4% (95%CI: 12.5-42.1) 
pooled prevalence of depression 
Not described  
6 Amare T, et al,  
2018 (18) 
Ethiopia CES-D, PHQ-9, 
Kessler-6, 
HADS, BDI 
13 articles  36.7% pooled prevalence of 
depression was reported  
Age, living alone, poor adherence, poor 
social support, clinical stages, stigma, no 
income 
7 Wang T, et al, 
2018 (10) 






74 articles  50.8% (95% CI: 46.0–55.5%) 
pooled prevalence of depression 
was reported.  
Not described  
Key: CES-D – Center for Epidemiological Studies Depression scale, DSM-IV – Diagnostic Statistical Manual fourth edition, HADS – Hospital Anxiety and 
Depression Scale, PLWHA – People Living With HIV/AIDS, MINI – Mini International Neuropsychiatric Interview, PHQ-9 – Patient Health Questionnaire   
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1.2. Risk factors for depression in the HIV population 
A complex interaction of biological, social and psychological vulnerabilities cause depression (28). 
Currently, scholars argue that the biopsychosocial model may not sufficiently explain causation 
of mental disorders, including depression, as spiritual beliefs, rituals and community habits have 
been found to be important aspects in defining and understanding depression (29).  
Studies demonstrate that depression consistently shows an association with socio-demographic 
adversities (30). Causal pathways of socio-demographic adversities and depression are not well 
understood, and the association seems mixed. Socio-demographic adversities can be outcomes 
of depression but can also cause depression. Lund and colleagues describe social causation and 
social drift theories, demonstrating that poverty is an important social adversity that can be a 
causative factor (31). In addition, a range of social determinants, particularly demographic, socio-
economic and social changes associated with depression (32).  
HIV/AIDS is a chronic, life threatening, and stigmatising disease, affecting the general wellbeing 
of PLWHA to a high extent (33). Due to HIV/AIDS, PLWHA are vulnerable to socio-economic 
adversities such as job loss, unemployment and poverty (34).  
The findings of previous studies in the HIV population indicated that psychosocial problems have 
shown strong correlations with depression. For example, life changes (such as poverty, job loss, 
unstable employment, sickness) (32) and social problems (such as divorce and separation, low 
social support and social isolation due to stigma) due to HIV/AIDS all increase the risk for 
depression (35). Commonly reported psychosocial problems such as stigma, conflict and 
interpersonal violence could lead to low self-esteem, helplessness or the onset of full-blown 
depression (36-38). The most reported risk factors for depression in PLWHA can be categorised 
as socio-demographic (39), psychosocial (40) and clinical (41). Low income, being jobless, marital 
separation/divorce, low perceived social support, being female, large family size and stigma are 
the most common socio-economic and socio-demographic factors associated with depression 
(18, 41, 42). Psychological factors such as maladaptive coping strategies, including substance 
use (43, 44), self-stigma (37, 38), and negative self-image (36, 38) are commonly associated with 
depressive symptoms.  
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1.3. Depression and Quality of Life  
Quality of Life (QoL) refers to the general wellbeing of an individual that involves several domains 
of functioning, namely physical, psychological, independence, social, environmental and spiritual, 
and can be affected by a variety of life circumstances (45, 46). Depression affects the QoL of 
PLWHA in various ways (47-50). Mood disturbance commonly associated with poor QoL (51, 52) 
and MDD has been reported to correlate with lower scores of psychological, social and 
environmental domains of QoL (53). Depression is believed to reduce immune functioning and 
exacerbate immune suppression (22). Poor immune functioning leads to the advanced stage of 
AIDS which can further lead to deterioration in physical, psychological and social health (54).  
Depression may also affect QoL indirectly through affecting adherence to HIV treatments leading 
to poor adherence and immunological outcomes, high viral load and an increased risk of mortality 
(55). PLWHA who have comorbid depression are more likely to have low treatment adherence 
than those without depression (56). This is supported by a systematic review of randomised 
controlled trials that shows that depression has a negative association with adherence to ART 
(57). This can be partially explained by the demotivation to adhere to HIV treatments due to 
affective symptoms of depression, negative thinking (for example, hopelessness about the future) 
and suicidality. Moreover, neurocognitive symptoms of depression, such as forgetfulness, can 
also explain the temporal relationships of depression with poor adherence to ART. Poor ART 
adherence, advanced clinical stage of AIDS, late ART initiation, poor immunological status (low 
CD4 count) and comorbid physical illness are all reported to contribute to poor QoL (41, 58). 
Figure 1 illustrates the association of HIV/AIDS, depression and health-related outcomes of 
PLWHA. 
Given the above body of evidence on the burden of depression and its effects mainly on 
adherence to HIV treatment and overall QoL of PLWHA, the development of evidence-based and 
acceptable interventions should be a priority to break the cycle between depression and poor 
QoL. In LMICs where less than 10% of the population has access to basic mental health care 
(59), the need to get affordable, accessible and effective interventions for depression remains 
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Figure 1. Conceptual framework linking HIV/AIDS, depressive disorders and health-related outcomes. 
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1.4. Treatment gap and the role of psychological treatments  
This section reviews literature in relation to the mental health treatment gap and its contributing 
factors in LMICs, particularly in Ethiopia. It describes the mental health treatment gap particularly 
among PLWHA in LMICs, with particular emphasis on Ethiopia. It also summarises the role of 
evidence-based psychological treatments to reduce the existing mental health treatment gap, 
particularly for PLWHA, using a task shifting approach. Task shifting, defined as “delegating tasks 
to existing or new cadres with either less training or narrowly tailored training, is a potential 
strategy to address these challenges” (61).    
1.4.1. Treatment gap 
Although effective mental health interventions are available, only a few people with depression 
are receiving treatment in LMICs (62). Whilst 80% of people with mental disorders reside in 
LMICs, the provision of mental health care is inadequate (63). Among people with depressive 
disorders, only 1 in 5 in high-income countries and 1 in 27 in LMICs are receiving even minimal 
treatment (64). More than 90% of people who need any mental health interventions are not 
receiving care and treatment in LMICs (59, 65, 66). The challenges contributing to this huge 
mental health treatment gap are complex. Most low-income countries have no stand-alone mental 
health policy or strategy and as a result the mental health services suffer from inadequate funding 
and limited access to evidence-based interventions (63-65, 67). In addition, the lack of mental 
health facilities and infrastructure (67) and the scarcity and maldistribution of trained human 
resources are major barriers to closing the treatment gap (65). Mental Health treatment gap is not 
limited to the lack of available services but also affected by low demand of mental health care 
services at community level. These demand related factors include mental health stigma and 
cultural norms of visiting traditional healers or faith healers which can discourage modern health 
service utilisation (68-70). Lack of information about availability of mental health services, Lack of 
awareness about mental health problems are also major contributors to low demand of mental 
health services (68, 70). To increase mental health demand, it is important to increase awareness 
and access to information through using media and community leaders.    
Mental health treatment gap “refers to the difference that exists between the number of people 
who need care and those who receive care” (71). Mental health care services in LMICs are 
commonly challenged by unmet needs that is due to the large gap between the need for and 
provision of mental health services (72). The treatment gap has become an important concept 
widely promoted by the WHO through the development of the mhGAP approach, which has been 
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demonstrated to have many benefits in building mental health services. However, its limitations 
should be addressed critically (71). The concept of mental health treatment gap is partially 
obscures due to the complex assemblage of therapeutic approaches which does not take variety 
of treatment choices (73). Because the concept of mental health treatment gap is conceptualised 
at “community” level and that does not allow to provide person centred care at individual level 
although it increases economic efficiency by reducing health care costs for LMICs (71).     
Ethiopia, a country with more than 100 million people, has no stand-alone mental health policy 
and legislation (74). According to the 2017 WHO Mental Health ATLAS report, the total number 
of mental health professionals is 1,739, with a proportion of 1.74 per 100,000 population. The 
ratio of mental health nurses, psychiatrists and psychologists is 1.00, 0.08 and 0.04 per 100,000 
population respectively. The treatment gap remains high and the existing health care system 
seems incapable of addressing mental disorders, including depression (75). In Ethiopia, the 
mental health report of 2006 indicated that 1.7% of the national health budget was allocated to 
mental health care (76), even though mental disorders had become the leading contributor to the 
disease burden caused by non-communicable diseases in Ethiopia (77).  
Given the large body of evidence on the existing mental health treatment gap described above, 
there is a clear need for the early detection and treatment of depression and other mental 
disorders along with existing HIV care (78). The health care of PLWHA has focused on biomedical 
treatments, leaving mental health problems relatively neglected (79). Depression, the most 
common mental health condition in PLWHA is responsive to a variety of treatments (80). 
However, the lack of evidence-based interventions, low mental health funding and lack of trained 
human resources has created huge a mental health treatment gap in Ethiopia. It is important to 
develop and revise mental health policies and utilise human resources more efficiently, such as 
using a task shifting approach by capacitating non-specialists to deliver psychological treatments 
(65).   
1.4.2. The role of psychological treatments  
Psychological treatments play an important role in preventing and treating mental health 
conditions (81). Several psychological treatments are proposed as being effective for treatment 
of depression (82) and also in preventing the onset of depressive disorders (83). Evidence-based 
and cost-effective psychological treatments that are used to facilitate recovery from depressive 
disorders have been emerging around the world (84). A recent systematic review and meta-
analysis of trials reported that psychological treatments are as effective as antidepressants in 
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reducing depression relapse (85). Another systematic review found that psychotherapies are 
equivalent in effectiveness to pharmacotherapies for the treatment of adult depression (86). 
Studies from high-income countries have indicated that psychological treatments that included 
cognitive behavioural therapy (CBT) are more effective than other psychological treatments (82). 
A systematic review of psychotherapies among adolescents with depression globally found 
interpersonal therapy (IPT) to be as effective as CBT, with more advantages in long-term 
effectiveness and higher attendance rates (87). The most recent systematic review on LMICs, 
presented in Chapter 2 of this thesis, has shown higher effect sizes using psychological 
treatments such as IPT (standard mean difference (smd) = -1.72; 95% confidence interval (CI): -
3.21,-0.23) instead of CBT (smd = -0.03; 95%CI: -0.27,0.21) (88). More research in LMICs has 
found high effectiveness in treating depression among different groups of people using IPT (84, 
89, 90). The success of IPT in LMICs poses the question of whether interpersonal theories are 
more important to explain depression than cognitive behavioural models in non-Western cultures 
(91) which is an important consideration for psychological therapies in countries like Ethiopia. IPT 
reduces depressive symptoms through enhancing social support, solving social disputes and 
conflict, and managing life changes (88).  
A systematic review and meta-analysis of trials in LMICs, presented in Chapter 2 of this thesis, 
found that both group- and individual-based psychological treatments are effective and there was 
no difference in effect size between the two approaches (88). Group-based psychological 
treatments have shown high acceptability in African cultures as evidenced by high treatment 
adherence and effectiveness (90). Verdeli and colleagues argue that group-based psychological 
treatments increase intervention coverage at a lower cost as compared to individual-based 
interventions (92). This is further supported by more recent reports by Rose-Clarke and 
colleagues (93) and Collins and colleagues (14) that group-based psychological treatments could 
be more cost-effective than individual-based interventions. Group-based interventions facilitate 
social support, enable the learning of problem-solving skills, promote group motivation and enable 
learning of new coping strategies (94). Symptom-specific evidence-informed counselling, 
psychoeducation and group-based IPT may be effective for the treatment of depression (80). 
Group IPT can be delivered by non-professionals successfully and can be a useful intervention 
for multiple cultural settings following cultural adaptation (14). However, there may also 
circumstances in which group-based interventions may not work, for example when groups are 
heterogeneous in terms of age, gender, educational status and socioeconomic class. Group-
based interventions may not be successful when confidentiality is a big concern (95, 96).      
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Psychological treatments that can be administered by non-specialists after a short period of 
training could have major implications for addressing the shortage of trained human resources in 
LMICs. Study findings have shown benefits for the treatment of depression using non-specialist 
administered psychological treatments (97). Non-specialist health workers are primary level 
health care providers who have received more general mental health training rather than 
specialist level training such as psychologists and psychiatrists (65). The use of non-specialist 
counsellors can be an economically feasible method of increasing the number of trained human 
resources for LMICs (98). In addition, non-specialist counsellors can usually speak the same 
language and share the same culture as their clients, allowing them to understand what is 
appropriate for the culture in a specific community (99, 100). Culturally adapted, non-specialist 
administered, group-based psychological treatments need to be accessible to PLWHA (81). All 
psychological treatments may not be uniformly effective when implemented in various settings 
and in different populations. Therefore, systematic cultural adaptations may be a requirement to 
optimise the acceptability and effectiveness of psychological treatments in the HIV population.      
1.5. Approaches to adapting psychological treatments   
Psychological treatments may not be consistently effective in every culture and setting due to 
several interacting barriers during their implementation. This becomes a challenge for worldwide 
scalability (81). The barriers that affect the implementation of these treatments include low 
acceptability and feasibility, the lack of proper adaptation of interventions when using for different 
populations, and the low competency of the administering agents (101, 102). Mental health stigma 
(enacted and self-stigma) and low mental health literacy can also hinder the delivery of quality 
care (70).  
Most psychological treatments have been developed in “Western countries” and, although several 
studies have examined their effectiveness in LMICs (103), may not be equally effective in LMICs 
due to the lack of systematic cultural adaptation to “non-Western” settings (104). The adaptation 
of psychological treatments has become an important method to optimise the acceptability and 
effectiveness of an intervention (93, 105). This is supported by two meta-analyses that found that 
culturally adapted psychological treatments are more effective than those non-adapted 
interventions (104, 106), although a third meta-analysis indicated no evidence for association 
between adapted interventions and effect size (103). The WHO recommends psychological 
treatments such as IPT and CBT as the first line treatment choice for depression after proper 
cultural adaptation and contextualisation (107). More recently, psychological treatments have 
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been adapted and tested in some LMICs and appeared to be effective for depression (88, 108). 
The adaptation of psychological treatment requires an understanding of the cultural explanations 
of illness and treatment preferences of the specific population (109).  
Common areas of adaptation include systematic language adaptation, such as the literal 
translation and inclusion of metaphors, and the use of idioms and local stories (104), and content 
adaptation, such as the modification of core components of an intervention (110). The lack of 
adaptation guidelines has led researchers to adopt different approaches ranging from haphazard 
and non-empirical methods to more systematic and participatory approaches guided by 
conceptual frameworks through engaging the local community and stakeholders (93). While 
conducting cultural adaptation, studies suggest including three important components: i) cultural 
concepts of illness; ii) core treatment principles of therapies; and iii) strategies of treatment 
delivery (105).  
Several studies have used the ecological validity and culture sensitivity model (111) to conduct 
cultural adaptation. This model is a broad framework that addresses several components of 
cultural adaptation, such as a local conceptual understanding of an illness, the use of culturally 
appropriate language, the selection of preferred delivering agents, and strategies for successful 
delivery of the selected intervention (111). Within the ecological validity and culture sensitivity 
model, nesting sub-frameworks may be important to explore each component in more detail. For 
example, including explanatory models of illness (112) allows us to explore the conceptual 
understanding and treatment preferences of a specific community. Similarly, the use of stepwise 
and participatory approaches, such as Participatory and Iterative Process Framework for 
Language Adaptation (PIPFLA), enables us to conduct appropriate language adaptation. The 
WHO has drafted a protocol for the adaptation of psychological treatments for common mental 
problems, including for depression, into the local context (113). This includes a stepwise language 
and content adaptation of evidence-based psychological treatments with special emphasis on the 
use of non-specialist counsellors in low resourced settings. Therefore, the findings of this thesis 
can be used to inform possible further changes to the WHO adaptation protocol.   
1.6. Health care system and mental health services in Ethiopia  
The Ethiopian health system comprises a three-tier system of care that incorporates primary, 
secondary and tertiary care systems (77). The primary care level is established at district level 
and comprises health posts, health centres and primary hospitals. The primary level of care uses 
a task shifting approach to provide basic health services at the community level. Most of the 
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functions conducted by Health Extension Workers (HEWs) at community level are health 
education, health promotion and provision of other basic primary care services. Most importantly, 
people with more serious health issues, including severe mental conditions, are usually referred 
by HEWs to secondary or tertiary care services, although the national Mental Health Strategy 
indicates that referral of people with severe mental disorders should be to primary care (health 
centres). More than 38,000 HEWs have been deployed across the districts since 2003 and this 
has been reported to be an effective approach in accessing basic health care for the community 
(114). This shows the potentially available human resources for improving mental health care 
coverage through a task shifting approach. These human resources can be trained to provide 
psychological treatments in ART clinics found in health centres, and district and referral hospitals. 
In ART service centres, there are different cadres of care providers, these includes physicians, 
health officers, nurses, pharmacists, laboratory technologist. There are also non-professional 
supportive staff members such as case managers (HIV counsellors), adherence supporters 
(adherence counsellors) and volunteers. All these human resources, particularly non-
professionals can provide psychological treatments for PLWHA if they are supported by trainings.         
The Federal Ministry of Health (FMOH) started to move towards the development of accessible, 
affordable and acceptable mental health care by introducing a strategic mental health plan for the 
period between 2012/13 and 2015/16 (115). The strategic plan was in place for a brief period and 
there are plans for a new strategic mental health plan to be developed in the future. The strategic 
plan strongly advocates for the efficient utilisation of existing resources when integrating mental 
health services into the primary level of care. The WHO Mental Health Gap Action Programme 
(mhGAP) conducted a pilot study by integrating mental health care services into the existing 
health care system using a task shifting approach in collaboration with the Ethiopian Ministry of 
Health (116). The pilot programme, that aimed to efficiently utilise the existing resources, has 
successfully addressed the basic mental health needs of people residing in selected areas in the 
Amhara, Oromia, Tigray and South Ethiopia regions. However, the detection rate particularly for 
depression was very low, with only 89 individuals identified with depression in 19 clinics in a six-
month period. This highlights how detection of depression is challenging for primary care 
clinicians. Other studies also found supporting evidence that 98% of cases with depression 
remained undetected in primary health care settings (75). The WHO mhGAP has continued 
providing mental health training for non-professionals, however the scale-up has been very slow 
in Ethiopia. The approach has been reported to be successful and could greatly contribute to 
reducing the treatment gap and mental health morbidity.   
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1.7. HIV/AIDS and mental health care services in Ethiopia   
In Ethiopia, the estimated prevalence of HIV/AIDS among adults (15-49) was 1.1% and it was 
estimated to be 0.9% among all age groups. This means that close to a million people have 
HIV/AIDS, according to the 2016 Demographic and Health Survey of Ethiopia (117). The trend of 
HIV prevalence has been significantly higher in urban (2.9%) than in rural areas (0.4%), and the 
Northwest, Northeast and Southern parts of the country were demarcated as high risk areas for 
HIV infection (118). In 2016, a total of 30,000 people were estimated to be infected with HIV and 
20,000 deaths had occurred due to HIV/AIDS (117). HIV services are provided at all levels of care 
services, these are at primary (at health posts and health centres), secondary (primary and district 
hospitals) and tertiary (specialised hospitals) level.     
The national mental health strategy of Ethiopia has developed an integrated care approach to 
address mental disorders with a particular emphasis on addressing mental, neurological and 
substance use disorders such as depression, psychosis and epilepsy (119). The Ethiopian health 
care policy for HIV focused on accessing ART treatments, and the integration of mental health 
services with HIV care received minimal attention (12). In line with the general mental health 
services described above, the integration of mental health services with the existing HIV care 
services has been piloted in some parts of the country and the integration model was found to be 
promising (80).  
Even though the Ethiopian government developed a strategy to integrate mental health services 
with HIV/AIDS care, there has been no specific trial conducted to adapt and examine the 
effectiveness of group IPT for PLWHA. Group-based IPT can be relevant to resource-limited 
settings to address difficult-to-reach communities as it can be delivered by non-specialists who 
received basic training. Examining the acceptability and feasibility of group IPT for PLWHA is an 
important step before conducting a randomised controlled trial to test its effectiveness. This thesis 
addresses this initial step as described in the next section.  
1.8. Rationale for the thesis  
Early treatment of depression can facilitate positive engagement with HIV care and treatment and 
can improve clinical outcomes of HIV. Although several studies have contributed a lot of evidence 
in showing the prevalence of probable depression using screening tools in PLWHA in Ethiopia, 
little has been done towards: i) assessing the burden, risk factors and outcomes of MDD; ii) 
developing or adapting evidence-based psychological interventions for depression for PLWHA; 
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iii) implementing effective interventions for treatment of depression to improve the overall QoL of 
PLWHA. More research is needed on adapting and developing evidence-based interventions that 
can work in harmony with the existing health care system. Prior to the implementation of evidence-
based interventions, the assessment of risk factors and outcomes of depression helps in 
identifying areas for intervention. It is also important to evaluate the acceptability and feasibility of 
evidence-based interventions and to examine the effectiveness of the interventions. This thesis 
presents the findings from the adaptation and pilot evaluation of a group IPT intervention for 
depression for PLWHA in Ethiopia. Unlike previous studies in the HIV population in Ethiopia, this 
thesis assessed the prevalence of MDD using a diagnostic instrument and examined its 
association with adherence to ART and QoL. The thesis also identified important areas for 
intervention for PLWHA. The areas for intervention were identified by factors associated with 
depression and exploring perceived causes of depression among PLWHA. Therefore, the findings 
of this thesis can contribute important insights to mental health research. The findings of this 
thesis further contribute to showing the process used in adapting and examining the acceptability 
and feasibility of psychological interventions for PLWHA and piloting an intervention that can be 
used in future trials. Moreover, the results of this thesis can be utilised by mental health 
researchers interested in adapting and implementing interventions, particularly in the HIV 
population.    
1.9. Aims and objectives 
The overall aim of this thesis was to generate new knowledge on the needs for depression care 
and the feasibility and acceptability of a psychological treatment for depression among PLWHA 
in Ethiopia. This will be addressed by the following four objectives.   
1. To systematically review the effectiveness of psychological treatments for depressive 
symptoms for PLWHA in LMICs: a systematic review and meta-analysis; 
2. To determine the prevalence of MDD and its association with adherence to ART and QoL: 
A cross-sectional survey of PLWHA in Northwest Ethiopia; 
3. To adapt the WHO group IPT for the treatment of depressive symptoms for PLWHA in 
Ethiopia specifically for delivery by trained non-specialists; 
4. To pilot the adapted group IPT intervention, and to assess its acceptability and feasibility 
for treatment of depressive symptoms for PLWHA in Ethiopia. 
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1.10. Overview of chapters 
Each objective of this thesis is presented in a separate chapter, from Chapters 2 to 5, with each 
chapter providing findings that inform a specific objective. Chapter 2 presents the systematic 
review and meta-analysis of randomised controlled trials that investigated the effectiveness of 
psychological treatments for depression for PLWHA in LMICs and provides evidence that group 
IPT is a good candidate for treating depression among PLWHA.  
Chapter 3 reports the findings of the baseline study that determined the association of MDD with 
adherence to ART and QoL of PLWHA. The evidence presented in this chapter helps to identify 
areas for intervention that supported the findings of the systematic review. It shows that there was 
a positive relationship between MDD and functional disability, optimal adherence to ART and low 
QoL.     
Chapter 4 presents the findings explored in adapting the group IPT intervention and the 
frameworks used to explore areas for the possible integration of group IPT in HIV care. This 
chapter sets out the steps and activities that were conducted in the adaptation of the intervention 
and summarises the findings. The WHO group IPT with its forms and structures was perceived to 
be appropriate for PLWHA if it is administered by peer-counsellors.   
Chapter 5 presents the findings of the pilot study of the adapted group IPT intervention and 
discusses important areas that should be addressed in future. The process of the intervention 
and its outcomes were acceptable, and the intervention was perceived as feasible. This chapter 
also presents both quantitative and qualitative findings of the intervention and the application of 
group IPT for PLWHA.  
Chapter 6 presents a synthesis of the findings in an overall discussion and conclusion of the 
thesis, with limitations of the study and recommendations for mental health researchers, 
stakeholders in HIV care and policy makers.   
1.11. Study setting and preparations for the study 
This study was conducted in the ART clinic in Felege Hiwot Referral Hospital (FHRH), which is 
the largest comprehensive referral hospital in Northwest part of Ethiopia. FHRH is located in Bahir 
Dar and serves a population of 7 million people in the catchment area. Bahir Dar is the capital city 
of the Amhara regional state where the regional government is located. Bahir Dar is the largest 
urban settlement in the Northwest part of Ethiopia, which is home to 750,000 people. Of these, 
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93.2% are from the Amhara ethnic group and 95.5% speak Amharic as their first language. More 
than 79.7% of the population practice Ethiopian Orthodox Christianity and 18.5% are Muslims. 
See the location of the study setting in Figure 2.  
A few months prior to starting the field work, I had visited the research setting and met local 
organisations working with PLWHA and other stakeholders, including the regional health bureau, 
head of the ART clinic, ART nurses, HIV counsellors and service users, separately. The purpose 
of these meetings was to identify the available resources to and short- and long-term needs of 
the stakeholders, and to identify the motivating factors for the stakeholders. These meetings were 
the first milestone in establishing a foundation for alliance and in getting buy-in to the research. 
Later, my supervisor (MS) and I visited the facility and the HIV care system of the study setting. 
We met some of the staff members at the ART clinic and received feedback on how to conduct 
the research and to further strengthen collaboration. I arranged a seminar to officially launch the 
research in collaboration with the College of Health Sciences of Bahir Dar University and made a 
presentation on the aims of the research to stakeholders and invited guests. I received 
constructive feedback from participants on how to put the protocol into practice. I presented the 
research purpose to ART nurses, case managers, adherence supporters and mental health 
professionals, and explained their contribution to the research and reaffirmed the goals of the 
research. The implementation of the research was conducted in consultation with the 
stakeholders. Training and data collection were arranged and provided at the convenient times 
as suggested by the stakeholders and in communication with the ART clinic head. The research 
team remained consistent throughout and until the completion of the research work without any 
drop-out of research staff.  
I, the principal investigator of this thesis (a mental health professional based in Northwest 
Ethiopia), coordinated all tasks of the field work, was involved in organising the group IPT training, 
provided the training with the three other trainers, oversaw the data collection and arranged 
facilities for the implementation of the group IPT. I was also responsible for communicating with 
officials at the College of Medicine and Health Sciences of Bahir Dar University to obtain a training 
hall for workshops and training. I reviewed the quality of the data on a regular basis and checked 
the completeness of the collected data. However, I was not involved in any of the survey data 
collection, focus group discussions, group IPT sessions or post-intervention interviews. All the 
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2.1. Abstract  
Background: Psychological treatments play a significant role in managing depressive symptoms. 
However, little is known about the most effective psychological treatments for depressive 
symptoms for PLWHA in LMICs. 
Aims: To identify effective psychological treatments to manage depressive symptoms for adult 
PLWHA in LMICs and to estimate pooled effect sizes using a meta-analysis.    
Method: Four databases were searched using key words and MeSH terms – PubMed, Scopus, 
Cochrane library and PsychINFO. The inclusion criteria were randomised controlled trials that 
examine psychological treatments that target depressive symptom for adult PLWHA in LMICs. 
The Cochrane risk of bias tool was used to assess the risk of bias. A meta-analysis was done 
using RevMan-5.      
Result: Nineteen studies were included in the systematic review and 14 of them were selected for 
meta-analysis. Eight (42%) of the trials used CBT. Pooled effect size of trials that used continuous 
outcomes was -0.61 (n=12; 95%CI: -1.24,0.02; I2=95%) at post-treatment assessment. The 
pooled effect size changed to -1.41 (n=8; 95%CI: -2.54, -0.28; I2=98%) at six months post 
treatment.  
Limitations: Studies varied in quality from low to high risk of bias and there was high heterogeneity 
across studies. 
Conclusion: Trials used group support psychotherapy (GSP), IPT, problem-solving therapy (PST), 
and peer-support counselling were effective in reducing depressive symptoms. However, better 
powered studies with more consistent methodologies are needed to investigate whether specific 
therapies delivered by lay counsellors are effective for PLWHA in LMICs.  







PLWHA commonly experience depressive symptoms due to their vulnerability to stressful life 
circumstances, including living with a life-threatening illness (14). Depressive symptoms are 
associated with disease progression and poor health-related outcomes in PLWHA (120).  
Psychological treatments play a significant role in managing depressive symptoms, including 
among PLWHA (121). These treatments have been preferred over pharmacotherapy (122) due 
to their flexibility, limited side effects and relatively low cost (123). However, variation in 
implementation due to cultural differences (for example idioms of distress used in psychological 
treatments may vary across cultures) and the lack of consistent measures to compare their 
effectiveness makes it difficult to choose one over the other (82, 124).  
Although studies from high-, middle- and low-income countries indicate that a variety of 
psychological treatments are successful in reducing depressive symptoms for PLWHA, there is 
variable and inconclusive evidence on what is the most effective psychological treatment (33, 
125-129).  
To illustrate, a systematic review and meta-analysis of 13 group-based CBT treatment for 
depressive symptoms of PLWHA found a small pooled effect size for group CBT in the reduction 
of depressive symptoms smd = -0.26; 95%CI: -0.42,-0.10) (33). In contrast, a systematic review 
of four group CBT trials indicated a larger pooled effect size (smd = 2.07; p=0.01) on the reduction 
of depressive symptoms in PLWHA (130). The effectiveness of psychological treatments may be 
influenced by several factors including cultural factors, level of competency of therapists and 
format of delivery.         
In relation to studies in LMICs a review of randomised controlled trials of psychological treatments 
of common mental disorders  for PLWHA was conducted by Chibanda and colleagues (131). The 
studies included in this review were few (only five trials included), but three of them had a high 
risk of bias and there was high heterogeneity in the nature and duration of treatment. This review 
did not indicate what type of psychological treatment and what format of delivery (group or 
individual) are the most effective and acceptable for treating depressive symptoms for PLWHA. 
A more recent systematic review was conducted of psychological treatments for depressive 
symptoms for PLWHA in Africa (132). This review included 18 studies with diverse methodologies 
(including cohort, quasi-experimental and randomised controlled designs). Of the included 
studies, seven used anti-depressant medications, seven used different psychological treatments 
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and the remaining used physical exercise and other unspecified psychosocial interventions. This 
review showed that the use of psychological treatments for depressive symptoms was acceptable 
and feasible in PLWHA in sub-Sahara Africa (SSA). This review did not compare effectiveness of 
each treatment, instead authors commented on the need for large studies to show efficacy (132). 
An overall review of mental health interventions identified a paucity of empirical data investigating 
effectiveness of treatments for mental disorders for PLWHA in LMICs (133). The data were widely 
diverse in terms of treatment approach, methodologies used and sample size. Therefore, it was 
not possible to identify the most effective treatment to improve mental health of PLWHA. The 
three systematic reviews conducted in this area have made important contributions to our 
understanding of psychological treatments in the HIV population. However, none of them have 
conducted a meta-analysis to compare the effectiveness of psychological treatment types in 
reducing depressive symptoms. Furthermore, as stated by the authors in the article using the 
Cochrane collaboration risk of bias tool, most studies included in their reviews were of poor quality 
making it difficult to assess the most effective psychological treatment in resource limited settings.      
In general, studies from different setting have shown that both CBT and IPT seem to be effective 
in reducing depressive symptoms among PLWHA. However, there remains limited information 
available on the best psychological treatments for depressive symptoms for PLWHA in LMICs. 
Hence, the overall aim of this review and meta-analysis was to identify the most effective 
psychological treatment and to quantitatively pool effect sizes.  The current systematic review and 
meta-analysis aimed to update the previous reviews (131-133). Newly published trials are 
identified, and their finding analysed together with the findings of the previous studies (studies 
published before 2015).  
2.3. Method  
We searched for studies evaluating psychological treatments targeting depressive symptoms 
among PLWHA in LMICs. The protocol was registered in PROSPERO (CRD42018093949). The 
PRISMA checklist for reporting of systematic reviews and meta-analysis was used (134).  
2.3.1. Inclusion Criteria  
The general criteria for including articles were: (1) the study must be conducted among adult 
PLWHA with age 18 years; (2) the study should include depressive symptoms as a primary or 
secondary outcome; (3) the study must be an RCT; (4) the intervention used in the study must be 
a psychological treatment in any format in any setting; and (5) the study must be conducted in 
LMICs. 
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2.3.2. Exclusion criteria 
The exclusion criteria were: (1) studies comparing effectiveness of psychological treatments 
among people with and without HIV/AIDS; (2) studies using psychological treatments and 
pharmacotherapy concurrently; and (3) including depressive disorders with psychotic features; 
(4) papers published other than in English.  
2.3.3. Literature search strategies  
A total of four databases (PubMed, Scopus, Cochrane library and PsychINFO) were searched 
from mid-August to the beginning of September 2018. We did not set any date restrictions on our 
search. PubMed and Scopus were searched on 16 th and 28th August 2018 respectively. Both 
Cochrane library and PsychINFO were searched on 5 th September 2018 using the selected 
search terms. Studies published in PubMed and Scopus before 16th and 28th August 2018 
respectively were retrieved. Furthermore, studies published in the Cochrane library and 
PsychINFO before 5th September 2018 were retrieved. The key terms used for searching articles 
were (1) psychological interventions (2) depression and (3) HIV/AIDS. The “all field” and “MeSH 
term” searches were used for all key terms in PubMed. Psychological interventions were searched 
using search terms such as – “psychological intervention” OR “psychological treatment” OR 
“psychosocial intervention” OR “psychoeducation” OR “counselling” OR “psychotherapy” OR 
“group psychotherapy” OR “cognitive therapy” OR “cognitive behavioural therapy” OR 
“interpersonal therapy” OR “problem-solving therapy” OR “psychodynamic therapy” OR 
“psychodrama” along with the MeSH terms. The key term “depression” was searched using the 
term “depression” and its synonyms such as – “depressive symptoms” OR “depressive disorders” 
OR “depressed mood” OR “major depressive disorder” OR “affective disorder”. Many MeSH terms 
for depression were included to broaden the search result, such as “depression”, “depressive 
disorder”, “depression, postpartum”, “depressive disorder, major”, “dysthymic disorder”. The key 
term “HIV/AIDS” was searched using “HIV” OR “AIDS” OR “HIV/AIDS” OR “human 
immunodeficiency virus” OR “acquired immunodeficiency syndrome” using the ‘all’ field and 
MeSH terms. The settings were searched from PubMed and PsychINFO using the detailed list of 
LMICs from the World Bank report 2018 at this link http://data.worldbank.org/about/country-and-
lending-groups. In the Scopus search, we managed to exclude the list of high-income countries 
to narrow the setting specific to LMICs. However, in the Cochrane library search all trial studies 
around the world were included. We linked the key terms using the Boolean operator “AND” such 
as: ((“psychological intervention” OR “psychosocial intervention” OR “psychoeducation” OR 
“psychotherapy”) AND (“depression” OR “depressive disorder” OR “depressive symptoms” OR 
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“Affective disorders”) AND (“HIV” OR “HIV/AIDS” OR “human immunodeficiency virus” OR “AIDS” 
OR “acquired immunodeficiency syndrome”) AND (world bank list of countries in LMICs)). The full 
search strategy can be accessed from the PROSPERO at this link 
https://www.crd.york.ac.uk/PROSPERO/#recordDetails. In addition, the references of published 
papers were searched manually.  
2.3.4. Study selection 
Studies identified were screened by topic and exported to the EndNote X9 software. Duplicate 
studies were removed from the EndNote X9 and the remaining studies underwent abstract 
screening. The studies which fulfilled at least four of the five inclusion criteria were selected from 
the abstract reading. The full articles of the selected studies were searched by BA. BA and MS 
assessed the full articles using the inclusion criteria. When there was a discrepancy between BA 
and MS a third reviewer (CL) was consulted and a decision reached by consensus.   
2.3.4. Data extraction and management  
The data extraction was conducted by the first author, in consultation with other authors. Data 
were extracted from the studies which fulfilled all the inclusion criteria using the Cochrane 
collaboration data collection form for RCTs. The extracted data included publication year, country, 
setting, sample size, type and format of intervention, result, and key conclusions. All relevant data 
in each study were extracted from the data extraction form for the systematic review and meta-
analysis. The characteristics and results of each study were summarised and presented in tables 
and figures.      
2.3.5. Assessment of risk of bias in individual studies  
Authors evaluated each study independently using the Cochrane collaboration risk of bias tool 
(135). The tool has seven evaluation criteria: random sequence generation, allocation 
concealment, blinding of participants, blinding of outcome assessment, incomplete outcome data, 
selective reporting, and other biases. For each of these criteria a study was rated with a low risk 
of bias or high risk of bias. For example, ‘Random sequence generation’ was judged as being low 
risk of bias if the study used a clearly stated random sequence generation method such as the 
use of random number table, using a computer number generation, coin tossing, throwing dice or 
use of envelops/cards. ‘Random sequence generation’ was judged as ‘high risk’ of bias if the 
study used a non-random method for sequence generation process, such as using date of birth, 
using day/date of admission, or medical record number. A study was rated ‘good quality’ when all 
the seven criteria were judged as low risk of bias, ‘fair quality’ when one of the seven criteria were 
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judged as high risk of bias, or ‘poor quality’ when two or more criteria were rated as high risk of 
bias.  
Two of the authors (BA and MS) evaluated each paper using the Cochrane risk of bias tool 
independently. Then BA, MS and CL met together to assess whether interrater disagreement 
occurred. The results of the evaluation were presented, and a final decision made by the 
reviewers (BA, MS and CL) on which studies to include for meta-analysis. Studies were selected 
for meta-analysis if they had complete data for the analysis and if they have low risk of bias on at 
least two criteria of the Cochrane risk of bias tool.  
2.3.6. Analysis of treatment effect 
The aim of this review was to identify effective psychological treatments and to examine the extent 
of their effectiveness in reducing depressive symptoms for PLWHA. We conducted a meta-
analysis to quantify pooled effect sizes and heterogeneity of studies. Data collected from each 
study were entered into the Cochrane collaboration Review manager (RevMan-5) for meta-
analysis. Effect size (standardised mean difference) was calculated by taking score differences 
between the intervention and the control groups after treatment. The after-treatment score 
difference was taken with the assumption that there was no significant difference in depressive 
symptoms between the intervention and control arms at baseline since the included studies were 
RCTs. Individual and cumulative effect size (standard mean difference (smd)), heterogeneity 
status (I2) (136, 137), and forest plots were generated using random effect analysis. Random 
effect analysis was used because we expected considerable heterogeneity across studies (136). 
The analysis of the effect size of continuous and dichotomous outcomes of depressive symptoms 
was done separately. Sub-group analysis of the effect size was calculated by (1) types of 
psychological treatment (CBT, IPT, peer-support psychoeducation/counselling and other 
interventions); (2) format of delivery of the treatment (group-based and individual-based); (3) 
training level of therapists (psychologist-delivered and non-psychologist-delivered); and (4) by 
follow-up evaluation status (post-intervention/immediately after treatment and after 6 months 
follow-up). Publication bias was assessed using a funnel plot. The funnel plot was interpreted 
through visual inspection of the distribution of plots (studies) around the funnel. The Egger’s test 
of intercept was conducted to identify sources of asymmetry in the funnel plot.   
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2.4. Results 
2.4.1. Characteristics of the included studies  
Of 1696 screened articles, 179 duplicates were removed. After removal of duplicates, 1107 
articles were excluded because they did not fulfil at least one of the inclusion criteria – i.e. studies 
from high-income countries, studies among non-HIV population, and other mental health 
outcomes. Full text review of 410 articles was conducted to check whether they fulfilled at least 4 
of the 5 inclusion criteria. Afterwards, 64 studies were screened further using all the inclusion 
criteria. This resulted in 45 articles being excluded from the qualitative review due to the following 
reasons: 12 studies were not intervention studies and included cohort and case-control studies, 
10 studies were done in mixed populations which included HIV-positive and HIV-negative 
participants, six studies were done among children or adolescents, four were RCT protocols, three 
were quasi-experimental, three were qualitative studies, three were non-psychological 
interventions (an aerobic exercise, laughter therapy, and palliative care), two were expert 





Figure 3. PRISMA flow diagram. 
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Finally, 19 studies were included for the qualitative review and 14 (74%) were selected for the 
meta-analysis. Five studies were excluded from the meta-analysis due to poor quality (high risk 
of bias in two or more domains, three studies) and incomplete reports of results for meta- analysis 
(two studies). The following studies were excluded for poor quality (1) Jalali (2018) was excluded 
for not meeting blinding of participants and personnel, blinding of outcome assessment, and other 
bias criteria; (2) Olley (2006) was excluded for not fulfilling random sequence generation, blinding 
of participants and personnel, and blinding of outcome assessment; (3) Tshabalala (2011) was 
excluded for not meeting blinding of participants and personnel and other bias criteria. See Table 
4. As shown in Table 2, more than half of the included studies were conducted in sub-Sahara 
African countries (n=10, 53%). Five studies (26%) were conducted in South Africa and the 
remaining African studies were done in Kenya, Nigeria, Tanzania, Uganda and Zimbabwe. The 
remaining studies (n=9, 47%) were conducted in Asia (three in China, two in India, two in Thailand 
and two in Iran). Of the 19 included studies, 16 (84%) were conducted since 2010 (two studies in 
2010, one study in 2011, three studies in 2012, two studies in 2013, four studies in 2014, two 
studies in 2015 and two studies in 2018). The cumulative number of participants for all included 
studies was 3255 participants (Intervention=1576, control=1676). Six (32%) studies included only 
female participants and two (11%) studies included men only. More than three quarters of the 
participants were female (n=2714, 83%). The smallest and the largest study sample sizes were 
16 and 1200 respectively.  
2.4.2. Outcome measurement  
Of the 19 included studies, 13 studies (69%) assessed depressive symptoms using validated 
tools and one (5%) study used a locally developed instrument. The remaining five (26%) studies 
did not provide information on the validation status of the tool they used. The most used 
instrument to assess depressive symptoms was the Beck Depressive Inventory (BDI-II) – used 
by six (32%) studies – followed by the Centre for Epidemiological Studies Depression scale (CES-
D) which was used by five (26%) studies. Fifteen studies (79%) assessed depressive symptoms 
as a continuous outcome measure, and the remaining used dichotomous outcome measures. Out 
of the 19 included studies in the systematic review, 17 (89%) reported depressive symptom 
scores both at baseline and after treatment. However, two studies reported incomplete 
quantitative results after treatment. In addition, 10 (53%) studies reported depressive symptoms 
scores at 6 months after treatment was completed). See Tables 2 and 3.  
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6 weekly 
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PST is feasible and 
acceptable. RCT studies 
with powered sample 
are needed to show 
efficacy.  






16 0 (0%) 38.2  Group CBT – 7 
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for HIV infected men  
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can be cost-effective 
and accessible to large 
number of people at a 
time.  
4. Futterman 
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information 
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CBT was successful in 
reducing depression 
scores and establishing 
social support. 
Mothers were capable 
to deliver the 
intervention 
successfully.     
5. Jalali et al – 
2018, Iran 
(142)  
RCT, prison  42 0 (0%) 31.8  Group CBT – 11 
weekly sessions 
for 90 min each 







CBT helps to reduce 
depression in prisoner 
PLWHA. Loss to follow-
up was high. 
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in reducing depression.  
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session duration 
not reported.  
depressive and suicide 
symptoms in PLWHA 
9. Molassiotis 
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CBT could have short-
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44.7  Group Support 
Psychotherapy @ 
– 8 weekly 
sessions for 2 to 









at 6 months  
Mental health 
workers with a 
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There was significant 
reduction of symptoms 
at the follow-up 
assessment. GSP is 
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31.2  Individual 
Behavioural 
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who finished at 
least high school  
There was substantial 
degree of reduction in 
depressive symptoms 
in the intervention 
group while it 
increased in the control 
group. 







28.6  Individual 
Psycho-
education – 4 
weekly sessions 
for 1 hour each 
Enhanced 
care  
BDI Validated in 
Nigeria 
Baseline, at 
8 weeks  
Unclear  The result showed 
encouraging efficacy of 
psychoeducation 




13. Peltzer et 




Hospital   
152  99 
(65%) 
36.9  Group CBT – 3 
monthly sessions 
for 1 hour each  
Standard 
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found. Lay health 
workers may deliver 
interventions only if 
they get advanced skill 
trainings.  
14. Petersen 
et al – 2014, 
South Africa 
(150) 
Pilot RCT – 





Group IPT – 8 
weekly sessions, 
session duration 
not reported.   
Standard 
care 
PHQ-9  Validated in 
South Africa  
Baseline, at 
3 months 
Lay counsellors  Group IPT for 
depression for PLWHA 
can potentially be 
















Therapists Key result  
lay HIV counsellors. 
Larger trial is needed. 
15. Richter et 
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weekly sessions, 
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not reported.    
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GHQ Validated in 






training for 2 
months) 
Attrition rate was very 




maternal and child 
outcomes.   







26.6 Telephone call 
counselling – for 
2 months, 1 to 3 
times a week, 
each call lasted 
15-30 minutes.  
Standard 
care  
CES-D  Validated in 
Thailand  
Baseline, at 
1 month, 2 
months   
Registered nurses  Depressive symptoms 
decreased over time in 
the intervention group. 
Telephone support 
could be an option but 
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SCL-90R  Validated in 
Iran   
Baseline, at 
3, 6, 9 and 







observed but it didn’t 
sustain after 6 months. 
The intervention could 
have potential to 
alleviate symptoms.  
18. Tshabalala 
– 2011, South 
Africa (154) 
Pilot RCT, 









reported.   





Unclear  Depression score 
decreased significantly 
in the experimental 
group. Similarly, 
positive coping 
increased after the 
therapy.  
19. Williams et 
al – 2014, 
China (155) 
RCT – 
Hospital   
110  32 
(29%) 
37.5  Individual 
Psycho-
education – 9 






CES-D Validated in 
China   
Baseline, at 
6 and 12 
months   
Nurses and peer 
educators  
Home visit or off-site 
visits are time 
consuming and difficult 
to arrange. Future 
studies should address 
both depression and 
adherence.  
Group Support Psychotherapy @ is developed from three theories: cognitive behaviour theory, social learning theory and the sustainable livelihood framework. “No information” 
regarding whether the instrument is validated in the local context or not. Acronyms: BDI-I or BDI-II (Beck Depression Inventory – I/II), CES-D (Centre for Epidemiological Studies – 
Depression Scale), DSST (Depressive Symptomatology Screening Test), GHQ (General Health Questionnaire), HSCL-25 (Hopkins Symptom Checklist - 25), M2M (Mother to Mother), 
PHQ-9 (Patient Health Questionnaire - 9), POMS - depression module (Profile Of Mood State – depression module), RCT (Randomised Controlled Trial), (SA= South Africa), SCL-90R 
(Symptom Checklist – 90 Revised), SRQ-20 (Self Report Questionnaire - 20), SSQ-14 (Shona Symptoms Questionnaire) 
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Table 3. Outcomes of the studies included in the meta-analysis (n=14). 
Author, Year, Country Tool Intervention Control Effect size by SMD or RR   
N (dropout) Baseline 
(mean, SD)  
Follow-up (mean, 
SD)   
N (dropout) Baseline 
(Mean, SD) 
Follow-up 




95% CI  












-0.71 -1.43, 0.01 
Chan et al – 2005, 
China (139) 
CES-D*  6 (no 
dropout) 
16.67 (6.59) 9.17 (5.31) 7 (no 
dropout) 
13.57 (9.50) 13.71 (9.88) 
 
-0.51 -1.64, 0.60 
Futterman et al – 












0.13 -0.34, 0.60 
Kaaya et al – 2013, 
Tanzania (143) 
HSCL-25# 
Cut-off for depression 
was 1.06   
97 (no 
dropout) 
70 (71.0%) 58 (60.0%) 91 (no 
dropout) 
68 (75.0%) 66 (73.0%) 0.82 0.67, 1.01 
Mathiga et al – 2015, 
Kenya (145) 
BDI-II* 152 (1) 15.0 (11.0) 5.4 (7.1)  153 (3) 17.3 (11.1) 24.2 (8.2) -2.44 -2.74, -2.15 
Molassiotis et al – 




CBT 10 (not 
reported) 
15.1 (6.2) 3 mo = 14.0 (6.9) 
6 mo = 14.1 (5.1) 
26 (not 
reported) 
17.7(12.1) 3 mo = 19.6 
(10.5) 






PSC 10 (not 
reported) 
20.6 (14.1) 3 mo = 29.3 (4.9) 
6 mo = 20.9 (11.9) 
3 mo = 19.6 
(10.5) 







al – 2015, Uganda 
(147) 
SRQ-20* 57 (7) 15.39 (3.40)  Post-treatment = 




52 (3) 15.57 (3.28)  Post GHE = 5.67 
(0.48)  
 










Nyamathi et al – 2012, 
India (148) 





Mean difference = -16.85 (9.6) 34 (no 
dropout) 
 
Mean difference = 10.56 (12.7) -2.41 -3.04, -1.77 
Peltzer et al – 2012, 
South Africa (95) 
BDI-II* 76 (3) 26.8(22.2) Post-treatment = 
21.5(21.3)  
76 (1) 25.5 (23.0)  Post-usual care 





Petersen et al – 2014, 
South Africa (150) 
PHQ-9* 17 (3) 15.47 (4.46) 6.94 (4.14)  17 (1) 15.18 (5.46) 11.06 (4.58) 
 
-0.92 -1.63, -0.21 
Richter et al – 2014, 
South Africa (151) 
GHQ# 
Cut-off for depression 
was 7   
544 (167) 80 (14.7%)  20 (5.3%)  656 (190) 89 (13.6%) 57 (12.2%)  
 
0.42 0.26, 0.70 
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Author, Year, Country Tool Intervention Control Effect size by SMD or RR   
N (dropout) Baseline 
(mean, SD)  
Follow-up (mean, 
SD)   
N (dropout) Baseline 
(Mean, SD) 
Follow-up 




95% CI  
Ross et al – 2013, 
Thailand (152) 
CES-D* 20 (not 
reported) 
25.3 (11.63) 2 mo after 








-0.24 -0.86, 0.38  
Seyed Alinaghi et al – 
2012, Iran (153) 




109.3 (64.8) Post-treatment = 
97.5 (60.7)  
At 6 mo = 106.3 
(61.8) 




109.2 (59.2)  Post-treatment 
= 109.4 (59.1) 








Williams et al – 2014, 
China (155) 
CES-D# 
Cut-off for depression 
was 16 
55 (3) 32 (58%)  At 6 mo = 28 
(51%) 
 
55 (13) 42 (76%)  At 6 mo = 37 
(67%) 
 
0.76  0.55, 1.04  
KEYs: continuous outcome measure (*), categorical outcome measure (#), Negative Standard Mean Difference (SMD) favours experiment group, but exception with Risk Ratio (RR). Acronyms: BDI-I or 
BDI-II (Beck Depression Inventory – I/II), CES-D (Centre for Epidemiological Studies – Depression Scale), GHE (Group HIV Education), GHQ (General Health Questionnaire), HSCL-25 (Hopkins Symptom 
Checklist - 25), mo (month), PHQ-9 (Patient Health Questionnaire - 9), POMS - depression module (Profile Of Mood State – depression module), RR (Risk Retio), SCL-90R (Symptom Checklist – 90 












Table 4. Studies excluded from the meta-analysis (n=5). 
Author, Year, Country  Tool  Intervention Control Reason for exclusion 
in the meta-analysis  N (dropout) Baseline 
(mean, SD)  
Follow-up (mean, 
SD)   
N (dropout) Baseline (Mean, 
SD) 
Follow-up 
(Mean, SD)   
Cook et al – 2014, 
India (140) 
BDI-II#  
Cut-off for depressed 
was 14  
34 (3) 9 (26%) Incomplete report  46 (4) 11 (24%) Incomplete 
report  
 
Incomplete report  
Jalali et al – 2018, Iran 
(142) 
BDI-II* 21 (not 
reported) 
25.04 (7.22) 12.14 (6.52) 21 (not 
reported) 
18.14 (9.32) 19.57 (8.36)  Poor quality  
Li Li et al – 2010, 
Thailand (144) 




12.2 (8.3)  Incomplete report  247 (not 
reported) 
12.4 (8.0)  Incomplete 
report   
Incomplete report  
Olley – 2006, Nigeria 
(149) 
BDI* 34 (2) 19.0 (6.4) Post-treatment = 
18.1 (1.2) 
Follow-up = 5.7 (1.5) 
33 (3) 17.0 (2.4) Post-usual care 
= 18.1 (3.7) 
Follow-up = 
14.2 (2.5) 
Poor quality  
Tshabalala – 2011, 
South Africa (154) 
BDI-II* 10 (not 
reported) 
28.1 (12.7) -19.2 (9.8) 10 (not 
reported) 
24.3 (6.2) -0.6 (5.9) Poor quality  
KEYs: continuous outcome measure (*), categorical outcome measure (#), Negative Standard Mean Difference (SMD) favours experiment group, but exception with Risk Ratio (RR). Acronyms: BDI-I or 
BDI-II (Beck Depression Inventory – I/II), CES-D (Centre for Epidemiological Studies – Depression Scale), GHE (Group HIV Education), GHQ (General Health Questionnaire), HSCL-25 (Hopkins Symptom 
Checklist - 25), mo (month), PHQ-9 (Patient Health Questionnaire - 9), POMS - depression module (Profile Of Mood State – depression module), RR (Risk Retio), SCL-90R (Symptom Checklist – 90 







2.4.3. Intervention characteristics 
The type of psychological treatments used were as follows: eight (42%) studies used CBT, five 
(26%) studies used psycho-education/counselling, two (11%) studies used IPT, two (11%) studies 
used PST. Of the total studies included for the systematic review, 12 (63%) used group 
psychological treatment (group-based) approaches. In terms of therapists, seven (37%) used 
trained non-specialists (lay counsellors) to deliver treatments. After excluding the study using a 
phone call counselling (phone call was made any time as needed), mean, median and mode of 
number of sessions was eight for all, ranging from four to 16 sessions. Six studies (32%) carried 
out their intervention for eight weekly sessions. Half (50%) of the studies reported duration of 
sessions for each intervention. The shortest session was 30 minutes and the longest was 180 
minutes. The mean duration of sessions was 86 minutes, and the mode and the median were 60 
minutes. See Table 2. 
2.4.4. Quality of included studies  
Of the 19 studies included in this review and meta-analysis, 16 (84%) had at least one unclear 
domain with respect to the Cochrane collaboration risk of bias checklist and 10 (53%) studies had 
at least one domain with a high risk of bias. Three studies were of very poor quality and two 










2.4.5. Meta-analysis and effect size 
Of the 14 (74%) studies included in the meta-analysis, 11 (79%) reported mean depressive 
symptoms scores along with the standard deviation, and three (21%) reported the proportion of 
participants who scored above and below the cut-off point. To manage this, a sub-group analysis 
was done for continuous and dichotomous outcomes independently. Pooled effect size of trials 
that used continuous outcomes was -0.61 (n=12; CI: -1.24, 0.02; I2=95%) at the post-treatment 
assessment (soon after the end of the treatment). The effect sizes at six months follow-up was 
analysed to determine whether treatment effects are sustainable. Figure 5 presents effect sizes 
of studies at the six months follow-up assessment and their pooled effect size was -1.41 (n=8; 
95%CI: -2.54, -0.28; I2 = 98%). See figures 5, 6, 7. 
The effect sizes in the meta-analysis ranged from none to large. The effect size at the post-
treatment was large (smd0.5) in eight (60%) studies. The largest effect size at the post-treatment 
assessment was found for a trial evaluating group IPT (smd = -2.44; 95% CI: -2.74, -2.15), and 
from a trial that evaluating locally developed peer-support counselling (smd = -2.41; 95%CI: -3.04, 
-1.77). See figure 8. 
 
Figure 5. Forest plot of effect sizes for continuous outcome measures at the post-intervention 
(n=12). 
















Figure 7. Forest plot of effect sizes for continuous outcome measures at six months follow-up 
(n=8). 
Molassiotis 2002 CBT and Molassiotis 2002 PSC are from the same study that compared CBT and PSC with the same control 
group.  
The pooled effect sizes by treatment type are presented in Figure 8. The pooled effect size of 
CBT trials was small (n=4; smd = -0.03; 95%CI: -0.27, 0.21). However, the pooled effect size of 
IPT trials was larger (smd= -1.72; n=2; 95%CI: -3.21, -0.23; I2=93%) than CBT trials. Furthermore, 
the pooled effect of trials that used peer-support counselling was -1.14 (n=2; 95%CI: -3.63, 1.35; 
I2 = 96%). 
A sub-group analysis by format of treatment delivery was conducted. The pooled effect size of 
group-based trials was -1.04 (n=9; 95%CI: -2.02, -0.05; I2 = 97%). Similarly, the pooled effect size 
of individual-based trials was -1.12 (n=3; 95%CI: -2.46, 0.22; I2 = 92%). The forest plot of pooled 
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effect sizes by format of delivery is presented in Figure 9.  Figure 10 presents a forest plot of 




Figure 8. Forest plot of effect sizes by type of psychological treatment for continuous outcome 
measures (n=12). 






















Figure 9. Forest plot of effect sizes by format of delivery for continuous outcome measures 
(n=12). 
 
Molassiotis 2002 CBT and Molassiotis 2002 PSC are from the same study that compared CBT and PSC with the same control 
group.  
 
Figure 10. Forest plot of effect sizes by level of qualification of counsellors (n=11). 
Molassiotis 2002 CBT and Molassiotis 2002 PSC are from the same study that compared CBT and PSC with the same control 
group.  
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A sub-group analysis was conducted by region where studies were conducted. Studies from 
Africa showed a larger pooled effect size (smd = -1.51; n=6, 95%CI: -2.90, -0.13; I2 = 98%) than 
studies from Asia (smd = -0.60, n=6, 95%CI: -1.36, 0.17; I2 = 89%). Another sub-group analysis 
by duration of treatment was conducted using eight sessions as the cut-off point since the mean 
number of sessions was eight. The studies that used eight sessions or less showed -1.12 (n=9; 
95%CI: -2.00, -0.25; I2 = 96%) pooled effect size. The pooled effect size of the group of studies 
that used nine or more sessions was -0.70 (n=3; 95%CI: -2.84, 1.44; I2=97%). See figures 11 and 
12.  
 
Figure 11. Forest Plot of effect sizes by region. 
 
Figure 12. Forest plot of effect sizes by number of sessions. 
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A funnel plot in Figure 13 shows that large studies are evenly scattered in- and outside the 
inverted funnel. It shows that there is relative closeness in study sizes, but the effect estimate 
varies across the studies. The funnel plot is asymmetric because most studies lay on the upper 
right side of the diagram. It suggests that few large and highly significant studies were missed on 
the upper left side of the diagram. The Egger’s test was conducted to look at the source of the 
asymmetry. The Egger test presents p=0.71 (n=12; coef. = 0.96; 95%CI: -4.10, 6.02) which 
indicates no publication bias.    
 
Figure 13. Funnel plot of effect sizes for continuous outcome measures at post-treatment. 
2.5. Discussion 
This systematic review and meta-analysis showed that a variety of psychological treatment trials 
have been conducted in LMICs. These trials are diverse and took place across a range of African 
and Asian countries. One third of these trials evaluated CBT either in a group or individual format 
and the remaining used Peer-support counselling, IPT, PST and Group Support Psychotherapy 
(GSP). All the included studies reported reduction in depressive symptoms from the baseline even 
though the reduction is not significant in some trials when compared to the control group. While 
acknowledging their limitations, most studies encouraged the use of psychological treatments for 
depressive symptoms in HIV populations and they suggested further studies be conducted.  
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Results from our review are consistent with other findings from LMICs (133). Several studies from 
Africa support the effectiveness and acceptability of group-based IPT, PST and peer-support 
counselling for treatment of depressive symptoms in HIV-affected communities (90, 96, 156-158). 
A pilot trial from rural South Africa reduced depressive symptoms over 12 sessions of group IPT 
using trained community health workers (96). In Uganda researchers were able to show high 
acceptability of group IPT with high reduction of depressive symptoms (90, 92). Similarly, in 
Zimbabwe clinically significant reduction of depressive symptoms was achieved over six sessions 
of group PST delivered by peer counsellors (156). Locally adapted or developed psychological 
treatments are becoming appropriate, acceptable and effective in African cultures (141, 151). For 
instance, the Friendship Bench programme using PST in Zimbabwe (159) and culture-sensitive 
GSP developed in Uganda (147, 159) have become an acceptable and effective treatment 
approach for common mental disorders provided by peer-counsellors. 
Even though the effect size across the studies varies from very low to high, the effect size at the 
six months follow-up increased significantly compared to the one at the post-treatment 
assessment (immediately after intervention). However, two studies reported a 12 months follow-
up result which showed that the depressive symptoms returned to the baseline level indicating 
that the effect of the intervention failed to be sustained for 12 months (153, 155).  
Group-based psychological treatment trials were effective in reducing depressive symptoms 
except for two group-based CBT trials (95, 141). A trial from Uganda which used GSP (147) and 
a trial from South Africa which used group IPT (150) had higher effect sizes compared to other 
trials using group CBT. These findings are supported by another meta-analysis and two further 
trials. The meta-analysis by van der Heijden et al (2017a) of group psychological treatments found 
a small effect size for group CBT. Two trials from non-HIV/AIDS populations found high effect 
sizes in reducing depressive symptoms from group-based IPT and PST therapies (90, 156). It is 
difficult to compare individual-based and group-based therapies in terms of acceptability as most 
trials, especially individual-based interventions, did not report findings (such as drop outs) related 
to it. In terms of pooled effect size, there was no statistical difference between group-based and 
individual-based treatments. On the surface this may indicate that neither approach is more 
effective than the other. However, it is crucial to take into consideration issues of confidentiality, 
cost and acceptability when considering the format of delivery. Furthermore, the small number of 
studies and the high level of heterogeneity indicate the need for further research in this area, 
testing and comparing treatment formats and types.      
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In this meta-analysis, there was no significant difference in effect size between the use of 
psychologists and non-psychologists (lay counsellors). Emerging task shifting studies from LMICs 
have produced evidence that encourages the use of trained and supervised lay counsellors to fill 
the human resource gap in low-income settings (158, 160-162). A study from five LMICs (Ethiopia, 
India, Nepal, South Africa and Uganda) indicated that a task-sharing approach in delivering 
different interventions was feasible and it was acceptable to service providers (163). A task 
shifting study from Brazil (164) examined the capability of community health workers to deliver 
IPT in primary health care settings. This pragmatic trial found that community health workers 
delivered the intervention successfully. Evidence from these studies showed that trained lay 
counsellors who have at least high school education can deliver psychological treatments 
effectively under supervision. Contrarily, most CBT trials (five of the seven CBT trials reviewed) 
used psychologists as therapist and the number of sessions used range from four to 13 which 
could be a costly treatment for LMICs. Although most CBT trials used qualified therapists, they 
showed a lower pooled effect size. This low effect size could be related to factors other than the 
effectiveness of CBT per se. For example, factors such as the therapist’s qualification, cultural 
acceptability of the intervention and whether the therapists culturally competent may influence the 
outcomes. These would need to be investigated further before coming to any conclusion.  
A sub-group analysis by type of psychological treatment shows larger effect sizes using IPT and 
PST, and smaller or no effect sizes for CBT. However, there was high heterogeneity both among 
and between types of psychological treatment, limiting the conclusions that can be drawn from 
these comparisons. This study did not look for effect modification by type of psychological 
intervention and there were only 2 IPT trials, so the apparent differences may not be statistically 
significant. Although heterogeneity was high, large effect sizes were observed at the post-
treatment assessment (immediately after the intervention) for the trials using peer-support 
counselling, IPT and PST. Statistical testing the differences between intervention types with one 
treatment type as a reference category may be inappropriate to compare treatment types and 
withdrawn any inference that specific treatment types are necessarily more effective than the 
others. However, there are other well documented studies that support the efficacy of these 
psychological treatments with the HIV/AIDS population (132, 165-167). In one study the effect 
size returned to its baseline state at the 12th month evaluation (153) – which may indicate that 
continuous support is needed after completion of psychological treatments to sustain the 
reduction of depressive symptoms beyond 12 months.   
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CBT trials with a high number of sessions that were delivered by non-psychologists were less 
effective (142, 144, 146) than IPT trials (145, 150). Furthermore, loss to follow-up was high in 
psychological treatments requiring a high number of sessions (142). CBT delivered by lay health 
workers may not be effective as it requires advanced skill training (95). This indicates the need 
for psychological treatments that are effective with a few numbers of sessions and can be 
delivered by trained lay counsellors.  
The findings presented on the funnel plot suggest that large and statistically significant studies 
are missing in the evidence base. It is implausible that large and highly significant studies remain 
unpublished. Thus, publication bias is unlikely to be the source of asymmetry for the funnel plot. 
This is in agreement with the result of the Egger’s test that indicates no publication bias. 
Therefore, the asymmetry and effect variation across studies in this funnel plot could be due to 
methodological heterogeneity (rather than publication bias) such as difference in type of 
treatments, in number of sessions, and difference in treatment of control groups, with some 
studies using enhanced usual care while others using only usual care. These reasons for 
asymmetry of the funnel plot could also indicate the high levels of heterogeneity for each sub-
group meta-analysis. 
Overall, based on this systematic review and meta-analysis result, the use of GSP, IPT, PST and 
peer-support counselling seem to be the most effective in reducing depressive symptoms in 
PLWHA in LMICs.  
Limitations  
This systematic review and meta-analysis relied on the results obtained from studies ranging from 
low to high risk of bias. The exclusion of the five studies from the meta-analysis is a limitation 
although they were of poor quality and including them would have compromised the quality of the 
analysis. Not having an independent person to screen abstracts may have resulted in missed 
identification of important articles, therefore it should be considered as one of the limitations of 
this study. False negative and false positive significant tests increase in likelihood rapidly as more 
sub-group analyses are performed. Therefore, we understand that the sub-group analysis with 
less than four studies per category may be under-powered to detect differences. Our approach to 
this sub-group meta-analysis was to apply a set of a priori criteria namely type of intervention, 
treatment approach/format of delivery, and therapist type. In some of the sub-groups so defined 
the number of studies is less than four but this does not apply to all sub-groups within each sub-
group meta-analysis. Therefore, results from the sub-group analysis should be interpreted with 
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caution as differences within different types of psychological treatment, may be as big as 
differences between types of psychological treatments. Variation in the instruments used and 
difference in cut-off points (the use of general population cut-off for HIV populations) across 
studies is another limitation of this meta-analysis. Furthermore, there was heterogeneity across 
the studies and the meta-analysis results should be interpreted with caution. In this study trials 
published in languages other than English were excluded.         
2.6. Conclusion  
This systematic review and meta-analysis found that psychological treatments are effective in 
reducing depressive symptoms for PLWHA in LMICs. The meta-analysis results indicated that 
GSP, IPT, PST, peer-support counselling seem effective in reducing depressive symptoms. 
Furthermore, both group- and individual-based psychological treatments displayed similar 
effectiveness in reducing depressive symptoms. Although CBT was a commonly used 
psychological treatment, it showed modest effectiveness in reducing depressive symptoms for 
PLWHA in LMICs. Psychological treatments that are simple to deliver by trained lay counsellors, 
and that could bring significant reduction of depressive symptoms with few numbers of sessions 
should be encouraged in LMICs. We recommend that future trials follow the Cochrane risk of bias 
assessment criteria to ensure high quality reporting. We suggest future studies should examine 
a number of mechanisms which may influence the outcomes of psychological treatments for this 
population, including delivery mechanisms, cognitive, affective and behavioural mechanisms of 
change, and strengthen the local validity of outcome assessment measures. We also recommend 
more studies that evaluate HIV outcomes alongside mental health outcomes and explore the 
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Background: Major depression is believed to affect treatment adherence and overall QoL of 
PLWHA. Comorbid major depression contributes to a two-fold higher risk of mortality among 
PLWHA. Understanding the relationships of major depression, adherence to ART and QoL is 
important to identify areas for intervention. The aim of this study is to examine relationship of MDD 
and adherence to ART with QoL, and to investigate socio-demographic and clinical factors 
associated with MDD, adherence and QoL among PLWHA in Northwest Ethiopia.  
Method: A cross-sectional study was conducted in the ART clinic of Felege-Hiwot Referral 
Hospital in Northwest Ethiopia from July to October 2019. Adult PLWHA were selected using a 
systematic random sampling technique. Data were collected using interview administered 
questionnaires and chart reviews. Mini International Neuropsychiatric Interview (MINI) and World 
Health Organization Quality of Life – HIV (WHOQOL-HIV) Ethiopian version instruments were 
used to measure MDD and QoL respectively. Adherence to ART was assessed using pill count 
data from patients’ adherence monitoring chart. Univariate and multivariate Poisson regressions 
were used to assess associations of socio-demographic and clinical factors with MDD and 
adherence to ART. A multivariate linear regression was used to examine the associations of both 
MDD and adherence with overall QoL.         
Result: Of the total of 393 invited participants, 391 (99.5%) completed the interviews. MDD was 
negatively associated with overall QoL: participants with MDD had a lower QoL score of 0.06 
points compared to those with no MDD (95%CI = 0.89, 0.99; p < 0.047). MDD was associated 
with reduced adherence to ART when functional disability was controlled for (unadjusted 
RR=1.48; 95%CI=1.14,1.92;0.004), (adjusted RR=1.43; 95%CI:1.05, 1.96; p=0.025). However, 
there was no statistical association between adherence to ART and overall QoL. Functional 
disability was associated with both MDD (RR=5.07; 95%CI:3.27,7.86; p<0.001) and overall QoL 
(β=0.29; 95%CI:0.21,0.36; p<0.001). 
Conclusion: The relationship between MDD and QoL indicates the need for feasible, acceptable 
and evidence-based mental health interventions to reduce depression and improve overall QoL 
of PLWHA. We recommend future studies investigate causal relationships of MDD, adherence to 
ART and QoL of PLWHA to better understand priority areas for intervention.  
Key words: Major depressive disorder; HIV; Adherence to ART; Quality of life; Ethiopia 
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3.2. Introduction  
Comorbid major depression affects the clinical outcomes of HIV/AIDS (78, 168) and contributes 
to a two-fold higher risk of mortality (169). Major depression has been one of the challenges of 
the 90-90-90 Joint United Nations Programme on HIV/AIDS (UNAIDS) (169) that aimed to end 
the epidemic of HIV/AIDS in the world . The SSA countries have been lagging far behind the 
target and comorbid major depression remains one of the challenges that has affected 
engagement with HIV care, leading to early loss to treatment and low viral suppression (169, 170).  
Major depression is the most common mental disorder among PLWHA and is estimated to be two 
to three times higher in PLWHA than in general population (10, 169, 171). However, prevalence 
reports are markedly variable across studies due partially to the use of different measurement 
approaches. A systematic review of studies from SSA found a range of 9% to 32% prevalence of 
probable depression (25). A meta-analysis of studies from East Africa indicated a 38% pooled 
prevalence of probable depression (24). A systematic review of studies from Ethiopia reported a 
37% pooled prevalence of probable depression among PLWHA (18) which was much higher 
compared to the 11% pooled prevalence in the general population (172).  
Major depression is prevalent in PLWHA due to their vulnerability to several factors. These factors 
can be classified as: 1) psychosocial factors such as HIV related stigma, disability and poverty 
(173-175); 2) biological factors, such as structural and functional changes in the brain due to HIV 
infection (alteration in hypothalamic-pituitary-thyroid pathway) (48, 171, 176, 177) and due to 
chronic immune activation (78); and 3) other comorbid conditions, including pre-existing comorbid 
illnesses other than HIV/AIDS which may increase risk of depression (176).   
Major depression is believed to be one of the factors that affects adherence to ART although 
findings are inconclusive (49, 178). While many studies support the strong association, two 
systematic reviews did not find an independent relationship between major depression and 
adherence to ART (179, 180). There are assumptions that cognitive impairment due to major 
depression, such as forgetfulness, poor concentration, impairment in memory, low executive 
functioning and difficulties with learning new behaviour, may contribute to non-adherence to ART 
(181). In addition, affective symptoms of major depression such as loss of interest, poor 
motivation, hopelessness and suicidality have also been reported to affect adherence to ART 
(169, 170).  
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Major depression is also an important determinant of QoL for PLWHA (14, 133, 170). QoL is a 
broad concept that includes several domains of functioning, namely physical, psychological, 
independence, social, environmental and spiritual functioning and can be affected by a variety of 
life circumstances (45, 182, 183). However, the impact of major depression on poorer QoL 
outcomes seems to be high for PLWHA (184).  
Although the pathways are not fully understood, major depression is reported to affect overall QoL 
of PLWHA either directly (47-49, 185) and/or indirectly by affecting adherence to ART (50, 177). 
Studies in HIV populations have indicated that major depression can affect several domains of 
QoL directly. For example, the effect of major depression on psychological and social functioning 
has been reported (186, 187). There are also studies that have shown a strong association 
between major depression and overall QoL, but the direction of association is unclear (184, 188).  
Biological studies support the association of major depression with poor physical health and poor 
immune functioning (177, 189, 190). For example, major depression has been reported to cause 
immunosuppression by altering the function of lymphocytes and decreasing natural killer cells 
(176). The association of major depression with decreased CD4 cells, altered immune response 
and increased release of proinflammatory cytokines has been commonly reported (171, 177). 
This may suggest that major depression can have a direct role in the physical deterioration and 
progress to advanced disease stage of PLWHA by interfering with immune functioning. Therefore, 
aiming to achieve overall improvement in QoL with the use of ART alone may not be successful 
without addressing major depression in PLWHA particularly in SSA (177, 191).    
In Ethiopia, several studies have examined prevalence of probable depression using screening 
tools (18). However, diagnosis of major depression is important to develop treatment protocols, 
training manuals and to revise patient teaching guidelines. Furthermore, understanding 
relationships of major depression, adherence and QoL is important to design acceptable, feasible 
and evidence-based interventions for PLWHA. This study was a baseline survey used to identify 
and recruit cases with MDD for a group IPT intervention for PLWHA. This paper presents 1) the 
prevalence and associated factors of MDD; 2) the prevalence and associated factors of 
adherence to ART; 3) the factors associated with QoL; and 4) the associations of MDD and 
adherence to ART with overall QoL among PLWHA in Northwest Ethiopia.  
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3.3. Method  
3.3.1. Setting and participants  
This cross-sectional study was conducted in the ART clinic of FHRH in Northwest Ethiopia from 
8th July to 7th October 2019. FHRH is one of the busiest hospitals in Northwest Ethiopia as 
described elsewhere (109) and serves a population of more than 7 million people. More than 
3,508 PLWHA had received ART treatment at the ART clinic over the 3 months preceding the 
data collection period, 2948 of which were adults 18 years and above. The ART clinic is staffed 
by physicians, health officers, nurses, pharmacists, laboratory technologists, case managers, 
adherence supporters and volunteers. The ART clinic serves more than six thousand clients per 
year. There is a mental health service centre in the hospital which is mainly run by mental health 
professionals. Sample size was calculated using the Select Statistical Services computer 
programme using the following assumptions: i) a population proportion of 37% prevalence of 
depression which was taken from previous meta-analysis study findings done among PLWHA in 
Ethiopia (18); ii) a 5% margin of error at 95% confidence interval. The sample size was estimated 
to be 357. Then we have added a 10% for the non-response rate which provided a total sample 
size of 392.7 (approximated to 393).  
Participants were recruited using a systematic sampling with a random start-point with an interval 
of seven. The first participant was selected randomly using a lottery method from the sample 
frame and the following participants were selected keeping the interval of seven. Patients medical 
cards were used to select every seventh client among those who were waiting for their ART follow-
up at the ART clinic. Inclusion criteria were for participants to be 18 years old and above, have 
had at least one previous appointment at the ART, and be able to provide informed consent. 
Exclusion criteria were being too ill to communicate or with a major physical illness, or emotional 
problems as result of being in a volatile or unstable emotional state or suffering from substance 
induced emotional problems. In addition, those participants who diagnosed with cognitive deficits 
(overt dementia and delirium) by ART clinicians were excluded from the study.   
3.3.2. Procedure  
A research assistant approached every eligible client to explain the purpose of study, to ask for 
their willingness to be included in the study and to clarify the information in the informed consent 
sheet. Research assistants (data collectors) were nurse professionals with a BSc degree in 
nursing, and one with an additional MSc degree in Public Health. All of them had extensive 
experience in participating in research activities and data collection. They received a three-day 
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training on the instruments and ethical procedures by the principal investigator. Participants who 
signed consent forms were interviewed by trained data collectors in a private room in the ART 
clinic. The interviews were conducted in the local language (Amharic) and responses noted on 
paper questionnaires with no names and just a participant ID. The signed consent forms and 
completed questionnaires were kept in a locked file.  
Data were collected using interview administered questionnaires and patient chart reviews. Socio-
demographic, MDD, adherence to ART, QoL, functioning and social support information was 
collected using an interviewer administered questionnaire. HIV related clinical information such 
as CD4 count, duration of ART treatment and ART regimen was collected from the patient charts. 
Field workers, including data collectors and supervisors, were trained for three days on participant 
selection, informed consent administration, data collection techniques and data handling. See the 
questionnaire in Module one of the Appendix D.     
Study participants who fulfilled the criteria for MDD or with suicidal idea were referred to group 
IPT counsellors for further evaluation and intervention. The counsellors evaluated the severity 
and treatment need of each referred study participant and they intervened based on the given 
standard operating procedure. Those study participants with severe mental conditions were 
referred to the psychiatric clinic located next to the ART clinic for advanced care and treatment.      
3.3.3. Measurements 
MDD: The MINI (Mini-International Neuropsychiatric Interview) depression module was used to 
assess MDD (192). The MINI-7.0.2 allows DSM-5 diagnosis and has been widely used as a gold 
standard measure of MDD (192, 193). The MINI has been adapted to the Ethiopian context for 
use by psychiatric nurses to detect MDD (194). The MINI adapted in Ethiopia found irritability as 
an important symptom of depression and “irritability” was included as an item for this study (see 
Appendix D, section 5). The diagnosis of MDD was made after organic causes were ruled out 
using the exclusion items in the MINI.      
QoL: The WHOQOL-HIV Ethiopian version, that was adapted from the World Health Organization 
quality of life module and validated in the local language (Amharic) (195), was used to measure 
QoL in this study. The WHOQOL-HIV Ethiopian version was validated for use in PLWHA in 
Ethiopia and has been used in several studies in HIV populations (45, 184, 188). The validation 
shows that it has an excellent internal consistency with Cronbach alpha of 0.93. The instrument 
included two general items and six domains that give a total of 27 items. Study participants were 
asked to rate their subjective general wellbeing from 1 to 5 where low scores indicate low general 
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wellbeing as perceived by study participants. Mean QoL score was calculated by dividing the sum 
scores of QoL by 27. Mean scores of each domain of QoL (physical, psychological, 
independence, social, environmental and spiritual) were also calculated independently. 
Adherence to ART: We assessed adherence to ART using the pill count data, captured from 
patients’ re-fill chart and used for the purpose of clinical monitoring, together with clinicians’ report 
of skipped doses. Pill count is a valid method used to measure adherence to ART and has been 
used by several studies in resource limited settings (196, 197). Upon examination of the 
frequencies and distribution of our data, we found that the data were skewed towards high 
adherence. Therefore, we narrowly defined high adherence as taking all doses of ART 
medications as prescribed by the clinician since the last appointment and suboptimal adherence 
was defined as skipping one or more doses of the prescribed medications.    
Functional disability: The World Health Organization Disability Assessment Schedule 
(WHODAS-12) was used to measure functional disability. The WHODAS-12 instrument was high 
in acceptability, understandability and relevance to the WHODAS-36 instrument for the Ethiopian 
context (198). Each item of the WHODAS-12 has Likert scale response options (No Difficulty = 0, 
Mild Difficulty = 1, Moderate Difficulty = 2, Severe Difficulty = 3, Extreme Difficulty/‘Cannot Do’ = 
4). The scores of each item were summed and total scores can range from minimum of 0 to 
maximum of 48. In this study, functional disability was defined as a score of 36 or higher (i.e. 
having severe or extreme difficulty). The use of simple scoring method (adding up scores) has 
been a recommended approach by the WHO.        
Perceived social support (PSS): The Multidimensional Scale of Perceived Social Support 
(MSPSS) was used to evaluate perceived social support. The MSPSS has been adapted and 
validated in different settings across the world including in Africa (199-201). The instrument has 
been shown to be reliable and valid for use in African cultures, for instance in Malawi (202) and 
Uganda (203). The instrument evaluates perceived social support adequacy using three 
subscales: family, friends and significant others (200). The MSPSS has 12-items (each subscale 
has 4-items) with 7-point Likert scale response options from 1 (very strongly disagree) to 7 (very 
strongly agree) (200). The value of each item was summed, and mean scores were calculated. 
The mean scores can range from minimum of 1 to maximum of 7. In this study mean scores 
ranging from 1 to 3 indicate low PSS, from 3 to 5 indicate moderate PSS and 5 to 7 indicate high 
PSS (204).      
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3.3.4. Data analysis  
Data were entered into Epidata and analysed using SPSS statistics version 26 computer 
programme. Items of MDD, QoL, adherence to ART, PSS, functional disability and suicidality 
were computed to generate aggregated variables. Descriptive statistical analysis was used to 
summarise outcome variables, socio-demographic and clinical factors. 
Univariate Poisson regression was used to identify association of each socio-demographic and 
clinical factor with MDD, and risk ratios are reported (205). Poisson regression can be used for 
binary data to calculate risk ratios (205). In multivariate Poisson regression, all factors with p-
value <0.2 in the univariate Poisson regression were entered in a multivariate analysis to control 
for confounding factors and generate adjusted risk ratios. Similarly, we used univariate Poisson 
regression to identify the association of socio-demographic and clinical variables with adherence 
to ART, and risk ratios are reported. All factors with p-value of <0.2 in the univariate Poisson 
regression were entered in a multivariate analysis to control for confounding factors and generate 
adjusted risk ratios.       
We used linear regression to identify factors associated with the overall QoL. First, each of the 
socio-demographic and clinical variables were entered in a univariate model. Then, factors 
associated with overall QoL in the univariate analyses at a p-value <0.2 were entered in a 
multivariate linear regression to adjust for confounding factors. These factors were also entered 
in a multivariate linear regression, for each domain of QoL separately, to examine the association 
of socio-demographic and clinical factors with each domain of QoL. Finally, association of MDD 
and adherence to ART with overall QoL was examined using a generalised linear model. All socio-
demographic and clinical factors associated with overall QoL at p-value of <0.05 in the previous 
analysis were adjusted for in the model. An interaction analysis was also used in the model to 
assess interaction of MDD and adherence to ART on overall QoL.              
3.3.5. Ethics Approval and Consent to Participate  
This study was approved by the University of Cape Town’s Human Research Ethics Committee 
(HREC reference No. 653/2018). In addition, an approval letter was obtained from Bahir Dar 
University College of Medicine and Health Sciences’ Ethics Committee (reference No. 007/2018) 
and a permission letter was obtained from the Amhara Public Health Institute (APHI). All study 
participants signed a written informed consent. Illiterate study participants signed by fingerprint 
after a witness read the written informed consent. See the ethical approval letters in the 
Appendices A and B and the consent form Appendix E. 
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3.4. Results 
3.4.1. Socio-demographic and clinical characteristics of study participants 
Of the total of 393 invited participants, 391 (99.5%) completed the interviews. More than two-
thirds (69.3%, n=269) of the study participants were women. The mean age of participants was 
38.7 years old (SD=9.1) ranging from 18 to 78 years old respectively. Three quarters (74.6%, 
n=288) of the study participants were on first line ART treatments.  
Table 5. Socio-demographic and clinical characteristics of the study participants, Felege-Hiwot 
Referral Hospital (FHRH), Northwest Ethiopia (N=391). 
Socio-demographic and clinical characteristics  Frequency Percent 
Age in years  18-29 51 13.2 
30-39 161 41.8 
40-49 119 30.9 
50+ 54 14.0 
Gender Male  119 30.7 
Female  269 69.3 
Marital status  Single  53 13.6 
Married/in relationship  187 47.8 
Divorced/widowed  151 38.6 
Educational status  Illiterate  123 31.5 
Primary education  125 32.0 
Secondary education  93 23.8 
Tertiary education    50 12.8 
Employment  Public servant    84 21.5 
Self employed 182 46.7 
None employed  124 31.8 
Current CD4 count (last 6 
months) 
<200  28 7.6 
200-349 69 18.6 
350-499 95 25.7 
>500 178 48.1 
Antiretroviral therapy regimen  First-line   288 74.6 
Second-line 98 25.4 
Duration of ART treatment in 
years 
1 – 5 72 19.0 
6 – 10 134 35.4 
11 and above  175 45.6 
Major depressive disorder Yes  127 32.5 
No  264 67.5 
ART adherence  High adherence   289 81.9 
Suboptimal adherence  64 18.1 
NOTE: First-line regimen is the use of first choice antiviral drugs and a switch to second-line regimen 
is recommended when there is treatment failure with first-line treatments.  
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3.4.2. Prevalence and associated factors of MDD 
The overall prevalence of MDD was 32.5% (n=127; 95%CI: 28.1,37.3) and it was 46.3% (n=57) 
among illiterate, 44.4% (n=55) among unemployed, 65.4% (n=100) among functionally disabled 
study participants. The prevalence of MDD in each variable is presented in Table 5.  
In the univariate regression (unadjusted analysis), being divorced or widowed, illiterate, 
unemployed, with low PSS, and on second line ART regimen were significantly associated with 
MDD. Results from the multivariate Poisson regression (adjusted analysis) show that only 
functional disability was associated with MDD: those who had functional disability (65.4%, n=100) 
had 5.07 times the risk of MDD compared to those who had no functional disability (11%, n=26) 
(95%CI: 3.27,7.86; p<0.001). See Table 6. 
3.4.3. Prevalence of adherence to ART and associated factors 
Overall, 81.9% of respondents (n=289; 95%CI: 77.9, 85.8) had high adherence to ART (see Table 
5). MDD was associated with reduced adherence to ART when functional disability was controlled 
for: those who had MDD (62.2%, n=74) had 1.43 times the risk of suboptimal adherence to ART 






Table 6. Poisson regression: Prevalence of and factors associated with major depressive disorder among people living with HIV/AIDS in 
Felege-Hiwot Referral Hospital, Northwest Ethiopia (N=391). 
Socio-demographic and clinical factors 
Prevalence of 
MDD, % (n) 
Unadjusted Poisson regression  Adjusted Poisson regression 
Risk ratio  95%CI P value  Risk ratio  95%CI P value 
Age in years a 18-29 31.4 (16)  1.11 0.56, 2.19 0.770     
30-39 33.5 (54) 1.18 0.69, 2.04 0.544     
40-49 33.6 (40) 1.19 0.67, 2.09 0.555     
50+ 29.6 (16) Reference Reference      
Gender Male 25.2 (30) Reference  Reference      
Female 36.1 (97) 1.47 0.97, 2.21 0.067  1.13 0.72, 1.78 0.600 
Marital status Married/in relationship 25.7 (48) Reference Reference   Reference Reference  
Single 37.7 (20) 1.47 0.87, 2.48 0.148  1.13 0.65, 1.96 0.675 
Divorced/widowed 39.1 (59) 1.52 1.04, 2.23 0.031  1.01 0.67, 1.53 0.968 
Educational status Illiterate 46.3 (57) 2.11 1.11, 4.02 0.024  1.04 0.43, 2.50 0.930 
Primary education 28.0 (35) 1.27 0.65, 2.51 0.485  0.90 0.39, 2.10 0.812 
Secondary education 25.8 (24) 1.17 0.58, 2.40 0.661  0.83 0.35, 1.99 0.682 
Tertiary education 22.0 (11) Reference Reference   Reference   
Employment Public employed 17.9 (15) Reference  Reference   Reference   
Self employed 30.8 (56) 1.64 0.94, 2.85 0.083  1.40 0.68, 2.89 0.366 
Unemployed 44.4 (55) 2.36 1.35, 4.11 <0.003  1.75 0.84, 3.63 0.135 
Perceived social 
support 
High support 24.3 (55) Reference Reference   Reference  Reference  
Moderate support 41.9 (54) 1.70 1.17, 2.46 <0.005  1.21 0.82, 1.78 0.337 
Low support  55.6 (15) 2.25 1.28, 3.97 <0.005  1.25 0.67, 2.31 0.481 
ART regimen  First-line 27.8 (80) Reference Reference   Reference Reference  
Second-line 45.9 (45) 1.64 1.14, 2.36  <0.008  1.31 0.90, 1.91 0.157 
Functional disability   No  11.0 (26) Reference Reference   Reference Reference  
Yes 65.4 (100) 5.76 3.77, 8.81 <0.001  5.07 3.27, 7.86  <0.001 
Current CD4 count 
(last 6 months) a 
<200  35.7 (10) 0.98 0.51, 1.91 0.969     
200-349 26.1 (18) 0.72 0.43, 1.21 0.215     
350-499 28.4 (27) 0.78 0.51, 1.22 0.285     
>500 36.5 (65) Reference Reference      
ART treatment 
duration in years a 
1 – 5 29.2 (21) 0.81 0.49, 1.32 0.387     
6 – 10 29.1 (39) 0.80 0.54, 1.19 0.278     
11 and above  36.4 (63) Reference Reference      
NOTE: First-line regimen is the use of first choice antiviral drugs and a switch to second-line regimen is recommended when there is 
treatment failure with first-line treatments. ART: antiretroviral therapy. a variables not included in multivariate Poisson regression; * 






Table 7. Poisson regression: Prevalence of and factors associated with adherence to antiretroviral therapy among people living with 
HIV/AIDS in Felege-Hiwot Referral Hospital, Northwest Ethiopia (N=353). 
Socio-demographic and clinical factors 
Prevalence of high 
adherence, % (n) 
Unadjusted Poisson regression  Adjusted Poisson regression 
Risk ratio  95%CI P value  Risk ratio  95%CI P value 
Age in years a 18-29 79.2 (38) Reference       
30-39 82.4 (122) 1.04 0.73, 1.47 0.845     
40-49 81.1 (86) 1.02 0.71, 1.47 0.920     
50+ 84.4 (38) 1.06 0.69, 1.64  0.792     
Gender a Male 83.3 (90) 1.03 0.80, 1.32 0.840     
Female 81.0 (196) Reference         
Marital status a Single  76.0 (38)  Reference        
Married/ in relationship 85.7 (144) 1.13 0.79, 1.61 0.510     
Divorced/widowed 79.3 (107) 1.04 0.72, 1.51 0.824     
Educational status a  Illiterate 77.9 (88) Reference        
Primary education  79.5 (89) 1.02 0.76, 1.37 0.893     
Secondary education  85.4 (70) 1.09 0.80, 1.50 0.566     
Tertiary education 91.3 (42) 1.17 0.81, 1.69 0.396     
Employment a Public employed 91.9 (68) 1.21 0.88, 1.66 0.245     
Self employed 81.3 (135) 1.07 0.82, 1.40 0.631     
Unemployed 75.9 (85) Reference        
Perceived social 
support  a 
High support 82.8 (164) 1.14 0.74, 1.75 0.552     
Moderate support 82.8 (101) 1.14 0.73, 1.78 0.568     
Low support  69.2 (18) Reference       
ART regimen a First-line    84.4 (217) 1.13 0.86, 1.47 0.383     
Second-line  75.8 (69) Reference        
Functional disability  No  89.6 (189) 1.27 0.99, 1.62 0.052   1.06 0.79, 1.41 0.710 
Yes 70.8 (98) Reference     Reference    
Current CD4 count 
(last 6 months) a 
<200  79.2 (19) Reference        
200-349 81.3 (52) 1.08 0.70, 1.68 0.719     
350-499 86.0 (74) 1.15  0.76, 1.73 0.512     
>500 81.8 (130) 1.09 0.74, 1.60 0.658     
ART treatment 
duration in years a 
1 – 5 82.3 (51) Reference        
6 – 10 82.4 (98) 1.05 0.76, 1.45 0.765     
11 and above  83.1 (133) 1.06 0.78, 1.44 0.709     
Major depressive 
disorder  
No 91.9 (215) 1.48 1.14, 1.92 0.004   1.43 1.05, 1.96 0.025 
Yes  62.2 (74) Reference     Reference    
a variables not included in multivariate Poisson regression; * statistically associated with MDD; ART: antiretroviral therapy 
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3.4.4. Factors associated with QoL 
The overall QoL mean score was 3.86 (SD=0.42) and the mean scores for physical, 
psychological, independence, social, environmental and spiritual domains were 4.16 (SD=0.56), 
3.73 (SD=0.65), 4.02 (SD=0.56), 3.76 (SD=0.60), 3.27 (SD=0.61) and 4.42 (0.44) respectively. 
The data of QoL was normally distributed and all assumptions were met to conduct linear 
regression. The multivariate linear regression shows that a higher level of education was positively 
associated with overall QoL: those with tertiary education had a higher QoL score of 0.34 
compared to those who were illiterate (95%CI: 0.19,0.49; p<0.001) (See Table 8). Taking first-
line ART treatment was positively associated with overall QoL: participants who were taking first-
line ART treatment had a higher QoL score of 0.12 compared to participants who were taking 
second-line ART treatment (95%CI: 0.03,0.20; p<0.008). Similarly, taking ART for a longer 
duration was also positively associated with overall QoL: those who had taken ART for 6-10 years 
had a higher QoL score of 0.12 compared to those who had taken ART for less than 6 years 
(95%CI: 0.02,0.22; p=0.022). High PSS was positively associated with overall QoL: participants 
who had high PSS had a higher QoL score of 0.43 compared to those who had low PSS (95%CI: 
0.29,0.57; p<0.001). Functional disability was also associated with overall QoL: those who had 
no functional disability had a higher QoL score of 0.29 compared to those who had functional 
disability (95%CI:  0.21,0.36; p<0.001).  
In addition, the adjusted linear regressions by domains of QoL show that age and employment 
were statistically associated with one or more domains of QoL. In the univariate analysis, being 
married or in a relationship and public employment were significantly associated with a higher 
QoL score. See Table 9. 
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Table 8. Linear regression: Association of socio-demographic and clinical factors with overall quality of life among people living with 
HIV/AIDS in Felege-Hiwot Referral Hospital, Northwest Ethiopia (N=391). 
Factors  Mean (SD) 
Unadjusted linear regression  Adjusted multivariate linear regression 
Coefficient  95%CI P value  Coefficient  95%CI P value  
Age in years 18-29 3.76 (0.40) Reference Reference   Reference Reference  
30-39 3.86 (0.44) 0.27 -0.26, 0.80 0.313  0.07 -0.04, 0.19 0.209 
40-49 3.91 (0.43) 0.49 -0.07, 1.05 0.087  0.10 -0.2, 0.23 0.102 
50+ 3.83 (0.37) 0.18 -0.48, 0.83 0.601  0.06 -0.08.0.21 0.371 
Gender a Male 3.90 (0.39) 0.23 -0.16, 0.61 0.255     
Female  3.84 (0.44) Reference Reference      
Marital status  Single 3.77 (0.45) -0.08 -0.65, 0.48 0.770  -0.04 -0.16, 0.08 0.530 
Married/ in relationship 3.93 (0.39) 0.57 0.18, 0.95 <0.004  -0.01 -0.08, 0.08 0.974 
Divorced/widowed 3.79 (0.45) Reference Reference   Reference Reference  
Educational 
status  
Illiterate 3.67 (0.50) Reference Reference   Reference Reference  
Primary education  3.87 (0.37) 0.78 0.35, 1.21 <0.001  0.13 0.03, 0.22 <0.008 
Secondary education  3.95 (0.35) 1.12 0.65, 1.58 <0.001  0.20 0.09, 0.31 <0.001 
Tertiary education 4.09 (0.31) 1.69 1.13, 2.25 <0.001  0.34 0.19, 0.49 <0.001 
Employment 
status  
Public employed 4.01 (0.32) 0.85 0.37, 1.33 0.001  -0.07 -0.19, 0.05 0.274 
Self employed 3.83 (0.42) 0.14 -0.27, 0.55 0.499  0.01 -0.08, 0.09 0.886 
None employed 3.81 (0.44) Reference Reference    Reference Reference   
ART regimen  First-line 3.90 (0.41) 0.59 0.18, 0.99 <0.005  0.12 0.03, 0.20 <0.008 
Second-line 3.76 (0.45) Reference Reference   Reference Reference  
Current CD4 
count (last 6 
months) 
<200   3.85 (0.45) Reference Reference   Reference  Reference   
200-349 3.88 (0.37) 0.34 -0.315, 0.99 0.307  -0.01 -0.14, 0.13 0.937 
350-499 3.94 (0.38) 0.58 -0.042, 1.20 0.067  0.06 -0.07, 0.19 0.343 
>500 3.83 (0.43) 0.16 -0.40, 0.72 0.575  0.01 -0.11, 0.13 0.865 
Duration of ART 
treatment in 
years   
1 – 5  3.83 (0.49) Reference     Reference Reference  
6 – 10  3.91 (0.41) 0.35  -0.14, 0.85 0.157  0.12 0.02, 0.22 0.022 
11 and above 3.84 (0.41) 0.05  -0.42, 0.52  0.835  -0.01 -0.11, 0.10 0.931 
Perceived social 
support   
Low support  3.38 (0.62) Reference Reference   Reference  Reference  
Moderate support  3.68 (0.36) 0.90 0.27, 1.54 0.006  0.18 0.04, 0.33 0.014 
High support  3.86 (0.42) 2.19 1.59, 2.80 <0.001  0.43 0.29, 0.57 <0.001 
Functional 
disability  
No  4.01 (0.33) 1.42  1.08, 1.75 <0.001  0.29 0.21, 0.36 <0.001 
Yes 3.64 (0.47) Reference   Reference   Reference Reference  
NOTE: First-line regimen is the use of first choice antiviral drugs and a switch to second-line regimen is recommended when there is treatment 





Table 9. Linear regression: Association of socio-demographic and clinical factors with the domains of quality of life among people living with 
HIV/AIDS in Felege-Hiwot Referral Hospital, Northwest Ethiopia (N=391). 













β (95%CI)  
Age  18-29 Reference  Reference  Reference  Reference  Reference  Reference  
30-39 -0.05 (-0.22, 0.11) 0.07 (-0.09, 0.23) -0.01 (-0.16, 0.15) 0.12 (-0.03, 0.28) 0.18 (0.01, 0.37) 0.07 (-0.07, 0.20) 
40-49 -0.10 (-0.27, 0.08) 0.10 (-0.07, 0.27) -0.03 (-0.20, 0.14) 0.10 (0.07, 0.27) 0.26 (0.06, 0.46) 0.08 (-0.06, 0.23) 
50+ -0.11 (-0.32, 0.09) 0.16 (-0.05, 0.36) -0.09 (-0.30, 0.09) 0.14 (-0.05, 0.33) 0.23 (0.02, 0.46) 0.11 (-0.05, 0.28) 
Marital status  Married/relationship  Reference Reference Reference  Reference Reference Reference 
Single  -0.10 (-0.27, 0.07) 0.01 (-0.16, 0.17) -0.09 (-0.25, 0.07) -0.16 (-0.32, 0.01) 0.18 (-0.02, 0.37) -0.09 (-0.23, 0.05) 
Divorced/ widowed  0.01 (-0.10, 0.13) 0.07 (-0.04, 0.18) 0.06 (-0.05, 0.17) -0.08 (-0.19, 0.03) 0.07 (-0.07, 0.20) -0.05 (-0.14, 0.05) 
Educational 
status  
Illiterate  Reference  Reference  Reference  Reference  Reference  Reference  
Primary education    0.20 (0.07, 0.33) 0.17 (0.04, 0.30) 0.22 (0.09, 0.35) 0.11 (-0.01, 0.24) 0.12 (-0.03, 0.28) 0.12 (0.01, 0.22) 
Secondary education    0.21 (0.06, 0.35) 0.22 (0.07, 0.36) 0.21 (0.07, 0.35) 0.13 (-0.01, 0.27) 0.31 (0.14, 0.48) 0.13 (0.01, 0.25) 
Tertiary education   0.27 (0.06, 0.48) 0.51 (0.30, 0.72) 0.35 (0.15, 0.56) 0.16 (-0.04, 0.37) 0.33 (0.10, 0.57) 0.23 (0.06, 0.41) 
Employment 
status  
Public servant  -0.08 (-0.26, 0.09) -0.09 (-0.26, 0.09) 0.01 (-0.16, 0.18) -0.01 (-0.17, 0.16) -0.04 (-0.23, 0.16) -0.09 (-0.23, 0.06) 
Self employed  -0.04 (-0.16, 0.08) 0.17 (0.05, 0.29) 0.07 (-0.04, 0.19) -0.11 (-0.22, 0.01) -0.01 (-0.14, 0.13) -0.07 (-0.17, 0.02) 
Unemployed  Reference  Reference Reference  Reference  Reference  Reference  
Perceived 
social support  
Low support  Reference  Reference  Reference  Reference  Reference  Reference  
Moderate support 0.15 (-0.05, 0.34) 0.34 (0.15, 0.53) 0.23 (0.05, 0.42) 0.10 (-0.08, 0.29) 0.11 (-0.13, 0.34) 0.19 (0.03, 0.35) 
High support 0.25 (0.06, 0.44) 0.60 (0.42, 0.79) 0.37 (0.19, 0.56) 0.68 (0.50, 0.87) 0.45 (0.22, 0.68) 0.28 (0.13, 0.44) 
ART regimen  First-line    0.15 (0.04, 0.27) 0.19 (0.07, 0.30) 0.11 (0.01, 0.23) 0.10 (-0.01, 0.21) 0.08 (-0.05, 0.22) 0.08 (-0.02, 0.17) 
Second-line   Reference  Reference  Reference  Reference  Reference  Reference  
Functional 
Disability  
No  0.39 (0.28, 0.49) 0.55 (0.44, 0.66) 0.35 (0.25, 0.45) 0.25 (0.15, 0.35) 0.10 (-0.02, 0.22) 0.17 (0.08, 0.26) 
Yes  Reference  Reference  Reference  Reference  Reference  Reference  
Current CD4 
count (last 6 
months) 
<200  Reference  Reference  Reference  Reference  Reference  Reference  
200-349 -0.07 (-0.27, 0.12) 0.07 (-0.12, 0.26) -0.03 (-0.21, 0.16) 0.04 (-0.14, 0.22) -0.08 (-0.30, 0.15) 0.14 (-0.02, 0.30) 
350-499 0.03 (-0.16, 0.21) 0.08 (-0.10, 0.26) 0.07 (-0.10, 0.25) 0.04 (-0.14, 0.21) -0.03 (-0.24, 0.18) 0.13 (-0.02, 0.28) 




1 – 5  Reference  Reference  Reference  Reference  Reference  Reference  
6 – 10  0.17 (0.03, 0.32) 0.12 (-0.02, 0.27) 0.13 (-0.01, 0.27) 0.05 (-0.09, 0.19) 0.01 (-0.15, 0.18) 0.17 (0.05, 0.29) 
11+ 0.03 (-0.11, 0.18) 0.03 (-0.12, 0.17) -0.05 (-0.19, 0.09) -0.04 (-0.09, 0.19) -0.14 (-0.30, 0.03) 0.04 (-0.08, 0.16) 
The results in this table were identified in multivariate linear regression. All variables associated with overall QoL at >0.2 were controlled multivariate analyses with each domain of 
QoL. First-line regimen is the use of first choice antiviral drugs and a switch to second-line regimen is recommended when there is treatment failure with first-line treatments. ART: 




3.4.5. Association of MDD and adherence to ART with overall QOL  
After controlling for socio-demographic and clinical factors associated with overall QoL, results of 
the multivariate linear regression show that MDD was negatively associated with overall QoL: 
participants with MDD had a lower QoL score of 0.06 compared to those with no MDD (95%CI: 
0.89,0.99; p<0.047) (see Table 6). However, there was no statistical association between 
adherence to ART and overall QOL. The generalised linear model presented no interaction effect 
of MDD and adherence to ART on QoL scores (95%CI: 0.94,1.07; β=0.01; p=0.866). See Table 
10. 
Table 10. Generalised linear model univariate analysis: Association of major depressive disorder 
and adherence to antiretroviral therapy with the overall quality of life after adjusting for socio-
demographic and clinical factors (N=391). 
Covariates   Mean (SD) 
Adjusted linear regression 
Coefficient   95%CI  P value  
Major depressive 
disorder 
No 3.99 (0.33) Reference  Reference   
Yes  3.59 (0.47) -0.06 0.89, 0.99 0.047 
Adherence to ART  High adherence  3.86 (0.40) Reference    
Suboptimal 
adherence   
3.73 (0.46) -0.03 0.93, 1.02 0.277 
MDD*Adherence to 
ART 
  0.01 0.94, 1.07 0.866 
NOTE: All variables associated with overall QoL at >0.05 were controlled for in this model (age, marital status, 
educational status, employment status, antiretroviral therapy (ART) regimen, CD4 count, duration of ART treatment, 
perceived social support and functional disability). ART: antiretroviral therapy.  
3.5. Discussion  
Unlike most of the previous studies in HIV populations in Ethiopia, this study examined the 
prevalence of major depression using a diagnostic instrument. We found that one third of the 
study participants had MDD, and that being divorced or widowed, illiterate, unemployed, with low 
perceived social support, and on second line ART regimen were significantly associated with 
MDD in univariate regressions (unadjusted analysis). MDD was strongly associated with 
functional disability and suboptimal adherence to ART in the multivariate regression (adjusted 
analysis). We also identified associations between higher overall QoL and better educational 
status, better PSS, functioning, taking ART for a longer duration and taking first-line ART 
treatments.  
More than two thirds of the study participants were women. However, there was no difference in 
prevalence of MDD between men and women. The reason for the majority of the participants 
being women could be due to a higher prevalence of HIV/AIDS among women than men. This is 
supported by several reports that have shown that HIV/AIDS is more prevalent in women than 
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men in Ethiopia (206). Our study found that there was no difference in prevalence of MDD by age 
and gender which is in agreement with findings from another study reporting that MDD is prevalent 
in all age groups and in both genders of PLWHA (207). However, there are also contrasting 
findings from other studies in the general population. Gender and income level have associations 
with depression, for example depression was found to be more prevalent in females than males 
(208).  Biological impact of HIV (209), stigma, poor social support, and low socio-economic 
conditions (207) all contribute to a high prevalence of MDD among PLWHA.   
In this study, there was a significant association between PSS and MDD in the univariate 
regression but no association between PSS and MDD in the multivariate regression. This may be 
due to, 1) introduction of several confounding variables in the multivariable model, 2) PLWHA 
may perceive the extent of social support differently as stigma predominates, and 3) It may also 
be due to less validity of the measure for HIV population in Ethiopian context. This finding is 
inconsistent with a systematic review of longitudinal studies that reported poorer PSS causes 
worse outcomes of MDD in terms of functioning and recovery (210) and with another systematic 
review of studies from Africa that reported presence of a strong relationship between PSS and 
MDD (211). However, a systematic review of studies from high-income countries (212) and 
another longitudinal study among adolescents from China (213) reported no relationship between 
level of PSS and MDD. There is conflicting global evidence on a causal relationship between PSS 
and MDD. Interpersonal theories of depression indicate that poor social support leads to onset of 
MDD (35). In contrast, a more recent longitudinal study presented evidence that PSS is a 
consequence of MDD contrary to social causation theories of depression (213), reporting that the 
negative views of people with MDD can make it uncomfortable for peers to provide social support. 
In addition, lack of social skills of people with MDD to create and maintain a relationship may 
result in a social avoidance state. Despite our findings, we believe that social support could be an 
important intervention for MDD. MDD caused by a psychosocial crisis can be effectively treated 
by strong social support, which helps to decrease interpersonal stress and improve interpersonal 
skills (35).        
Our study shows that functional disability was independently associated with MDD. Functional 
disability prevents people with MDD from performing daily activities, leads to loss of social roles 
and lack of access to resources for basic needs (214). Failure to fulfil self needs and social 
responsibilities can lead to onset of full blown MDD, or reciprocally MDD can lead to functional 
disability (215). Furthermore, people with functional disability need more intensive social and 
material support due to poverty and this could aggravate pre-existing MDD (31).   
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Our finding about the association of several socio-demographic and clinical factors with overall 
QoL is consistent with previous findings. Better educational status (216-218), being employed 
(219), good social support (49, 216), functioning (49) and access to first line ART treatment (218, 
220) have been identified as predictors of improved QoL. Our findings support the hypothesis that 
PLWHA with better education and with good physical functioning could have better income and 
employment opportunities to gain better QoL.  
None of the socio-demographic and clinical factors showed statistical associations with 
adherence to ART which is inconsistent with previous findings (180). This can be explained by 
challenges in measuring adherence to ART using pill count There was also inconsistency in using 
specific measures across studies that may be misleading in assessing treatment adherence in 
HIV populations. But MDD seems an important predictor of suboptimal adherence to ART which 
is supported by several findings from previous studies (75, 76). This could be due to MDD related 
cognitive impairment, such as memory loss and forgetfulness in taking ART medications (77-79), 
or due to poor motivation, hopelessness and wishing to die (4). Our findings show the need to 
integrate mental health interventions with existing HIV care as MDD has been found to be one of 
the major barriers to the global agenda to end the HIV epidemic specially in SSA countries (169, 
170).   
The observed relationship between MDD and overall QoL was consistent with previous findings 
in HIV populations (216, 218, 219). Evidence shows that MDD consistently leads to worse health 
outcomes in PLHWA not solely due to difference in adherence to ART but may also be due to 
direct effect of MDD on physiological functioning (168). Firstly, MDD can affect QoL by interfering 
with immune system functioning. Secondly, MDD affects positive thoughts for change that can 
lead to lower adherence to ART. Thirdly, the relationship between MDD and poor QoL can also 
explained by indirect effects of MDD on QoL such as financial insecurity, unemployment and 
financial dependency on others (211). The overall findings of this study indicated that addressing 
MDD should be a priority to facilitate recovery and functioning of PLWHA. A recent systematic 
review and meta-analysis of RCTs found that psychological treatments enhance immune system 
functioning (221). Therefore, we recommend the use of psychological treatments for treatment of 
depressive symptoms and to improve immune functioning that could help to improve overall QoL 
of PLWHA. We recommend that mental health researchers develop evidence-based 
psychological treatments that are appropriate for PLWHA to manage depression, and to improve 
adherence to ART and overall quality of life of PLWHA. Furthermore, we believe that this study 
could have several implications for health care providers and policy makers to consider mental 
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health conditions as a priority and to act accordingly. Specifically, routine screening services for 
depression and other mental disorders should be established at ART clinics and mental health 
services integrated with HIV care services in Ethiopia.    
A major strength of this study was the use of instruments validated in Ethiopia. However, it has 
also several limitations. Firstly, it is a cross-sectional study that doesn’t allow us to identify causal 
relationships between independent and outcome variables. Secondly, the use of pill count data 
alone to measure adherence to ART may not be the right approach and future studies should 
consider alternative approaches. Thirdly, readers should note that suboptimal adherence to ART 
was defined narrowly as skipping one or more doses of ART medications. Fourth, there may have 
been recall bias in the manner in which study participants shared their information. Fifth, there 
was no measure of socio-economic status, which means that the association between MDD and 
quality of life could have been confounded by socioeconomic factors. Sixth, the use of nurse-
administered fully structured diagnostic measure (MINI) to diagnose MDD may also be a limitation 
as such an administration of the MINI is not a gold standard measure for diagnosis. Seventh, 
MDD could have had a mediating effect on the relationship between non-adherence and QoL. 
However, this did not seem to be supported by statistical analysis.   
3.6. Conclusion     
This study indicates that both MDD and QoL have a strong relationship with functional disability 
among PLWHA in Northwest Ethiopia. The strong relationship between MDD and QoL indicates 
the need to integrate feasible, acceptable and evidence-based mental health interventions within 
the existing HIV care services to improve the overall QoL of PLWHA. We recommend future 
studies to investigate causal relationships of MDD, adherence to ART and QoL of PLWHA to 
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4.1. Abstract  
Background: Psychological treatments improve depressive symptoms in PLWHA. Adaptation of 
treatments should be based on explanatory models of depression and other elements within the 
given context. This study aimed to examine explanatory models of depression and acceptable 
approaches for implementation of group IPT in Northwest Ethiopia.  
Methods: Qualitative data were collected from April to May 2019 from a total of 18 participants 
using focus group discussions. Three separate focus group discussions were conducted among 
case managers (6 participants), adherence supporters (5 participants) and service users (7 
participants). Data were analysed using the framework approach.  
Results: PLWHA attributed depression to psychosocial problems, spiritual factors and biological 
factors. Depression had several impacts at individual and family level. Group-based IPT was 
acceptable if provided by trained peer counsellors.  
Conclusion: The current study findings informed how to conduct feasibility and acceptability trials 
of group IPT in the HIV population in Ethiopia.  
 














A number of psychological treatments show benefits for improving depressive symptoms among 
different groups of people (222, 223). However, when they are implemented in different settings, 
they may not appear as effective as they were during their development (223-226). This indicates 
the need for dynamic adaptation and contextualisation of psychological treatments when they are 
replicated in different settings (223, 225). The use of Western treatment models in diversified 
settings using an etic approach can invalidate psychological treatments (227). Chowdhary and 
colleagues support this argument in a systematic review showing that trials following proper 
adaptation and contextualisation of psychological treatments were more effective than trials that 
used non-adapted treatments (104). The adaptation of evidence-based psychological treatments 
requires appropriate understanding of local explanatory models and contextualisation of preferred 
treatments into the existing health care systems (89, 104, 227). Although several studies have 
shown the effectiveness of psychological treatments for depression in LMICs, the attention given 
to appropriate adaptation remains limited (89).     
Studies have shown that group IPT has been effective for treatment of depression in LMICs (90, 
137, 228). However, there is a challenge to integrating group IPT into the routine health care 
systems because of a lack of systematic adaptation and contextualisation of the therapy (89). 
There are several issues that should be considered while adapting group IPT for treatment of 
depression in LMICs (229). Furthermore, engaging stakeholders in the process of 
contextualisation of the group IPT is fundamental to enhance its acceptability and effectiveness 
(89, 227, 229). In relation to PLWHA, there are several positive results on the effectiveness of 
group IPT for treatment of depression in LMICs (228-231). However, systematic adaptation of 
group IPT specifically for PLWHA has received minimal attention to expand the intervention to 
larger populations.  
The Kleinman’s explanatory model of illness remains a useful approach to integrate cultural 
beliefs within clinical processes by exploring views of therapists and patients on the nature, name, 
cause, course and desired treatment for a specific episode of illness (112, 232, 233). This model 
views cultural and psychosocial variables as important determinants of health (234), and it helps 
to understand and integrate stakeholders views within health care systems (232).   
Symptoms of depression and HIV/AIDS are intertwined with each other (227, 235). For instance, 
several narratives  indicate that PLWHA consider depressive symptoms as part of HIV/AIDS (227, 
231, 235) and they believe that depression is caused by HIV/AIDS (231, 235). Moreover, many 
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others attribute depression to spiritual possession and witchcraft (227, 231). Similarly, PLWHA 
may have different beliefs on the impacts of depression and treatment needs including on the 
preferred approach of interventions and delivering agents for the intervention.  
Evidence shows that depression is caused by biological, psychological or/and social 
vulnerabilities (22, 29, 236). The biological process of HIV such as “cytokine-induced sickness 
behavior” and immune activation markers can cause onset of depressive features in PLWHA (48, 
237, 238). Furthermore, the life threatening nature of HIV/AIDS has a psychological impact on 
PLWHA leading to low self-esteem and self-stigma that can precipitate development of 
depression (22, 239). The social aspect of PLWHA is complicated with difficult life circumstances 
such as public stigma and poverty (173). As a result, several studies indicated that depression 
can be caused by i) interpersonal problems such as separation, conflict, stigma and loneliness 
(240, 241), and ii) life changes in relation to the HIV/AIDS such as sickness, unemployment and 
poverty (18, 25, 242). 
The origin of most triggering factors of depression are understood within IPT as mainly social 
problems that are then the focus of treatment (problem areas) of  IPT (229, 231). IPT hypothesises 
that depression can be treated when social support is enhanced and interpersonal stress is 
resolved (35). Other scholars suggest including spiritual and cultural components into treatment 
models of depression (243, 244) and mental health care services (245) since they are important 
aspects for treatment of many people, especially at the end of life (244). However, further studies 
are needed on how to address the spiritual elements within IPT specifically for PLWHA in LMICs.    
Studies from SSA have shown that depressed PLWHA prefer group-based psychological 
treatments (96, 147, 150, 231, 241) as these provide supportive environments and help 
participants to learn new social skills (150, 241). Furthermore, providing or receiving social 
support during group sessions gives one a sense of belonging and meaning in life (150, 231). 
Participants report gaining a feeling of acceptance, sense of empowerment and confidence when 
they are in a group (241). This implies that group-based interpersonal therapy can be a potentially 
acceptable option for treatment of depression for PLWHA in Ethiopia. Formative studies for 
adaptation of psychological therapies in Ethiopia have indicated that individual therapy is 
preferred (246). However, PLWHA seem to be more receptive to groups than individual 
approaches. PLWHA may feel less stigmatised when they are together with their peers and more 
able to discuss their psychosocial problems (96). In Ethiopia, IPT has never been adapted for 
PLWHA. Adaptation is an essential initial step for testing the feasibility and acceptability for this 
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target population in Ethiopia. This paper focuses on examining the explanatory models of 
depression and acceptable contexts for implementation of group IPT, such as appropriateness, 
preferred treatment providers and perceived barriers for the delivery of the group IPT in the HIV 
care setting.  This information is essential for the overall adaptation process.   
4.3. Materials and methods 
A formative qualitative study was conducted to inform the adaptation of the WHO group IPT 
intervention. An individual-based IPT training was provided for physicians and health professions 
to integrate IPT based care at primary health care facilities in Ethiopia (247).   
4.3.1. The process of adapting group IPT  
The WHO developed the group IPT manual in 2016 (229) to provide guidance on the 
implementation of group IPT for treatment of depression. The WHO recommends adaptation of 
the manual for different settings and groups of people. We received approval from the WHO to 
translate and publish the manual in the Amharic language (Agreement letter TR/18/041). The 
WHO group IPT manual was adapted over a 5-month period from April to August 2019. 
Initially, the authors of this paper reviewed existing literature to identify effective psychological 
treatments for depression for PLWHA in LMICs (88). From this systematic review we found that 
interpersonal therapy is effective for treatment of depression especially for people with 
psychosocial problems. We also learned that there is a culture of conducting group HIV education 
in our study setting in Northwest Ethiopia. The adaptation process of the group IPT was guided 
by the ecological validity and culture sensitivity model (111). Furthermore, we used Kleinman’s 
explanatory model of illness to understand broader views of PLWHA on depression (112).  
4.3.2. Setting  
This study was conducted in FHRH which is located in Bahir Dar, Amhara regional state in 
Northwest Ethiopia. Bahir Dar is the capital city of the regional state that has a population of more 
than 750,991 residents. According to the Central Statistical Agency of Ethiopia, 96.8% of the 
population speaks Amharic as their first language and 93.2% are from Amhara ethnic group. Of 
the total population in Bahir Dar, 79.7% are Ethiopian Orthodox Christians, 18.47% Muslims, and 
1.62% Protestants.  FHRH is one of the busiest hospitals in Ethiopia and serves a population of 
more than 7 million people with 430 beds (248) and 422 health professionals (249). Of the total 
health professionals, 107 were medical doctors, 174 were nurses and 7 were mental health 
professionals (248). The hospital records show that 6,251 PLWHA have attended the ART clinic 
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for their treatment over the last six months. People living with HIV/AIDS play a significant role in 
the HIV/AIDS care and treatment in the clinic as paid case managers and adherence supporters. 
Case managers and adherence supporters are HIV positive and they are considered as 
supportive staffs at the ART clinic. Case managers provide mainly HIV counselling and adherence 
supporters are responsible for client tracing and home visits.  
4.3.3. Participants’ recruitment   
Eligible participants for focus group discussions were adults who were 18 years old or older and 
currently receiving ART treatment at the clinic, and included case managers, adherence 
supporters and users of the services. We aimed to conduct separate focus group discussions in 
each group. Study participants were assigned into three focus groups: a focus group of case 
managers (6 participants), adherence supporters (5 participants) and service users (7 
participants). For case managers’ and adherence supporters’ groups, we selected participants 
who were working on the day of data collection. In addition, for service users’ focus group, we 
selected seven eligible participants randomly (selected randomly at the time they come to the 
ART clinic for follow up) who were 18 years and above, and not severely ill from the list of 
participants waiting for treatment on the day of the data collection. Focus group discussions were 
conducted in a private space in the ART clinic and all of them were led by the first author (BA). 
All the focus group discussions were conducted in the local language (Amharic) and lasted from 
one and a half to two hours. 
4.3.4. Data collection    
We used focus group discussions to collect information from participants. Focus group 
discussions were chosen because the area that was covered in the interviews was believed to be 
new to the population particularly discussing the explanatory model of depression and group 
interpersonal therapy. In addition, focus group discussions can also provide useful information on 
the feasibility and acceptability of running groups in this setting. Focus group discussions were 
facilitated using an open-ended interview guide. The interview guide was informed by the 
framework of Kleinman’s explanatory model of illness (232). After initial review, the authors 
decided to expand the interview guide to include information related to acceptable contexts for 
implementation of group IPT in the HIV care setting, such as appropriateness of the group IPT 
and perceived barriers. The interview guide was further revised and translated into Amharic (See 
the English version of the interview guide in the Appendix D, Module two, section A and B).    
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We used a case vignette of major depressive disorder to initiate conversation during the focus 
group discussion (See the case vignette in the Appendix D, Module 2, section C). The case 
vignette was selected from one of the case studies presented by Sai and Furnham (2013) (250)  
that was used for detection of depression. The selected case was adapted to the local context by 
BA and FA and further reviewed by MS. After that, the case study was translated into the local 
language by BA and it was reviewed by FA for its consistency with the initial case.  
The focus group facilitator read the case study (Mrs. Selam) of a major depressive disorder twice 
(see the case study at the annex) and a printed case description was given to each participant to 
read once before starting the discussion (17 of the 18 participants were able to read and write). 
Afterwards, participants were asked to give their general opinion about the case of Mrs. Selam. 
Participants were probed to name the problem that Mrs. Selam may have, what causes the 
condition, what other symptoms they know about the condition, its severity, where people with 
Mrs Selam’s condition look for treatment and what impacts it could have specifically for PLWHA.  
Furthermore, participants were asked to give their opinion on what psychological treatments are 
and whether they know of any kind of group counselling. Participants were asked for their opinions 
on the acceptability of group counselling specifically for PLWHA, who could facilitate the group 
counselling sessions, how the group should be structured in terms of group composition, group 
size, session frequency and meeting days, how it would be conducted in the ART clinic without 
affecting the regular service and what barriers could affect the implementation of group 
counselling in the ART setting in general. The focus group discussions were conducted in a 
private room which enabled free conversation among participants and provided rich information 
on the subject matter. Focus group participants were peers (all of them are HIV positive) but were 
mixed in terms of gender and age, which was a good strategy used to collect valid information.      
All focus group discussions were audio-recorded, and the facilitator took notes as needed, for 
example, to document emotional changes among the focus group participants during the 
discussion. At the end of the discussion, the facilitator summarised the discussion points and 
acknowledged all participants for contributing their opinion in the focus group discussion.    
4.3.5. Data management and analysis  
Audio-recorded data were transcribed verbatim by the first author (BA) and a research assistant 
(HT) in the local language (Amharic). Afterwards, the transcripts were translated into English and 
double checked for accuracy. Transcripts were imported into NVivo 12 and data was thematically 
analysed using a framework analysis. Initially, nodes were created based on the framework of 
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Kleinman’s explanatory model of illness (232). The drafted nodes informed by the framework were 
naming of the condition, perceived causes, perceived symptoms, perceived severity, impacts of 
the condition and treatment preferences. We also added acceptability, preferred providers and 
acceptable context nodes for implementation of group IPT in the ART setting. Sub-nodes 
emerged from most of the initial nodes. For example, sub-nodes that emerged from perceived 
cause of depression were biological, psychological, social and spiritual causes. In addition, 
perceived symptoms were sub-coded as affective, behavioural and somatic symptoms. Word 
count and word cloud were generated to identify the most important themes. Data coding and 
theme identification was done by two authors (BA and MS). 
4.3.6. Ethical approval   
A proposal of this qualitative study was approved by both the University of Cape Town’s Human 
Research Ethics Committee (HREC reference No. 653/2018) and Bahir Dar University College of 
Medicine and Health Sciences’ Ethics Committee (reference No. 007/2018). A permission letter 
was obtained from the Amhara Public Health Institute. All study participants provided written 
informed consent. One of the participants was illiterate and she signed by fingerprint after a 
witness read the written informed consent for her. Refreshments were served during the 
discussion. Each study participant received compensation to defray transport costs. 
4.4. Results  
4.4.1. Demographic characteristics of study participants 
A total of 18 adult PLWHA (included from case managers, adherence supporters and service 
users) participated in the focus group discussions. The average age of the focus group 
participants was 38, 34 and 34 years for case managers, adherence supporters and service users 
respectively. In terms of gender, one of the six case managers, two of the five adherence 
supporters and three of the seven service users were male. The average duration of ART 
treatment was 7.8, 5.5, 7.0 years for case managers, adherence supporters and service users 







Table 11. Socio-demographic characteristics of focus group participants (N=18). 
Participants  Gender   Age in years  Educational status  Duration of 
ART treatment  
Case managers 5 females and 1 
male   
33 – 45  10th grade to 10th +3  3 – 12 years  
Adherence supporters 3 females and 2 
males 
21 – 58  10th grade to 10th +2 2 – 10 years  
Service users  4 females and 3 
males  
18 – 48 From illiterate to 10th +2  2 – 18 years  
4.4.2. Explanatory model of depression  
a) Naming the problem  
Participants debated on naming the condition in the presented case study. Many of them 
explained that the condition presented in the case vignette is called ‘Dibirt’ [depression] and ‘Ye-
Dibirt chigir’ [depression problem].  
AS3: “We cannot bring another name for this condition, this is ‘Dibirt’ [depression]. If someone 
shows symptoms such as timidity most of the time, lost interest in everything and hopelessness 
in every simple problem so that s/he has depression (Dibirt)”. A 58 years old male participant who 
completed high school education. 
CM4: “I think it can be named as ‘Ye-Dibirt chigir’ [depression problem]. Because the symptoms 
could be linked with different problems including HIV, imprisonment and any more problems. … 
Sadness, hopelessness and suicidal ideation appears when multiple problems are occurring on 
person”.  
A few participants reported that mental health professionals call depression differently, that is 
‘Medebet’ [similar meaning for depression]. 
AS1: “In general, I call it ‘Dibirt’ [depression] but there are people (mental health professionals) 
who call it ‘Medebet’”.   
b) Perceived causes of depression  
The perceived causes of depression reported by study participants included biological, 






Table 12. Perceived causes of depression among people living with HIV/AIDS using 
biopsychosocial-spiritual model. 







• Change in 
body image  












• Divorce/separation  
• Poverty 
• Family pressure/death of loved 
one 
• Conflict 
• Stigma by health professionals 
and community members 
• Failure to succeed 
• Loneliness 
• Self-stigma  
• Sexual abuse 
• Evil attack/ 
spirit 
possession 
• Failure to 
fulfil rituals 






Problematic relationships were the most reported causes of depression as described in the quotes 
below.  
CM6: “Married people could be HIV discordant. One would be HIV positive and the other may be 
negative. When they get divorced, the one who is HIV positive will have a difficult life. Then s/he 
becomes very sad, desperate, guilty saying ‘I am divorced because I am HIV positive’. They regret 
a lot, thinking how beautiful their previous life was and finally they could be sick.”  
AS3: “This could happen because of problematic love. For example, she could be hurt if her 
husband is in love with another woman somewhere. This would have two problems for Selam. 
One thing, his unfaithfulness stresses a lot; and secondly, she would have economic problems. 
All these together would put big pressure on her. If she is economically dependent on him, she 
will not get a chance to discuss such difficult issues with him. Because she may afraid that he 
could leave her alone.”   
Public stigma was commonly reported stressor that is believed to cause depression.  
AS2: “… when our kids play with other kids outside home, they have been insulted with bad words 
such as “Ye-AIDSam Lije” [son of AIDS].  
Another participant reflected the same idea in relation to public stigma.  
CM4: “… we have unique names in our village which was labeled in relation to our HIV status”. 
Many of the study participants highlighted that they faced the worst stigma from health 
professionals, family and from neighbors. The following two quotes show how much health 
professionals stigmatise PLWHA when providing medical care to them.      
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CM1: “I faced a similar problem when I gave birth in a hospital. … I was on the couch to give birth. 
When midwives recognised that I am HIV positive, they put off their gloves and they left me alone 
on the delivery couch [tear shed]. … Someone requested me to leave the couch and they moved 
me to the corridor. … In the meantime, labor was pushing, and placenta was descending. … I 
gave birth at the corridor assisted by one student.”  
CM3: “Similar to others, I was stigmatised by my family. …I gave birth to a baby girl after I was 
diagnosed with the HIV/AIDS. I was not breast feeding her and later she was not growing well. 
She did not gain weight, instead she started losing weight. Afterwards, my family members were 
blaming me saying ‘you infected your baby girl with HIV/AIDS’. … I was stigmatised a lot. I felt 
lonely, sad, disturbed and worried a lot until she diagnosed negative from HIV.” 
Many focus group participants associated mental health problems, including depression with 
spiritual possession and evil attack. 
AS1: “People associate the cause of the problem with ‘Atela lay mekom’ [evil attack while standing 
on local beer residue], ‘Be’amed lay mehed’ [walking on ash] and they also link it with ‘Ye’aganint 
likift’ [evil attack]. 
SU1: “Mrs. Selam probably received a ritual tradition from her ancestors. She could be attacked 
by a spirit When she failed to fulfil the ritual.”  
Adherence supporters and case managers attributed depression to psychological problems.  
AS1: “I believe that we are creating our problems in our mind. … this happens because of our 
incorrect thinking about ourselves and others.”  
In relation to biological factors, focus group participants attributed depression to HIV/AIDS and 
medications. They believe that HIV/AIDS made them sensitive to simple stressors and taking HIV 
medications for ever makes them become hopeless to enjoy life.  
CM4: “There is HIV in our blood which is a big problem. That is why we cannot handle simple 
problems. HIV/AIDS has an association with our weak psychology. …. I think HIV and depression 
have a relationship.” 
AS3: “Taking ART medications is stressful and makes you feel sad. … one of the causes for our 
stress is the disease itself”.  
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SU4: “Hopelessness comes from taking the ART medications for life long. We are expected to 
follow a scheduled medication regimen strictly. That is very stressful.”  
c) Perceived symptoms of depression 
The participants predominantly described affective and behavioural symptoms. The affective 
symptoms predominantly reported were hopelessness, depressed mood, loss of interest, being 
sad, helplessness, and irritability.  
CM1: “…. I was crying day and night holding my baby on my arm. I was extremely sad and worried, 
no food and drink in my mouth. There were many people around me such as my husband and 
family were with me, everything was available, but I was feeling hopelessness and helplessness.”  
Frequently reported behavioural symptoms were loneliness, not eating meals, difficulty sleeping, 
timidity, being violent, restlessness, sitting in one place for long time, talking slowly, suicidal 
attempt, looking downward and poor self-hygiene. 
CM2: “I have seen Selam’s problem on me. I was living and sleeping alone when I was sick. I was 
not sure I can woke up on the next day. I was saying to myself that I could die while I am sleeping 
so that I should sleep properly, stretching my legs and hands forward. At least my dead body 
should be found in a proper position. … I had never eat, I had no interest to eat at all. I felt I was 
the only person straggling with this much problems in this world. I used to write letters mentioning 
my father’s and mother’s name, my uncles’ names, their address details, and I put the letter in my 
pocket when I went to bed for sleep. At least they should know that I died because of natural 
cause.”     
Another case manager said, CM4: I know when clients are depressed. They become angry, 
irritable, they have no patience, they fight and try to strangulate health professionals with no 
reason. This is not their fault because they are sick. During interviews, they do not tell us that they 
are sick but they lose weight from time to time, they are worrying and their behaviour becomes 
unstable.    
Somatic symptoms were also reported by study participants, such as body pain, headache, 
hearing a noise in the head as if insects are moving in their head (chichichi) and bell ringing in 




CM6: “ When I was depressed, I used to boil water to pour it on me. I was trying to end my life 
several times. I used to have chronic headache. … It was a difficult time, I was angry all the time 
and I used to hear a disturbing noise “chichichi” which looks like insects are moving inside my 
head. … Now, I suspect depression when clients are behaving inappropriately, when they say ‘I 
lost my card’ while holding the card on their hand (when they loss their attention), when they 
frequently reported forgetting to take their medications.”  
d) Perceived severity of depression 
Participants debated on ranking the severity of the condition presented in the case study. Half of 
the participants said that the condition was moderate.  
AS1: “I would say Selam’s illness is moderate. Because, depression comes with one’s own 
problem (fault). Therefore, it should be solved by herself. If she explains her problem to others, 
she will become fine. She is keeping problems secret. She must start talking then she could 
improve.”      
SU5: “Her illness is moderate. Why I said ‘her illness is moderate’, because she is not crazy like 
others on the street. What she actually did is just she sat down and think about herself.”    
The remaining half classified depression as a severe problem. The rationale for classifying the 
condition as a severe problem was the presence of hopelessness and suicidal ideation in the 
case study. 
SU6: “She (Mrs. Selam) becomes hopeless in life so that her illness is severe. Because 
hopelessness itself is enough to classify her illness as severe. She is not eating, and she is losing 
weight. When the hopelessness is added to these, it makes her illness so severe.”  
AS3: “I would say her illness is severe. She has a wish to die. She would die if she were in the 
right time and place. Therefore, her illness is severe.” 
e) Perceived impact 
All participants agreed that depression has several impacts at individual and family level, 
especially when it comes to PLWHA. Most of them reported that the immediate consequence of 
depression is ART non-adherence which leads to rapid increase in viral load count.    
In relation to the impact of depression at individual level, a 35 years old female adherence 
supporter said, AS2: “People with depression do not take their medications properly. At the time 
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of depression, not only avoiding to take their medication on time but also they dislike to eat meals. 
At that miserable time of hopelessness, they would prefer to die rather than extending their life a 
bit longer with the support of medications. Therefore, it is quite obvious that people with 
depression discontinue their medication commonly.”    
Similarly, a 40 years old case manager added, CM2: “… The main impact is on the medication 
adherence. Medications may not be taken properly. If medications are not taken properly, drug 
resistance follows, and their viral load increases rapidly. They forget what they are told to do so. 
… they may take medications twice when they were ordered to take once per day. …. They may 
skip taking the medications because they think that they already have taken their daily 
medications. There were people who came to the clinic within ten days after finishing all the 
medications prescribed for one month”.  
Moreover, many study participants described many long-term impacts of depression such as 
separation, family disintegration, non-functioning and poverty.  
SU6: “It is very difficult. HIV/AIDS is affecting our social life especially when it is combined w ith 
depression. We distance ourselves from our friends and families. I used to hate my family and 
myself. I guess I was depressed that time.” 
A similar idea was reflected from another adherence supporter as follows: 
AS1: “First it leads to self-stigmatisation [self-isolation from social affairs] from the community. 
Second, it leads to economic problems because people with depression cannot work properly. 
Third, they become incapable to support their family. Afterwards, they may be separated from 
their family.”  
Substance use was reported to be one of the long-term impacts of depression.  
CM4: “People with depression get into a different life style, for example they may start using 
substances and drugs. They start cigarette smoking, khat chewing and alcohol drinking habits” 
Some other participants reported that the risk of committing suicide is much higher among 
depressed PLWHA. One of the participants narrated the risk of committing suicide as follows.  
AS3: “She (Mrs. Selam) has a wish to die so the impact of depression is clear. She could die if 




f) Pathways to care 
Many participants reported that Holy water/faith healers, witchcrafts and traditional healers are 
preferred pathways for treatment in the community. Some of the participants believe that bathing 
or drinking with ‘tsebel’ (Holy water) – which is a common traditional healing treatment in Ethiopia, 
could help to treat depression and other mental problems. Holy water is water blessed by a 
religious father, priest or member of the clergy.   
CM6: “When I was mentally sick, I went to Holy water ‘Tsebel bet’, and I visited traditional healers 
including witchcraft men several times. Because the community believe that mental problems that 
are acquired from ancestors or caused by evil attack or spiritual possession can be treated only 
by Holy water and traditional healers. To be honest, finally, I was treated by Holy water called 
‘Abune Hara tsebel’”.  
CM6 continued… “There is a saying that ‘a witchcraft man does not have any treatment for his 
illness, however the community still prefer to go to witchcraft to get help for mental problems” 
g) Treatment preference  
When focus group participants were asked what possible interventions are needed for the 
condition presented in the case study, all of them spontaneously stated that counselling can be 
helpful to treat the described case (depression). All of the focus group participants emphasised 
the need to include psychological treatments with HIV care. Most of them had a basic 
understanding of psychological treatments and described these in different ways, such as 
counselling, psychological therapy, talk therapy, active listening and psychosocial support. All 
focus group participants agreed on the benefits of psychological treatments for depression for 
PLWHA.  
CM4: “What comes to my mind all the time is why psychologists were not included in the team 
when the HIV care was started. This was a must to include psychologists in the HIV care. I know 
how many people we lost by suicide, I know how many people became mentally sick and I know 
how many people discontinued their ART follow up. The past is passed once. But we should start 
working together for the future.” 




AS3: “Mrs. Selam needs someone who can listen to her. Active listening treats many people who 
are in trouble and those suffering from excessive worry and sadness.” 
Another participant added a similar idea.  
CM5: “From my experience as a case manager, I came to understand that listening to their 
problem alone treats half of their condition. …. We come up with solutions together, such as 
creating a supporting system in every aspect – socially, psychologically and even economically.” 
Some of the participants narrated that counselling can be as effective as antidepressant 
medications.  
CM6: “I believe that counselling can treat depression as well as the medications. As to me, it is 
not right to prescribe medications when clients tell us stories such as anger, forgetfulness, and 
sadness. Medications should be prescribed if and only if counselling failed to treat depression.” 
This point was further elaborated by another participant:  
CM2: “Counselling should come first before prescribing antidepressants. I mean we should 
provide adequate counselling and see the outcome before giving medication. First, the client 
should believe in any treatment. Therefore, counselling can help a client to be aware and adhere 
with any type of treatment.” 
Many participants believe that peer counselling can help people with depression. 
SU3: “A psychosocial group should be established for depressed people as well. Peer-counselling 
can help to identify solutions for our day to day problems. We can learn a lot from others.”  
h) Acceptability of Group IPT  
Study participants were asked what format of counselling would be preferred by PLWHA and they 
supported group counselling as can help clients to make decisions and to learn social skills. Some 
of them described how much they had benefited from a group-based youth HIV counseling 
programmes a few years back.   
AS1: “People with the same problem (HIV) gain energy when they are together. They could solve 
problems and make decisions together. There is a saying ‘Dire biaber anbessa yasir’ [a mass of 
thread can tie a lion] which means you can win any problem when you are together. There is 
nothing that can make clients afraid to talk when they are in group. Because all of us share the 
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same problem and all have passed through difficult life circumstances. I believe they will become 
eager to talk about their life stories during the group sessions.” 
The above opinion was supported by a number of other participants.  
SU3: “I am sure people like the group counselling. It can be acceptable. For example, the 
psychosocial group helped me a lot when I was a child. I acquired HIV from my mother and I was 
not aware from whom I acquired it for so long. After I joined group of peers, I have learned a lot. 
I have got a lot of support from my peers related to HIV/AIDS. Everyone in the group was happy 
to support me at that difficult time. Moreover, such group counselling programme should be 
started for adults too.” 
SU4: “It is a great opportunity when people with the same problem talk to each other. People have 
a tradition of discussing in groups in this clinic. They exchange ideas with their friends. I believe 
the approach can be acceptable.” 
i) Delivering agent  
Focus group participants were asked who would be preferred to facilitate group sessions. All study 
participants strongly proposed the use of trained peer counsellors to facilitate psychological 
interventions.  
AS1: “Peer counsellors can communicate with clients very easily, including with their gestures.”  
Focus group participants argued that the use of professionals suggests “severe mental health 
problem” and they were concerned about such labelling.   
CM2: “The group counselling you planned to introduce would be great if it is provided by trained 
peers. Peers can be selected from clients. …… Sometimes, when we take mentally disturbed 
clients to other professionals, their illness worsens. For example, if I am referred to a psychiatrist 
or psychologist, I will be worried more and more about the severity of my illness. I may say, ‘why 
they refer me…am I getting crazy?’. … Depressed clients can be treated effectively if they are 
counselled by their peers. They can get a lot more lessons and problem-solving techniques from 
peers than from professionals.” 
One of the focus group participants emphasised on the need to get competent group facilitators 
to make the intervention effective.  
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SU4: “There should be a competent person to facilitate group counselling among us. To make 
the group counselling effective, a better person should be selected to lead the group counselling.” 
j) Context 
Most of the participants suggested that the group counselling should be conducted inside rooms 
not in open spaces.  
SU5: “People may not be comfortable when group sessions are conducted in an open space. 
Therefore, an ideal meeting space should be selected. The group sessions should be conducted 
inside a room that should not be accessible by other people who are not a member of the group.” 
Not everyone was happy on the idea to have separate groups by gender as they felt this was not 
an acceptable approach. As supported by the quotes below, all focus group participants 
recommended that men and women be mixed in one group.    
AS2 (Female): “As to me, it is not fair to make a separate group for males and females. Because 
all are matured and are family leaders and passed through difficult life circumstances. The 
experience of men and women complements each other and that would be great for the group 
harmony.” 
CM2 (Male): “I do not completely agree on the idea to have separate groups by gender. I think 
the mixture of the two genders would be a great tool to facilitate team support. They can share 
ideas especially on issues related to marital problems.” 
However, most participants agreed the need to make separate groups by age. They believe that 
children (below 18 years old) and adults should be assigned in separate groups. Their rationale 
for having separate groups by age was because young children may not talk freely in front of 
adults.   
CM3 (Female): “….. Clients can be categorised by age, such as below and above 18 years old. 
Eighteen-year-old man can think similarly to 60-year-old man, so they are the same. We should 
not make too many categories by age difference.” 
There was a debate on frequency of sessions and meeting days. Some participants suggested 
having  group counselling sessions once per month and during the weekend days, either Saturday 
or Sunday. This idea was not accepted by the majority. Many of the participants argued that the 
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learned skills and techniques of the therapy will be forgotten if the group sessions are conducted 
every month. They rather suggested to make group sessions at least once a week.  
SU2 (Male): “Having a group counselling once per week for 2 months is simple to attend for me. 
But what I would advise is the group sessions should be conducted in a place that should be 
convenient for many of the group members. The meeting place should be chosen with agreement 
of the group members.” 
The weekend days were not accepted by many of the participants. Their concern was related to 
confidentiality. They debated that coming to group sessions every weekend may elicit questions 
from people around them.  
AS2 (Female): “The weekend days may not be convenient for many of us. The group counselling 
should be integrated with regular ART care on the working days from Monday to Friday.” 
k) Potential barriers 
Participants discussed potential barriers to implementing the group counselling for PLWHA. Lack 
of transportation access, denial of depression, high case load at the ART clinic, lack of trained 
staff, stigma and availability of convenient meeting spaces were identified as potential barriers to 
implement the group counselling.   
CM4: “We have clients who are coming from different rural areas far from here. I am afraid that 
they cannot pay fees for their transportation or they may not have easy access to transportation.”     
SU6: “People may not accept their illness. They may say ‘I do not have depression’. This is a 
knowledge gap that needs a lot of work to change their attitude. First, they should believe they 
are sick.” 
4.5. Discussion 
This study investigated explanatory models of depression and treatment contextualisation for 
depressed PLWHA in Northwest Ethiopia. It is clear that depression has a name given as ‘Dibirt’ 
[depression] or ‘Ye Dibirt chigir’ [depression problem] by most of the study participants. Some 
study participants reported that ‘Medebet’ [depression] is a name used by mental health 
professionals in Ethiopia to describe depression, but they believe that the general population may 
not understand the term ‘Medebet’. Study participants believed that depression has several 
impacts at individual and family levels for PLWHA, and that it is one of the factors leading to non-
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adherence to ART, increasing drug resistance, high viral load, disability, poverty and death. Given 
this understanding, participants strongly supported the use of psychological treatments for 
depression among PLWHA.  
Important sub-themes emerged from the perceived causes, symptoms and treatment needs. We 
identified that depression is understood to be predominantly caused by psychosocial problems 
among PLWHA. Most identified psychosocial problems as the target areas (problem areas) for 
interpersonal therapy, including conflict, life change and loneliness (35). Our study supports 
reports of previous studies (211, 251) that PLWHA attribute depressive symptoms to psychosocial 
problems. The lived experience of PLWHA confirms the inevitable presence of interpersonal 
stressors, such as conflict within a family, life changes in relation to acquisition of HIV/AIDS and 
stigma attached to HIV/AIDS, that contribute to the onset of depression (241, 252). The findings 
of our study confirmed the relevance of spiritual beliefs in relation to the onset of depression that 
is supported by results of previous studies (243, 244).  
In our study, affective symptoms were the main ones with few mentions of somatic symptoms 
described whereas in previous studies somatic symptoms were predominantly reported by 
PLWHA (227, 235, 251). Our study participants may have been prompted to focus on affective 
symptoms of depression after listening to the presented case study. Furthermore, the mhGAP 
training that some of the participants had received five years back may have helped them to 
understand depression as an affective disorder. However, most study participants described 
depressive symptoms from their lived experience.    
Study participants believed that peer counselling can be helpful for people suffering from 
depression. They described their prior experience on a youth HIV counselling programme which 
brought social support and social connection for many of them. They emphasised the benefits of 
group-based peer counselling that can help with socialisation and social support. This finding is 
consistent with previous studies which have reported that group-based treatments have been 
preferred by depressed PLWHA in sub-Sahara Africa (147, 150, 231, 241) as they enhance social 
networking, social support and allow participants to learn new social skills (231). Furthermore, 
they believe that group-based treatments provide feelings of empowerment, acceptance and 
companionship (241). Study participants perceived the benefits of spiritual treatments such as 
Holy water for healing and recovery from mental conditions including depression. This indicates 
that spiritual interventions of any faith and religion could have important implications for treatment 
of depression for PLWHA in Ethiopia. Therefore, developing/adapting evidence-based treatments 
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that target psychosocial needs and incorporating spiritual elements into treatment models may 
improve acceptability and efficacy of psychological treatments particularly for PLWHA. This 
finding is supported by results from several studies that incorporating spiritual elements with 
psychological interventions can help to treat severe psychological problems associated with life 
threatening health conditions (243-245, 253). However, peer evaluation of counsellors, refresher 
training and regular supervision by health professionals should be in place.  
Group IPT could be an acceptable treatment for depressed PLWHA in the ART settings but 
requires structural and content adaptation within the context of existing health care systems (104, 
223). The findings from our study suggest that a strong emphasis should be given to selection of 
delivering agents and identifying meeting spaces. Study participants from all focus group 
discussions emphasised that case managers and adherence supporters should facilitate group 
sessions. Case managers and adherence supporters were perceived as trusted peers and study 
participants believed that they can understand psychosocial problems of PLWHA. There was 
some concern that they may not have the competency to deliver the group IPT since most of them 
had secondary education only. However, several studies have shown successful reduction of 
depressive symptoms using lay counsellors (96, 131, 138, 141, 148).  
The structure of groups was recommended to be age specific. Adults 18 years and above should 
not be mixed with adolescents. The reason was that adolescents may not feel free to talk about 
their personal stories in front of adults during the group sessions. However, all men and women 
study participants recommended the mixing of men and women clients in one group. They 
believed that mixing men and women can facilitate social support and group harmony. The 
participants felt that all, including clients and facilitators, should be PLWHA so that common 
feature would be sufficient to ensure cohesion for mixed groups.  This finding is different from the 
previous study report by Nakimuli-Mpungu and colleagues that groups should be same gender 
because women may fear to talk their mind in front of men (231). Cultural and educational status 
of group participants may affect the group atmosphere. For example, in a patriarchal and largely 
illiterate community, mixing men and women in one group may not be successful.              
In relation to group size, six to ten clients per group was seen as acceptable by study participants, 
with the size of the venue determining the actual size. Large meeting spaces/rooms can 
accommodate up to ten individuals in one group. However, large group sizes require long session 
duration to allocate sufficient time for each client, otherwise, the therapy may not be delivered as 
intended. In terms of session frequency, one group session per week was welcomed by many of 
86 
 
the study participants. Running group sessions every week allows sufficient time for clients to 
exercise the learned skills at home and it may help them to engage actively in each session. This 
finding is in agreement with the WHO group IPT guideline and with the previous study report from 
Uganda (229, 231). With the above conditions, the group IPT could become an acceptable 
treatment for depression for PLWHA in Ethiopia. 
In relation to confidentiality, study participants preferred indoor settings for group meetings as 
they prevent intrusion from non-members. In addition, as described above, the timing is important 
to ensure confidentiality, that is not on weekends. Hence, future studies should consider 
confidentiality issues, such as venue and timing of group sessions, when implementing 
psychological treatments for PLWHA. Study participants described potential barriers to 
conducting group IPT in the ART settings.  For example, lack of trained facilitators was described 
as a barrier to conduct the intervention by all/many of the groups. The other anticipated barrier 
was lack of access to transportation and travel fatigue for group members. This is a practical 
barrier common to many interventions in low-income countries (84, 254, 255). Arranging meeting 
spaces in the nearest setting may be an option. However, clients may not prefer the nearest 
settings to their home due to fear of stigma and discrimination in the community. But lack of 
transport does mean that interventions will remain inaccessible for the majority of poor and 
disadvantaged communities.  
The ecological and cultural validity model was helpful to generate important findings that informed 
the adaptation of group IPT as described in the result and discussion sections. For example, it 
was helpful to, 1) identify acceptable counsellors and approaches used for the intervention, 2) 
make appropriate language adaptation for the intervention, 3) validate the problem areas of IPT, 
4) design intervention methods/strategies. Using the Kleinman’s explanatory model of illness 
within the ecological validity model (233) was found to be an important approach that helps to 
frame themes for analysis. The conceptual framework contains a set of components that helps to 
explore clients’ perceptions and beliefs about a particular illness. However, understanding some 
of the items in the model needs good knowledge in the area. This was noticed in this study when 
the study participants had a challenge explaining biological causes and risk factors for depression. 
Generally, the model worked well as a guide for this study’s data collection and analysis. If 
Kleinman’s explanatory model of illness is contextually used for different illnesses and 
populations, it can be a reasonable approach applicable to develop and adapt mental health 
interventions.             
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Finally, we found that understanding local explanatory models of depression could maximise 
acceptability and effectiveness of group IPT for treatment of depression for PLWHA in Northwest 
Ethiopia. Thus, local terminologies used to describe depression such as “Dibirt” [depression] or 
“Y’Dibirt chigir” [depression problem] should be incorporated into the group IPT manual and other 
intervention guidelines. In addition, group IPT facilitators should be trained to understand local 
explanatory models, including the biological, psychological, social and spiritual explanations that 
local people have for depression.    
Limitations  
This qualitative study has several limitations that should be noted. Firstly, we used a relatively 
small number of participants with only one focus group per stakeholder category. Secondly, the 
study participants may have been biased by the case vignette presented during the focus group 
discussion. Although there was strong agreement on most of the themes, the results found from 
perceived symptoms of depression may be influenced by the story of the case vignette. Third, our 
study used focus group discussions for data collection, therefore it may have limited exploration 
of sensitive issues such as sexual abuse and harassment.   
4.6. Conclusion      
This study highlighted that a number of psychosocial problems were perceived as contributing to 
the onset of depression among PLWHA in Northwest Ethiopia. PLWHA believe that depression 
affects adherence to ART and leads to increasing drug resistance, high viral load, disability, 
poverty and death. Group-based psychological treatments delivered by trained peers were the 
preferred intervention approaches for depressed PLWHA. Group IPT was seen as acceptable for 
PLWHA. However, special attention should be given to the adaptation and contextualisation of 
the intervention particularly on incorporation of local explanatory models, selection of facilitators, 
selection of meeting spaces and group structure. We recommend further studies to investigate 
whether to include spiritual elements with core principles of group IPT especially for PLWHA in 
Ethiopia. The current study findings will be used to assess feasibility and acceptability trials of 
group IPT in large HIV populations in Ethiopia.  
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Introduction: Psychological treatments are widely tested and have been effective in treating 
depressive symptoms. However, implementation of psychological treatments in the real world and 
in diverse population remains difficult due to several interacting barriers. In this study, we 
assessed the acceptability and feasibility of peer-administered group IPT for depressive 
symptoms among PLWHA.  
Method: We conducted a single-arm, peer-administered, group IPT intervention with eight weekly 
sessions from 15th August to 15th December 2019 among PLWHA in Northwest Ethiopia. Four 
IPT groups were formed for intervention with a total of 31 participants. The intervention was 
provided for PLWHA who had depressive symptoms and were identified from the survey study 
reported on in Chapter 3.    
Results: Of 31 recruited participants, 29 completed the intervention providing a retention rate of 
93.5%. The process of the intervention and its outcomes were highly acceptable as most 
participants expressed success in resolving their psychosocial problems, adjusting to life changes 
and coping with stigma. The intervention was also reported to be feasible despite anticipated 
barriers such as access to transportation, perceived stigma and confidentiality concerns. The 
post-intervention assessment revealed significant reduction in depressive symptoms (mean 
difference (MD)=9.92, t=-7.82, p<0.001), improvement in PSS (MD=0.79, t=2.84, p=0.009) and 
quality of life (MD=0.39, t=4.58, p<0.001).  
Conclusion: Group IPT is feasible and acceptable and PLWHA can benefit from group IPT in 
managing depressive symptoms and in improving perceived social support (PSS) and quality of 
life (QoL). Future studies should examine the effectiveness of group IPT. 
 








Psychological treatments have been widely tested and have shown effectiveness in treating 
depressive symptoms and other common mental disorders (84, 222, 223, 256). The use of 
evidence-based and culture sensitive psychological interventions has attracted attention of the 
scientific community as a result of their promising effectiveness and replicability even in low-
income settings (223). Hence, the WHO advocates access to evidence-based psychological 
treatments for moderate to severe depressive disorders after following proper adaptation 
procedures (257). However, implementation of psychological treatments in diverse population 
and in different settings remains difficult due to several interacting barriers during the 
implementation process (223, 258). Implementation is often undermined by problems related to 
low acceptability and feasibility of the interventions in a new context (102, 258). Several factors 
contribute to low acceptability and feasibility, such as lack of resources and access, workload of 
task-sharing providers, low workforce retention and inadequate levels of competency of delivering 
agents (102).   
In LMICs, common barriers for implementation of evidence-based psychological treatments 
include: i) lack of adaptation of psychological treatments for new populations (101), ii) low 
emphasis given to the importance of conducting cultural adaptation for psychological treatments 
(259), iii) a failure to understand feasibility of the new interventions (260, 261), and iv) low mental 
health literacy of the community limiting their uptake of the interventions (262, 263).  
Psychological treatments may not always need to involve highly skilled health professionals (258). 
They can be delivered by peer counsellors effectively if appropriate training and supervision is 
provided (223). However, it is important to establish whether the treatment is acceptable and 
feasible for a new population and in a new setting. Therefore proper adaptation and systematic 
harmonisation are fundamental to improving ecological validity, cultural sensitivity and 
effectiveness of interventions for new populations (104, 264). Moreover, examining the 
acceptability and feasibility of psychological treatments is crucial before moving into full scale 
evaluation of effectiveness.  
Acceptability is the perception of those receiving the treatment, or any other stakeholders, on 
whether a given intervention and its outcomes are applicable and satisfactory (223, 258, 265). 
From a research perspective, it allows us to determine whether an adequate number of subjects 
will be willing to be recruited for a larger study (89, 265). Feasibility is the extent to which an 
intervention can be provided successfully for a specific population despite constraints (265). It 
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examines overall barriers and facilitators to the implementation of an intervention such as 
applicability (deliverable as planned) and practicality (delivered despite barriers) (266, 267). 
Feasibility evaluation is particularly important for implementation of psychological treatments in 
low resourced settings and in communities with different cultural backgrounds where the context 
of implementation may differ from the one where it was originally developed (266).           
IPT, a well-tested psychological treatment in high-income countries, has shown efficacy for 
treatment of depressive symptoms in a variety of populations (92). A recent systematic review 
and meta-analysis (reported in Chapter 2 of this thesis) found that group IPT was effective in 
reducing depressive symptoms in PLWHA in LMICs (88) and a further study (reported in Chapter 
4 of this thesis) found that most of the triggering factors for depression were core intervention 
areas of IPT (109). IPT explores interpersonal problems, finds the link between interpersonal 
problems and depression, and solves the problem areas (92, 268). The group format of IPT is 
believed to increase coverage and reduce cost of the intervention (14, 92). Furthermore, it helps 
counsellors to identify and work on specific problematic communication patterns during 
interactions among group participants to solve interpersonal problems (92).   
In this study, we aimed to assess the acceptability and feasibility of peer-administered group IPT 
for treatment of depressive symptoms among a selected group of PLWHA in Northwest Ethiopia. 
We also examined retention rate and the effect of the intervention in reducing depressive 
symptoms, and improving QoL, functionality and social support by comparing baseline and post 
intervention assessments. Although peer-administered psychological treatments are widely 
implemented in a task shifting approach in LMICs (269-271), their acceptability and feasibility 
have not been explored in Ethiopia. The current study was the first effort to pilot group IPT in an 
HIV population in Ethiopia. The CONSORT extension to the pilot and feasibility checklist (272) 
was used to report the findings of this study. Items that were not applicable to this study, such as 
randomisation and blinding items were omitted as there was no comparable control group.   
5.3. Methods 
5.3.1. Study design and Setting  
A single-arm intervention study with a nested qualitative study was conducted from 15th August 
to 15th December 2019 with PLWHA who attended ART follow-up appointments during the study 
period at Felege-Hiwot Referral Hospital (FHRH) in Northwest Ethiopia. We used peer-
administered group IPT intervention with eight weekly-sessions for treatment of depressive 
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symptoms and examined the acceptability and feasibility of the group IPT for PLWHA in Ethiopia. 
A detailed description of the setting is available in Chapters 3 and 4 of this thesis (109).  
5.3.2. Participants  
Study participants were recruited from a sample enrolled in a randomly selected cross-sectional 
survey of PLWHA (N=393) attending the facility from 8th July to 7th October 2019. Results of the 
survey are published and available in Chapter 3 of this thesis (273). A formal sample size 
calculation is not appropriate for pilot studies (274), therefore participants were recruited into the 
intervention consecutively from the survey (273) until sufficient participants were recruited to form 
four IPT groups. When participants were found eligible for the intervention during the survey (273), 
they were immediately referred to the group IPT intervention. The survey assessment served as 
the baseline for the pilot study. Both the MINI and PHQ-9 were administered during the baseline 
study. But in chapter 5, I used PHQ-9 because, this thesis is built up from the findings of chapter 
2, systematic review and meta-analysis, that identified effective interventions for depressive 
symptoms not for MDD. Moreover, PHQ-9 is more appropriate to measure outcomes of the 
intervention as a continuous variable than the MINI. 
Participants who (i) were adults aged 18 years old or above attending clinical follow-up at the ART 
clinic of FHRH; (ii) scored five or more on a locally validated Amharic version of the PHQ-9 (275); 
and/or (iii) were diagnosed with MDD using the MINI were referred by research assistants to group 
IPT counsellors immediately. Peer counsellors received those clients who had already provided 
verbal consent to the data collectors. Peer counsellors then took further written consent. In 
addition, peer counsellors have no role in deciding on the care of PLWHA. Counsellors checked 
clients’ documents for eligibility and approached them to invite them to participate in the 
intervention. Exclusion criteria for the intervention were (i) being severely sick with a major 
physical illness or needing urgent medical attention (for example, people with TB); (ii) those 
identified as being a danger to themselves or others, such as through reports of suicidal or 
homicidal ideation; (iii) having emotional problems as a result of an organic cause or substance 
use – detected by research assistants using the MINI exclusion criteria for MDD; (iv) having a 
major depressive disorder with psychotic or catatonic features; and (v) those who were diagnosed 
with cognitive deficits or Tuberculosis by ART clinicians or as indicated in the patient’s clinical 
chart. It would be good to include people with TB who completed the initial phase of TB therapy. 
However, there is a risk of TB treatment failure at any phase of TB therapy which could have a 
potential risk. The decision to exclude people diagnosed with TB regardless of their treatment 
phase was made based on a recommendation of counsellors for full safety of group participants.  
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Group IPT counsellors provided a detailed explanation on the purpose and content of the 
intervention.  
Baseline information of each participant who agreed to join the intervention was then captured 
into a patient folder. IPT groups were formed as soon as six to ten participants agreed and 
consented to join the intervention. Group sessions were started within a week after groups were 
formed. Session days in the week and regular meeting times were set according to the availability 
of all participants in that group. See figure 14 illustrates how participants were recruited to the 
intervention. See the standard operating procedure in Appendix F. 
At the end of the intervention, we randomly selected a total of 12 group IPT participants (three 
participants from each IPT group), for in-depth interviews to explore their views on the 
acceptability and feasibility of group IPT for PLWHA in Ethiopia. We also recruited all of the 
counsellors (n=6) for a focus group discussion to elicit their opinions on the acceptability and 
feasibility of the group IPT intervention.  
 
Figure 14. Procedures of recruitment into the pilot study. 
5.3.3. Procedures 
a) Selection of trainers, supervisors and potential counsellors 
Group IPT trainers were selected from the academic staff in the Department of Psychiatry in Bahir 
Dar University. The selected group IPT trainers were mental health professionals with a Master’s 
level educational background who studied clinical and community mental health for at least 2 
years. They had completed the group IPT training of trainers’ course and had five to ten years’ 
experience in organising and facilitating mental health training for health professionals. In addition 
to their academic work, they were also providing clinical services at the Psychiatric clinic in FHRH. 
They provided the group IPT training for supervisors and potential counsellors in accordance with 
the adapted WHO group IPT manual (229).  
Cases were detected by 
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In consultation with stakeholders of the ART clinic, we set the minimum criteria for selecting 
potential counsellors. These were: a minimum of secondary education (grade 10 and above), 
being an adherence supporter, case manager, HIV educator or community health worker at the 
ART clinic, involved in the direct care of PLWHA in the last one year, and being highly motivated 
to help others. After further discussions with the trainers and supervisors, we decided that the 
most suitable people to do the counselling were the adherence supporters and case managers. 
Case managers and adherence supporters were most suitable to provide the intervention 
because of their shared lived experiences with difficult life circumstances, views about cause and 
treatment of depression, and to minimise stigma and maintain confidentiality (109).  
b) Group IPT training for candidate counsellors and supervisors  
A total of 12 people (ten candidate counsellors and two candidate supervisors) received intensive 
group IPT training for seven days guided by the WHO group IPT curriculum (229). The duration 
of the training was decided by the group IPT trainers’ recommendations. The training was 
facilitated by four group IPT trainers – two trainers led the morning sessions and the other two 
facilitated the afternoon sessions. The training included brainstorming, brief presentations, group 
discussion and many role plays to demonstrate group facilitation skills. Daily training evaluations 
were conducted at the end of each training day and the trainers adjusted the training to 
accommodate given comments. At the completion of the training, all trainees took an exit test to 
assess their level of competency. The test was developed by the WHO group IPT team that 
included 15-item questions available at the appendix of the manual (229). The score was 
calculated based on the scoring instruction indicated in the manual as follows: 2 points if the 
question was answered adequately, 1 point if important information was missing, and 0 if it was 
not answered correctly. The WHO-IPT guideline recommends that group IPT trainees should 
achieve a score of at least 70% to effectively facilitate the group IPT intervention (229). Of the ten 
candidate counsellors, six of them scored above 70% and were recruited to facilitate the group 
IPT intervention as counsellors. The main responsibilities of counsellors are indicated in Box 5.1.  
The two nurse professionals (HT and TG) who were recruited initially with the intention to serve 
as supervisors were also found competent in mastering the group IPT (scored above 70% on the 
exit test). The group IPT trainers provided brief supervision training for HT and TG for one 
additional day after the completion of the group IPT training. This focused on how to conduct 
constructive and effective supervision, when and how to conduct supervision, how to conduct 
fidelity assessments for each group session, and when and how to exchange feedback with 
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counsellors and the PI. Both HT and TG practiced supervision in role plays in front of the trainers 
before being recruited as supervisors. Each supervisor practiced real supervision in three IPT 
sessions under supervision of the trainers before conducting supervision independently as 
recommended in the manual (229).          
The main responsibilities of the supervisors were supporting and organising the overall delivery 
of the project and maintaining contact with stakeholders such as the PI, counsellors and staff 
members working at the ART clinic. This includes overseeing, monitoring and evaluating the 
progress of the intervention, coordinating the intervention team, and checking fidelity. Supervisors 
observed each IPT group during sessions at least every two weeks. They also listened to the 
audio-recorded sessions and evaluated fidelity of each session. They were also responsible for 
evaluating group sessions using fidelity checklists, to provide feedback to counsellors and to 
report to the principal investigator.  
Box 5.1. The main responsibilities of peer-counsellors  
• Receiving eligible participants, getting consent, conducting pre-group counseling and 
documenting participants’ physical address and telephone number. 
• Forming IPT groups, setting a meeting date, time and place. 
• Evaluating depressive symptoms of each participant, taking attendance notes.   
• Facilitating the group counselling (conducting the problem inventory, encouraging 
participants to generate possible solutions, make decision analysis, set strategies, 
providing guidance and counseling). 
• Referring clients who refused to participate in the group IPT to supervisors and 
transferring severely sick or dangerous clients to the Psychiatric clinic.   
c) Theory of change workshop 
A theory of change can be defined as follows “A particular approach for making underlying 
assumptions in a change project explicit, and using the desired outcomes of the project as a 
mechanism to guide project planning, implementation, and evaluation” (276).  A Theory of Change 
workshop was conducted one month before the initiation of the intervention to identify available 
resources, potential barriers for implementation of group IPT and to design acceptable 
implementation approaches without affecting the usual HIV care at the ART clinic. Case 
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managers, adherence supporters, mental health professionals, group IPT trainers, nurses and a 
unit leader at the ART clinic were invited to attend the workshop. A total of 12 people participated 
in the workshop (five case managers, three nurses, two adherence supporters, one mental health 
professional and the head of the ART). Workshop participants explored problems that affect the 
life of PLWHA, intervention strategies for group IPT, and set assumptions and indicators. The 
assumption that managing depression improves social support, functioning and quality of life was 
identified as prior conditions to the intervention. The availability of meeting spaces, human 
resources to be trained as counsellors, and staff good will and motivation were identified as 
facilitators for implementation of the group IPT. Limited access to transportation, fear of stigma, 
poor help-seeking behaviour, low understanding by the public about the disabling nature of 
depression, and illiteracy of most PLWHA (for documenting homework during the intervention) 
were identified as barriers to the implementation of the intervention. See Figure 15 for Theory of 
Change map.  
 
Figure 15. Theory of change on the implementation of group interpersonal therapy for depression for 
people living with HIV/AIDS. 
Note: Post intervention assessment of CD4 count or viral load was not conducted, as it is not likely that significant 
change in CD4 count or viral load would be observed immediately after two months of a group IPT intervention.   
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d) Implementation   
The intervention was guided by the adapted WHO group IPT manual (109). Prior to initiating the 
intervention, we completed a substantial process of adapting the original WHO group IPT manual 
into the local context (reported in Chapter 3 of this thesis). This helped to determine preferred 
counsellors, group size and dynamics, meeting space and place, and suggested number, duration 
and frequency of sessions. We followed several steps while conducting the adaptation using the 
Participatory and Iterative Process Framework for Language Adaptation (PIPFLA) which is 
available at the Appendix G (277). Initially, the original manual was translated into Amharic by HT 
then back translated by TG. The harmonised document and the original manual were sent to four 
scientific reviewers (three of them were mental health professionals and one of them was clinical 
psychologist) for review and their comments incorporated by BA. Finally, a half day adaptation 
workshop was conducted to further revise the manual. Several stakeholders participated in the 
workshop such as nurses working at the ART clinic, adherence supporters, case managers, head 
of the ART clinic and mental health professionals. The final harmonised manual was used in the 
training for this pilot evaluation.      
The intervention comprised of eight weekly 90 minute sessions structured into three phases: 
initial, middle and termination phases. Two counsellors were assigned per IPT group (one mainly 
documenting and the other leading the discussion, but neither limited to these activities). The 
sessions were conducted at the ART clinic in rooms arranged to accommodate 10 to 12 people 
at a time.  
Prior to joining group sessions, every participant received pre-group counselling (one individual 
session). During the pre-group session, counsellors assisted each participant to recognise 
depressive symptoms, to link their interpersonal problems with depressive symptoms and to set 
strategies and goals for solving the problems. The initial group phase (session one) included a 
brief discussion on depression and its impacts, and the IPT problem areas (intervention 
components), followed by presentation of their own depressive symptoms by each participant and 
exploration of the links between depressive symptoms and the problem areas. In this initial group 
session, the group members agreed on group goals that should be achieved in the next seven 
sessions. In the middle phase (sessions two to seven) group participants developed strategies to 
address the identified problems and to implement selected strategies. Depressive symptoms and 
the links to problem areas were reviewed every week from sessions two to seven. The strategies 
were evaluated in every session and participants shared stories related to their success to 
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encourage others. Homework and practical exercises were given every week. In the termination 
phase (session eight), depressive symptoms and problem areas were reviewed, and plans set for 
each participant. Discussions were held on how to recognise a relapse in depressive symptoms 
and what they should do when they have symptoms. The implementation phases and respective 
activities are described in Table 13. Counsellors document the progress of every participant every 
week on counsellors’ weekly note (See Appendix H).  
e) Review meetings  
The implementation team (counsellors, supervisors and the principal investigator) met every week 
for an hour. The aim of the review meeting was to exchange feedback, evaluate the progress of 
the intervention and address challenges that affected the intervention. The meetings focused on 
enhancing the implementation, for example adherence to the protocol and evaluating decisions 
made by the counsellors and supervisors.  
f) Fidelity of the intervention  
All group IPT sessions were audio-recorded for the purpose of fidelity evaluation. At completion 
of each session, fidelity was rated by the two supervisors (HT and TG) and the Principal 
Investigator (BA) independently using the WHO group IPT fidelity checklist which is available at 
the appendix of the manual (229) which is also included in the appendix of this thesis (See 
Appendix D, module three).  Subsequently, identified gaps in adhering to the intervention protocol 
were communicated to the counsellors in a brief post-session meeting. Discrepancies in the 











Table 13. The structure of the group interpersonal therapy implemented at the ART clinic in 
Felege-Hiwot Referral Hospital. 





• Conducting symptom inventory guided by PHQ-9 items.  
• Exploring links between onset of symptoms and 
interpersonal problems.  
• Providing hope and help clients to join the IPT group. 
Initial phase  Session 1 • Facilitate the group members to introduce themselves to 
each other. 
• General discussion about depressive symptoms and 
interpersonal problems. 
• Facilitate participants to talk about their symptoms and 
triggering factors. 




Session 2 – 
7  
• Review symptoms of each participant.  
• Link depressive symptoms to events from the previous week. 
• Encourage participants to contribute problem-solving 
options. 
• Decision analysis and implement the strategies to achieve 
the goals. 
• Providing homework for every participant.  
Termination 
phase  
Session 8 • Evaluate number and severity of symptoms. 
• Make plans, consider referral or consultation if symptoms 
persist. 
• Discuss relapse of symptoms and actions to be taken. 
5.3.4. Implementation outcomes  
a) Acceptability  
Group IPT participants were asked to provide their overall views and specific issues on the 
acceptability of the group IPT intervention. They were asked to provide their views on the number 
of sessions, session duration, frequency of sessions, competency of counsellors, group size and 
intervention site. They were also asked to describe their level of satisfaction with the sessions, 
process of the intervention, competency and approach of counsellors, the convenience and 
comfort of intervention location, handling of clients’ information and confidentiality, and with the 
outcome of the intervention. They were also asked to rate their level of satisfaction with the overall 
process of the intervention with a range from very dissatisfied to very satisfied. At the completion 
of the intervention, counsellors shared their views on the acceptability of the intervention in the 
interviews, and provided detailed suggestions on an acceptable approach for future use referring 
to their observations and experience of providing the intervention.        
101 
 
b) Feasibility  
Feasibility of the intervention was explored using semi-structured open-ended questions. The 
questions were framed to explore the following concepts: i) available resources and trained 
people to carry out the intervention, ii) applicability of the intervention to the larger HIV population, 
and iii) compatibility of the intervention with existing health service systems. In addition, we 
calculated the retention rate by dividing the number of participants who completed the intervention 
by the number of participants who began the intervention to evaluate whether group participants 
were able to complete the intervention despite anticipated barriers. 
c) Depressive symptoms, QoL, functioning and perceived social support 
Group IPT participants who completed the intervention were reassessed for depressive 
symptoms, PSS, functioning and QoL using the PHQ-9, MDPSS, WHODAS-12 and the brief 
Ethiopian version of the WHOQOL-HIV instruments respectively. PHQ-9 has been widely used in 
epidemiological studies in Ethiopia. A validation study (unpublished) with an HIV population in 
Ethiopia reported that a sum score of five and above of the PHQ-9 predicts probable depression 
among PLWHA. PHQ-9 because, this thesis is built up from the findings of chapter 2, systematic 
review and meta-analysis, that identified effective interventions for depressive symptoms. 
Moreover, PHQ-9 is more appropriate to measure intervention outcome as a continuous variable 
than the MINI (278). Detailed description of these instruments is available in Chapter 3 of this 
thesis (273).  
5.3.5. Data collection 
Qualitative data collection and pre-post assessments were conducted by independent research 
assistants who were trained for data collection purposes only. All of the research assistants were 
nurse professionals who had prior experience in mental health research with PLWHA and had 
received mhGAP training. We provided them with a three-day practical training on qualitative and 
quantitative data collection applicable to the intervention. Qualitative data were collected using 
audio-recorded individual in-depth interviews of the group IPT and a focus group discussion with 
counsellors. In-depth interviews were conducted with selected participants from each IPT group 
at the completion of the intervention as described above. The in-depth interviews and the focus 
group discussion were aimed at assessing acceptability and feasibility of the group IPT.   
At the completion of the intervention the same measures used in the baseline were administered 
to all group participants to evaluate the status of depressive symptoms, perceived social support, 
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functioning and Quality of Life. The post-intervention quantitative data were collected by one 
research assistant who did not participate in any other way in the intervention.   
5.3.6. Analysis 
A framework approach was used to analyse the qualitative data and to explore the acceptability 
and feasibility of the intervention. The audio-recorded data were transcribed verbatim into 
Amharic and translated into English. The translated transcripts were double checked for accuracy 
and imported into NVivo 12 computer programme for analysis. The data were analysed using 
predefined themes using a framework approach (279, 280). The themes for acceptability were 
overall acceptability of the intervention, benefits gained from the intervention, satisfaction with 
counsellors, acceptability of the structure and process of the intervention. The themes for 
feasibility were general views on the feasibility of using the intervention for a larger population, 
barriers to the intervention and strategies to solve the barriers, feasibility of using peer 
counsellors, and general recommendations. The themes for acceptability and feasibility were 
selected from core elements of intervention adaptation and implementation science (89, 223, 265) 
and based on the scope of our study. 
Quantitative data were analysed using SPSS version 26. We used descriptive statistics to 
summarise participants’ characteristics and to calculate mean scores. Paired samples t-test 
analysis was used to compare the scores of depressive symptoms, QoL, functioning and PSS 
before and after the intervention, and to examine the direction of the change of the intervention. 
The paired samples t-test analysis was conducted after homogeneity and normal distribution 
assumptions were fitted in the model.   
5.3.7. Ethical approval 
The University of Cape Town’s Human Research Ethics Committee and Bahir Dar University 
College of Medicine and Health Sciences’ Ethics Committee approved this study. The ethical 
approval letters are attached at the Appendix (see Appendices A and B). A permission letter was 
also obtained from the Amhara Public Health Institute. All study participants provided written 
informed consent. Illiterate participants signed using a fingerprint after a witness read the written 





5.4.1. Participants recruitment and retention   
A total of 36 clients were approached and 31 of these recruited as participants and assigned into 
four groups for the intervention within a one-month recruitment period. Of the total participants 
recruited for the intervention, 29 of them completed the intervention providing a retention rate of 
93.5%. Among those who completed the intervention, 28 were reassessed for depressive 
symptoms, QoL, functionality and PSS one week after the end of the intervention and one 
participant did not return for re-assessment (Fig 16). One of the participants from group 1, who 
had a previous history of psychosis, was referred to the psychiatric clinic as she started showing 
inappropriate behaviour and suspiciousness towards other group members at the 4th group 
session. One more participant from group 2 was lost after the fifth group session and the 
intervention team could not find him using his contact address. One of the participants from group 
3 who completed the intervention refused to come for re-assessment.           
 
Figure 16. Recruitment, group formation and retention of group IPT participants. 
5.4.2. Socio-demographic characteristics of the participants  
Of the total recruited participants for the intervention (N=31), three quarters (n=23, 74.2%) of them 
were women and 41.9% (n=13) were either divorced or widowed. More than half of the recruited 












6 completed the 
intervention












31 Participants assigned in four IPT 
groups
2 refused, 2 moved, 1 referred 
104 
 
Table 14. Baseline socio-demographic and clinical characteristics of the group IPT participants 
(N=31). 
Socio-demographic and clinical characteristics  Number  Percent  
Age in years  18-29 6 19.4 
30-39 13 41.9 
40-49 9 29.0 
50+ 3 9.7 
Gender Male  8 25.8 
Female  23 74.2 
Marital status  Single  7 22.6 
Married/ in relationship  11 35.5 
Divorced/widowed  13 41.9 
Educational status  Illiterate  17 54.8 
Completed primary education   9 29.0 
Completed secondary education  4 12.9 
Completed tertiary education   1 3.2 
Employment  Public servant    2 6.5 
Self employed 17 54.8 
unemployed  12 38.7 
Current CD4 
count  
<200  5 17.9 
200-349 4 14.3 
350-499 5 17.9 
>500 14 50.0 
ART treatment 
regimen 
first-line treatment 17 56.7 
second-line treatment  13 43.3 
Duration of ART 
treatment in 
years 
1 - 5 8 26.7 
6 - 10 11 36.7 
11 and above  11 36.7 
FHRH – Felege-Hiwot referral hospital; Current CD4 count refers to the recent CD4 count within the last 6 months; IPT – 
interpersonal therapy.  
5.4.3. Acceptability 
a) Overall acceptability 
All the processes and outcomes of the intervention were generally reported to be acceptable by 
all of the participants as it is a time-limited intervention with weekly sessions lasting less than two 
hours.  Some of them stated that the intervention facilitated the generation of solutions for social 
and legal problems such as marital and parental problems, neighbourhood disagreements and 
conflict in relation to property (for example related to their land or house), psychological problems 
such as fear of disclosing their HIV status, fear of establishing relationship, and self-stigma. 
Note: The codes used along with the quotes below refers to the following. The letter “G” refers to 
“Group”, “N” refers to “Participant number” and “C” refers to “Counsellor”. For example, “G4N12” 
refers to “Group 4, participant number 12” and “C4” refers to “Counsellor 4”. 
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G4N12: “I really enjoyed the group counselling …. the group was great in generating solutions for 
problems common to everyone such as disagreement and self-isolation from social participation.  
That is why I am coming every week to attend sessions.” (35 year old female). 
Most of the participants believe that the existing culture in the community supports group 
counselling and one of the participants considering “becoming a counsellor”.  
G3N7: “Our culture supports open discussion and togetherness during difficult times. … I found it 
much better when it is conducted in a formal way in the clinic. …. I have a diploma in nursing, and 
I have discussed with my husband about becoming a counsellor. I am confident that I can facilitate 
group sessions effectively if I can get the counsellors training.” (28 years old female). 
Most participants reported that the group counselling was helpful to establish socialisation and 
friendship.  
G2N4: “… Now, I have got wise and supportive friends. The group counselling has helped me to 
understand that there are many people who have more severe problems than mine.” (28 year old 
male).  
Most of the participants agreed that the group counselling was helpful to work as a team on 
common social problems.  
G2N5: “The group counselling was helpful to work as a team on common problems… people in 
the group come up with a lot of problems including marital problems, legal and land issues. Group 
members suggest different strategies to solve each problem. We shared these problems and we 
tried to solve each of them step by step. We achieved good results in solving such problems in 
the group.” (42 year old, male participant). 
The diversity of the group participants was perceived to be helpful to find solution for problems.   
G4N11: “Group members were diverse who were better than me... and they were caring like a 
mother. There were many people who had bigger problems than mine and I reassured myself 
that my problem was easier to be solved. Solutions were generated when people share their 
problems with other group members.” (40 year old, female participant). 
However, one of the group participants was disappointed when her comments were rejected by 
the participants during group discussion but was able to move beyond that. 
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G1N2: “Once, I felt disrespected when most of the group participants rejected my opinion. I felt 
ashamed, sad and tearful. However, it did not stop me from coming to the group sessions. The 
good thing was counsellors apologised to me for it and they told to the participants to respect 
each other.” (32 year old, female participant). 
Counsellors also reported that the group IPT was acceptable because it was a medium that 
encouraged most of the participants to bring change into their lives.  
C4: “The group counselling was a source of motivation for all of the participants. I have been 
observing a great change in their behaviour and facial expression. They appeared comfortable 
from session to session – they had warm greetings, free communications, and socialisation with 
their friends.” (45 year old, female counsellor). 
Another counsellor added that all of the participants were happy and thankful to the group 
counselling.  
C3: “They did not rush to go home…. they wish to stay with us the whole day …all of them were 
happy in the intervention and they all thank us at the end of each session.” (35 year old female 
counsellor). 
b) Perceived Benefits 
More than half of the participants reported that the intervention helped them in solving social 
conflicts and those participants who had not done so, said that the intervention helped them to 
disclose their HIV status to their family and to be hopeful in their life.  
G1N1: “I had long lasting conflict with one of my neighbours. She (the neighbour) was a pain for 
me for a long time. Last week, I greeted her, and she hugged me with a smile. I felt as if a big 
burden has removed from my shoulder. After that day, I am getting good sleep and a feeling of 
freedom.” (50 year old, female participant). 
The group counselling was helpful to build smooth communication within a family. 
G1N2: “My husband and I used to have disagreement for long time. I used to feel lonely, 
depressed and even thinking of committing suicide. Now, I have learned techniques on how to 
have smooth conversation with him despite our disagreement. I have gained confidence, 
tolerance and calmness to have smooth conversation with him. I have no more anger feelings, 




For others, the intervention helped them in gaining confidence to disclose their HIV status to their 
family members.  
G1N3: “I used to cry day-in day-out, I used to have severe headache all the time. …. After I 
attended the first few sessions, I have decided to disclose my HIV status to my closest people. 
Later on, my pain has gone. I have no shame any more to share my story to others, Thanks to 
God.” (37 year old, female participant). 
G4N12: “Before joining the group counselling, I was thinking too much, I used to worry a lot. 
Currently, I am feeling better, I am sleeping very well. I have started a peaceful life. In addition, I 
have got an opportunity to meet new people.” (35 year old, female participant). 
Counsellors also reported that they have noticed positive changes in most group participants. 
C4: “I have seen changes from session to session – they become comfortable with group 
members from session to session. They had warm greetings, free communications, and 
established good socialisation with their friends which indicates how they all are improving. I am 
really happy for seeing changes among participants and for being part of the intervention team.” 
(45 year old, female counsellor).  
All of the counsellors also believed that the group IPT was successful in reducing depressive 
symptoms of the participants. 
C5: “The group counselling was effective in bringing significant changes. Participants understood 
what depression is and how it affects their daily lives which is a good thing. We believe that most 
of the problems that cause depression were managed.” (58 year old male counsellor). 
C6: “Many of the group participants had similar problems. Most of them had sleep problem, some 
had poor appetite, some were living lonely and most of the symptoms were resolved.” (40 year 
old, male counsellor). 
c) Satisfaction with counsellors     
All the participants were happy with the competency and skills of counsellors. They said that the 
peer counsellors could understand common problems of PLWHA.  
G2N6: “I am happy with the counsellors because all of them were our peers who passed through 
the same difficult life circumstances. They have given us a lot of hope and we feel we can be 
healthy as they are.” (55 year old, female participant). 
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Another participant said that the words of counsellors were encouraging and brought hope in 
everyone’s life.   
G4N12: “They are very supportive like a family – like a mother and a father. … Their word is 
encouraging and gave us a lot of hope.” (35 year old, Female participant). 
d) Satisfaction with the intervention setting 
Most of the participants were happy with the meeting place and space. However, some of them 
recommended conducting group sessions in a more private place that has minimal social 
interruptions. One participant said that group sessions can be conducted anywhere but felt 
uncomfortable to come to the ART clinics due to her “bad memories” at the ART.  (40 year old, 
female participant). 
G2N6: “I would appreciate if the group sessions were conducted in “gelel yale” [a bit isolated] and 
open place, … an open place that has minimal social contact but it should be inside this hospital.” 
(65 year old, female participant). 
G4N11: “It can be conducted in open spaces or anywhere that can create relaxing feelings. For 
example, under a tree or anywhere even in any green area. Then, everyone can feel free to share 
their ideas.” (40 year old female). 
e) Views on number and duration of sessions 
Conducting one session weekly for a duration of eight weeks was accepted by all participants. 
G3N8: “… Having one session every week gives us much time to work on our homework. 
Completing the intervention after eight group counselling is fine with me.” (44 year old, male 
participant). 
G4N11: “All was perfect for me. It was not too much not too little, so I do not have any suggestion 
to be changed.” (40 year old, female participant).  
The 90 minutes session duration was perceived to be sufficient.  
C1: “Sometimes, too long sessions may become boring. There were occasions that some group 
participants appeared bored during group discussions. I think, sessions were good because we 
have used an average session duration that can make everyone happy.” (36 year old, female 
counsellor). 
Another counsellor emphasised the importance of proper time management during sessions. 
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C5: “I think the time is sufficient if we are structured and goal directed. I think we should manage 
the time properly in leading sessions.” (58 year old, male counsellor). 
However, some of the counsellors argued that 90 minutes is too short, while most counsellors 
argued that it was enough to review each group participant’s issues.  
C4: “The 90 minutes session duration was short for me to cover all ideas coming from every 
participant.” (45 year old female counsellor). 
Counsellors were optimistic about the intervention bringing significant change for all group 
participants. But, they wanted to extend group sessions “until everyone feels healthy” and they 
suggested inclusion of more sessions “up to 10 or 12”. 
C2: “If our aim is to bring change for every person, we should extend the number of sessions until 
everyone feels healthy. We have seen great changes with eight sessions but we can solve a lot 
of their problems if it was extended to more than eight sessions. There were people who were not 
fully recovered after completing all the eight sessions, they could bring change if it was extended 
to 10 or 12 sessions.” (33 year old, female counsellor). 
C1: “… One session every week for two months could be fine. Because it gives participants more 
time to think and work on their homework. I suggest having graduation for those who recovered 
fully…. But those who did not recover after completing all the eight session should continue taking 
the intervention. Perhaps, we can mix those whose problem remains unresolved to other groups.” 
(36 year old, female). 
5.4.4. Feasibility of group IPT  
a) General views on feasibility of the intervention  
IPT in a group format was perceived to be feasible by almost all participants, as long as it is 
conducted in an accessible and private setting and an adequate number of peer counsellors are 
available. Some of them mentioned that the lack of trained peer counsellors could be a barrier to 
expanding the intervention. To make the group IPT feasible for everyone, a participant suggested 
making a special arrangement for public employees such as “conducting one session per month 
with a longer session duration”.  
G4N11: “For public employees like me, asking bosses for permission every week may be difficult. 
Therefore, special arrangement could be made for people who cannot attend sessions every 
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week for example, conducting sessions, once per month for longer session duration would be 
another option.” (40 year old, female participants). 
G3N7: “The challenge, when expanding this intervention to larger populations may be lack of 
trained counsellors. … I am confident that the intervention can attract a lot of people. This is 
something special that has changed my social life.” (28 years old, female participants). 
Stigma was a concern for some informants, but they believed that people can learn coping skills 
after a few sessions.   
G4N12: “Initially, I was thinking like what if people stigmatise me. ….. but later I gained the 
confidence to face any stigma. It was no more my concern after few sessions, and it did not affect 
me to come to the group.” (35 year old female). 
All the counsellors believe that the group IPT can be feasible “in involving more people in the 
future as long as clients are responsive”. 
C1: “The group counselling can be successful and can address more people.” (36 year old, female 
counsellor).  
b) Views on feasibility of using trained peer counsellors  
All group participants felt that the counsellors were successful in delivering the intervention.  
G1N2: “… All of them were great facilitators. They took notes and summarise ideas of each 
participant.” (32 year old, female participant). 
One of the informants appreciated the level of the training given to counsellors.    
G4N11: “…. They facilitated group discussions in a professional way. …. To be honest, I did not 
expect this much knowledge and skill and in them. They were leading sessions as a professional 
who has intensive experience in counselling. It shows how they were well trained in counselling.” 
(40 year old, female participant). 
c) Experienced barriers 
Participants experienced several barriers to attending group sessions such as access to 
transportation, employment, social responsibilities, sickness and stigma.  
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G1N1: “Initially, I thought that I had no energy to come every week because my home was far 
from the town. Later, I found it a good opportunity to go out of home for a good reason.” (50 year 
old female). 
G2N6: “Unfortunately, I did not come for two session due to family issues. My daughter gave birth 
and I was with her to take care of her. I could not come because of social responsibility towards 
my daughter.” (65 year old female). 
Sickness of oneself or a family member was one of the barriers reported by participants. 
G3N9: “I was unfortunate that I skipped the last three sessions because I was sick with kidney 
disease. I had urgency to urinate and I should go for toileting frequently. That disturbs others 
which was also against our group rule. Second, the pain could not allow me to maintain my focus 
fully on the discussion.” (42 year old, male participant). 
G3N7: “I skipped one session because my child was severely sick with flu.” 28 years old, female 
participant). 
Lack of mental health literacy and stigma were also reported as barriers to attending sessions. 
G3N9: “People who have poor understanding about depression may not come to group sessions. 
They may not expect getting solutions or they may be afraid not be named “chinketam” [an insult 
for people with excessive worry].” (42 year old, male participant). 
To most of the counsellors, the intervention was completed smoothly, however some of them 
reported that phone calls were causing interruptions during sessions.  
C2: “We did not face any big barrier to deliver the intervention because every group participant 
was well organised. I am sure people like to participate in such a lovely counselling programme 
however it should be accessible to everyone including people in rural part of the country.” (33 
year old, female counsellor). 
C5: “Initially, some clients were not silencing their phone calls but later everyone silenced their 
phone after we included it in the list of the group rules.” (58 year old male counsellor). 
In addition, presentation of new and bigger problems in every session by participants affected the 
process of the intervention to achieve the initial goals.  
112 
 
C3: “Some problems presented by participants were not achievable in the short term. When we 
focused on achievable problems, they became less interested and they took the group discussion 
to the biggest problem that we could not fix it alone.” (35 year old female counsellor). 
d) General recommendations received    
Group participants recognised the burden of depression in people with HIV/AIDS and they 
recommended expanding the group counselling programme for a larger HIV population.  
 G1N2: “We have been fortunate to be included in the group counselling, however there are many 
hopeless, sad and depressed people who need urgent help. I recommend you to make this 
programme accessible to many people.”  (32 year old, female).  
G2N6: “There are many people who are in need of help,  therefore you all should give them 
priority. Similar counselling programmes should reach out to others suffering from depression 
elsewhere.” (65 year old female). 
G2N7: “It should continue and should address more people. You should make it accessible for 
those who are staying in rural areas.” (28 year old female). 
Counsellors also recommended expanding the intervention by involving other stakeholders.   
C5: “It is good to include more stakeholders to expand the intervention and to increase its access 
for many people. For example, you should consider involving the government because some 
problems reflected from participants require multisectoral involvement.” (58 year old male 
counsellor). 
C3: “Yes, it needs collaboration…because some of the problems require involvement of other 
stakeholders to support these people. Some participants may not have shelter, and some may 
not have food. Even some may need lawyers to solve their legal problems in courts. I would say 
most of our clients died not because of HIV but due to psychosocial and financial problems.” (35 
year old female counsellor). 
C1: “We understood that depression is caused by life change due to the HIV in many of our clients. 
Therefore, this intervention should be provided for everyone before starting the HIV treatment.” 
(36 year old, female counsellor). 
5.4.5. Fidelity evaluation 
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A fidelity assessment was conducted for each session during the implementation phase mainly 
for supervision purpose and to provide feedback to the counsellors. Failure to adhere to the 
protocol was communicated to counsellors in weekly review meetings. Generally, counsellors 
were evaluated as being satisfactory in adhering to the protocol. A Likert scale checklist was used 
to evaluate fidelity. Each items of the checklist contained six responses options from a score 1 
“not assessed” to 6 “excellent”. The mean fidelity scores were 5.30 (0.38), 4.91 (0.62), 4.78 (0.54) 
and 4.93 (0.39) for group 1, group 2, group 3 and group 4 respectively. The average mean score 
of fidelity for all IPT groups was 4.98 (0.19) which can be interpreted as satisfactory based on the 
rating references in the group IPT manual (229). Some gaps in fidelity to the protocol were 
identified by supervisors.  These included skipping the interpersonal inventory, failure to prioritise 
problems, forgetting to link interpersonal problems with onset of depressive symptoms, failure to 
work on a specific prioritised problem and changing the intervention goal as driven by participants 
interest.    
5.4.6. Depressive symptoms, QoL, functioning and perceived social support 
The mean PHQ-9 depression scores reduced significantly between baseline and post-
intervention (mean difference (MD)=9.92; t=-7.82; p<0.001). The mean PSS scores (MD=0.79; 
t=2.84; p=0.009) and the mean QoL scores (MD=0.39, t=4.58, p<0.001) improved significantly 
between baseline and post-intervention. However, there was no statistically significant difference 
in mean scores for functioning between baseline and post-intervention (MD=1.27; t=0.70; 
p=0.492) (Table 15). 
Table 15. Paired t-test analysis, change in depressive symptoms, quality of life, perceived social 
support and functioning (N=28). 
Outcome  Baseline mean 
score  
Post group IPT 
mean score   
Mean 
difference  
t 95%CI P value  
Depressive symptoms (PHQ-9) 16.77 (6.74) 6.74 (4.62) -9.92 -7.82 -12.54, -7.31 <0.001 
Functionality (WHODAS-12)  36.81 (8.99) 38.08 (8.09) 1.27 0.70 -2.48, 5.02 0.492 
PSS (PSS-12) 4.63 (1.36) 5.43 (0.92) 0.79 2.84 0.22, 1.37 0.009 
Quality of life (WHOQOL-HIV-
BREF-Eth) 
3.23 (0.50) 3.67 (0.51) 0.39 4.58 0.21, 0.56 <0.001 
5.5. Discussion  
This study was the first to pilot the acceptability and feasibility of group IPT for treatment of 
depressive symptoms for PLWHA in Ethiopia and group IPT was perceived as being an 
acceptable and helpful intervention in addressing psychosocial problems and in reducing 
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depressive symptoms. The process of the intervention and its outcomes were judged to be highly 
acceptable for three reasons: first 93.5% (n=29) of the participants completed the intervention; 
second most participants reported benefit from resolving psychosocial problems such as marital 
and family conflicts, adjusting to life changes and coping with stigma; and third, the intervention 
created good opportunities for participants to establish friendships, learn social skills and gain 
social support. In addition, the context of the ART clinic with a highly stable workforce and the 
process of consultation on the need for and implementation of the intervention together with 
stakeholders, may have contributed to this positive outcome. This positive finding may also be 
because of the use of peer counsellors, an accessible intervention setting, and reimbursement of 
transportation costs. Moreover, establishing good therapeutic alliance during pre-group sessions 
can also have contributed to engaging the participants in the group sessions. This finding is 
supported by a randomised controlled trial from Uganda that demonstrated high acceptability and 
effectiveness of group IPT with an excellent acceptability (only 7.8% dropout rate) (90) and 
findings of other studies from LMICs (92, 96, 281). The interpersonal theory that hypothesises 
that IPT can decrease interpersonal stress and enhance social support through improving social 
skills, emotion processing and resolution of interpersonal problems (35) seems to hold true for 
the HIV population.  
The structure of the group IPT with a total of eight weekly group sessions was acceptable. 
However, some counsellors wished to increase the number of sessions to 10 or 12 to ensure that 
all participants improved. Many previous studies have used up to 16 or more weekly sessions 
which could be important in producing long-term benefits (282). The use of an extended number 
of sessions is time consuming, labour intensive and resource demanding – and may also suffer 
from low acceptability. The high cost and low availability of trained personnel in LMICs 
encourages the use of adapted psychological interventions that are brief, structured and simple 
to be delivered by peers or lay counsellors rather than the complex interventions that demand 
more resources and time (283). However, attention should be paid not to miss core elements 
such as the four IPT problem areas when adapting group IPT and other interventions (284).  
Peer-administered group IPT was acceptable to the group IPT participants, as they felt that peer 
counsellors can understand psychosocial problems of PLWHA and were happy with the skills and 
competency level of the counsellors. However, they emphasised that supervision should be in 
place. This is supported by previous findings that peer counsellors successfully deliver 
psychological interventions (88, 223). The randomised controlled trial from Uganda successfully 
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used trained community health workers as counsellors who were also accepted by the community 
as they have a common understanding and shared world view on depression (90, 92).       
Most of the participants were comfortable with the ART clinic setting, although one stated that she 
felt uncomfortable to come at the ART clinic due to “bad memories”. The ART clinic setting was 
probably in the most accessible location for residents in the town and it was chosen to maintain 
confidentiality and minimise stigma (109). Therefore, the integration of mental health services 
such as group IPT within the services provided by the ART clinic seems an acceptable approach.  
Generally the group IPT was found to be feasible for use in larger HIV populations which is in 
agreement with reports of previous studies in LMICs (92, 96, 281, 285). However, it is important 
to note that several barriers could affect its implementation. Access to and cost for transportation, 
sickness, stigma, social factors and public employment were the main challenges that could affect 
similar interventions. Most of these barriers can be addressed in designing special arrangements 
and with strong commitment of the clients and counsellors. This includes deployment of adequate 
numbers of trained counsellors and high commitment of clients in minimising social barriers.   
From the quantitative results, we found a significant reduction of depressive symptoms, and 
improvement in PSS and QoL at the post-intervention assessment. These findings need to be 
viewed with caution given the lack of a control group. Nevertheless, the quantitative findings were 
supported by in-depth interviews with group IPT participants – most of them said that they 
benefited greatly from the intervention. The significant reduction in depressive symptoms and 
improvement in QoL is supported by findings of several randomised controlled trials in LMICs (90, 
104, 282), suggesting that increased social support mediates depressive symptoms that can lead 
to improved QoL. There was no significant improvement in functioning at the end of the 
intervention. The comorbidity of HIV/AIDS with depression could have a bigger effect than 
HIV/AIDS alone on functioning that may not be improved with group IPT alone.  
IPT has been extensively examined and widely used for treatment of depression in high income 
countries. The basis for IPT is interpersonal theory which makes a practical link between mood 
disturbance and problematic life events (286). In principle, IPT considers depression as a medical 
illness (286), however it does not specifically address biological risk factors. Thus, it has limited 
therapeutic scope for depression caused by biological factors, since its foundation is built on only 
interpersonal aspects of life. Despite its limitations, IPT has been found to be potentially effective, 




There are arguments among scholars on acceptable treatment approaches of IPT. On the one 
hand, scholars argue that a group-based approach is more acceptable and feasible than the 
individual-based approach (14, 90), while on the other hand, others favour individual-based 
intervention (246). The findings in this study indicated that, despite its implementation barriers, 
group-based IPT can be an acceptable and feasible approach for PLWHA in Ethiopia. Common 
challenges for implementation of group-based IPT in low income settings may include, 1) 
structural problems such as inconvenient intervention setting, and 2) unsupportive model of care 
such as health systems unfavourable to the integration of group-based interventions into the 
existing services. Implementation of group-based IPT could also be challenging when there is 
lack of trust among the therapeutic team and if confidentiality becomes a concern for clients. The 
cost of the intervention could also be a challenge but that needs further cost analysis studies. 
However, cost wise, different studies authored by well-known global mental health researchers 
favours group-based intervention (14, 287).                    
Finally, the participants strongly recommended expanding the intervention in collaboration with 
other stakeholders such as with the government, non-governmental and charity organisations. 
Without collaboration, the intervention will remain inaccessible and limited to those who are 
located near the intervention setting, and who can afford paying transport costs. Moreover, 
accessibility and affordability should be a priority when replicating psychological treatments 
including group interpersonal therapy.          
I believe that the findings of this study are trustworthy. Qualitative data were collected from a 
range of participants and both focus group discussion and in-depth interviews using theory-based 
frameworks. In addition, quantitative data was collected using structured and validated 
instruments. Focus group discussions and in-depth interviews were conducted by trained and 
independent research assistants. I conducted rigorous framework-based qualitative analysis to 
maintain the credibility and trustworthiness of the results. I, the principal investigator had no role 
in facilitating group sessions and in conducting any of the post-intervention interviews.  
Limitation 
Despite its important findings, our study had several limitations that should be considered while 
interpreting the results. First, our study had no control group which makes the observed change 
difficult to interpret as it is difficult to control the natural course of depression and other 
confounders.  Second, the sample included in the pilot intervention was small as the main aim of 
the study was to explore the acceptability and feasibility of the group IPT. Third, the outcome 
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assessments were conducted at the place where therapy was delivered and that could have led 
to social desirability bias from respondents. However, we used independent data collectors for 
the baseline and post-intervention interviews to minimise the social desirability bias. Fourth, it is 
important to note that the post-intervention assessment was conducted immediately after the 
completion of the intervention and so longer-term impacts of the intervention cannot be assumed.  
5.6. Conclusion 
The intervention procedures and strategies of group IPT delivered by peer counsellors seemed 
acceptable and feasible for PLWHA in Ethiopia. PLWHA can benefit from a group IPT intervention 
in treating depressive symptoms in low-income settings. We recommend future studies to focus 




Chapter 6. Discussion  
In this chapter, I summarise and discuss findings in relation to the aim of this thesis and the 
strategies I followed to adapt and pilot the intervention in the HIV care setting in Ethiopia. This is 
followed by a discussion on the implications of this study for the field. Finally, the limitations of the 
thesis are discussed, and the recommendations presented.   
6.1. Summary and discussion of findings  
6.1.1. Effectiveness of psychological treatments for depressive symptoms in LMICs 
Chapter 2 presents the systematic review and meta-analysis of trials of psychological treatments 
that were aimed at managing depressive symptoms among adult PLWHA in LMICs. The current 
systematic review and meta-analysis was helpful for drawing conclusions in areas such as in 
identifying effective psychological treatments and treatment providers and formats of 
interventions for adult PLWHA in LMICs. The included studies used different interventions either 
in a group or individual format in community or institution settings. The studies were 
heterogeneous in terms of sample size, outcome measures and type of intervention. The main 
findings of the systematic review and meta-analysis were: i) studies that used psychological 
treatments that focused on resolving psychosocial problems were effective in reducing depressive 
symptoms; ii) trained and supervised non-specialist counsellors can deliver psychological 
treatments effectively; and iii) both group and individual-based interventions were acceptable and 
effective. 
In a sub-group analysis, trials administered by non-specialist counsellors were found to be 
effective (88). The use of trained non-specialist counsellors helps to efficiently utilise human 
resources in a task shifting approach (98), and has been widely advocated to reduce the gap in 
mental health care in LMICs (98). In LMICs, one of the contributing factors for the huge mental 
health treatment gap has been reported to be the scarcity of highly skilled human resources such 
as psychiatrists, psychologists, social workers and mental health professionals (65, 74). The use 
of supervised non-specialist counsellors in a task shifting approach seems an important and 
effective approach for low resourced settings that can contribute to closing the mental health 
treatment gap. The “friendship bench” programme in Zimbabwe (108) and the GSP in Uganda 
(287) have shown the global community that the use of non-specialist counsellors in administering 
psychological treatments has been successful in enabling access to basic mental health services 
in low-income countries.   
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Chapter 2 found that both group and individual-based interventions were effective and there was 
no difference in effect size between the two intervention approaches. Group-based interventions 
have been commonly used in LMICs and are reported to be acceptable in a number of African 
cultures (92). Group-based interventions are particularly important to establish therapeutic 
alliance, develop social support and build social skills (94, 288, 289). Group-based interventions 
enable the increase in access to basic mental health interventions for large groups of people at a 
time (92). Individuals are not alone in groups, and it is also easier to change people’s negative 
thought patterns in groups than in individual-based interventions (94). This argument is supported 
by the findings presented in Chapter 4 of this thesis that PLWHA preferred group-based 
counselling such as group IPT over individual-based counselling. This is further supported by the 
findings from Chapter 5 of this thesis that indicate that group IPT was found to be an acceptable 
intervention for PLWHA. The post-intervention evaluation in Chapter 5 indicates that participants 
felt that their problems were recognised and heard by others. The social support and reassurance 
they got from group members helped them to solve their psychosocial problems. The experience 
they gained from others assisted them to disclose their HIV status to their family members and 
helped them to trust other people. In addition, the observed reduction in the score of depressive 
symptoms, significant improvement in PSS and QoL in Chapter 5 of this thesis shows the potential 
effectiveness of group IPT for PLWHA with depression in Ethiopia.                
6.1.2. Burden of depression and areas for psychological intervention  
In Chapter 3, I examined the prevalence of MDD using the MINI diagnostic instrument and 
assessed its association with adherence to ART and QoL among PLWHA in FHRH in Northwest 
Ethiopia. I also identified socio-demographic and clinical factors that are associated with the MDD, 
adherence to ART and QoL. The prevalence of MDD was 32.5% and the indicated prevalence 
was comparable with findings of other previous studies in SSA, such as 28.7% in Nigeria (290), 
34.9% in South Africa (291), 24.7% in another study in South Africa (292), and 40% in western 
Uganda (293). However, the 32.5% prevalence of MDD indicated in Chapter 3 was higher when 
compared to findings from other similar studies in SSA such as 2.7% in rural Tanzania (294),  
8.1% in semi-urban areas in Uganda (41), and 9.6% in Zambia (295). There are big differences 
in the prevalence of MDD between the study findings, although all of the above studies used 
international diagnostic criteria, mainly the MINI. The reasons for the observed wide variability in 
the prevalence of MDD seems to be very complex. Judd and colleagues argued that it is difficult 
to draw a clear conclusion about the prevalence of depression as long as methodological 
variations between studies exist and the characteristics of study populations are different (296). 
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This is further explained by Simoni and colleagues who stated that culture plays a central role in 
shaping the experience and language used to describe depression (22). Using international 
diagnostic criteria to diagnose MDD may not be ideal due to cultural differences across different 
populations and every individual being unique (22). Simoni and colleagues emphasised the “emic” 
perspectives that propose that depression research must address cultural differences and pay 
attention to the validity of measures critically when using these in different populations. Another 
reason for variation is that few studies have used gold standard measures of depression, which 
would be semi-structured clinical interviews administered by psychiatrists or clinical 
psychologists. Fully structured diagnostic interviews, as used in this study, are known to have 
validity problems. Whatever variations exist between several studies, nevertheless, MDD remains 
the most common mental disorder in HIV populations, and affects the treatment outcome of 
HIV/AIDS and the overall QoL of PLWHA. 
Social and psychological problems play an important role in causing and triggering depression 
among PLWHA, such as problematic relationships, divorce or being a widow, lack of social 
support, stigma, loneliness, unemployment and poverty, which were all associated with MDD 
(Chapters 3 and 4). Previous studies also indicated that social problems are risk factors for 
depression (14, 41, 297, 298). PLWHA are affected by several psychosocial problems (299, 300) 
such as the diagnosis of HIV/AIDS leading to distress as HIV is incurable, and this is then followed 
by the fear of rejection by important people, the fear of losing loved ones and the fear of infecting 
other people (300, 301). Low self-worth, self-stigma and non-disclosure increases vulnerability to 
developing psychiatric symptoms such as depression (239). For example, a longitudinal study in 
China found that HIV-related stress is highly associated with depressive symptoms (298). 
Moreover, the disclosure of HIV status remains profoundly limited as PLWHA are afraid of 
exclusion from their socio-economic participation in their community which increases their 
vulnerability to depression (301). In addition, people with advanced stage of HIV/AIDS suffer from 
physical pain and psychological distress such as helplessness, hopelessness, worthlessness and 
low mood (22). HIV/AIDS-associated adverse life events, food insecurity and poverty can cause 
depression (41). Clinical factors, for example, advanced stage of HIV/AIDS (298) and functional 
disability (302), can also lead to the onset of depressive disorders among PLWHA.  
Most of these determinants are core problem areas of IPT. Interpersonal theory identifies four 
core principles (problem areas) that can both cause and maintain depression: dispute or conflict, 
life change, grief, and loneliness or social isolation (286, 303). External, developmental and 
interpersonal problems can increase interpersonal stress, reduce social support, and create 
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emotional difficulties, and these factors can trigger or maintain depression (91). IPT can treat 
depression by resolving interpersonal problems, improving social skills, reducing social stressors 
and enhancing social support (35). This is supported by previous studies in SSA that 
demonstrated the effectiveness in treating depression using IPT (92, 96). Verdeli and colleagues 
argue that depression due to excessive worry and difficulty to fulfil basic necessities (due to 
poverty) can also be managed using group IPT (31, 92, 150). In addition to psychological 
interventions, PLWHA need poverty alleviation interventions such as assistance with 
employment, income generation and housing support (14).  
6.1.3. Selection of a psychological treatment for piloting 
A candidate intervention was chosen based on the results from Chapters 2, 3 and 4. These were: 
i) findings of the systematic review and meta-analysis in Chapter 2 suggested that psychosocial 
treatments such as IPT are beneficial for the treatment of depression; ii) findings in Chapters 3 
and 4 showed that depression among PLWHA in Ethiopia maps onto all four problem areas of 
IPT: life change, conflict, grief, and loneliness or social isolation; and iii) findings from previous 
studies on depression among PLWHA in Ethiopia indicated that psychosocial problems are 
important areas for intervention (18). Most importantly, social problems such as divorce, 
separation, stigma, a lack of social support and loneliness are important determinants of 
depression. All of these factors can be addressed by using IPT (35, 229). Finally, IPT was chosen 
for this study to assess its acceptability and feasibility for the treatment of depression for PLWHA 
in Ethiopia. The availability of IPT guidelines, already trained IPT trainers and other resources, 
including favourable infrastructure (space and private rooms) to conduct the intervention, were 
facilitators in choosing IPT for piloting. The preferred mode of delivery of the intervention was in 
group format due to the following conditions: i) group-based interventions are as effective as 
individual-based interventions (see Chapter 2 of this thesis); ii) group IPT is a manualised, time-
limited and structured intervention; iii) social skills and coping strategies can be learned between 
the group members (304); and iv) group IPT was reported to be a low cost intervention that can 
be delivered by non-specialist counsellors (14). 
6.1.4. Adaptation of group IPT manual   
In Chapter 4, I described the adaptation of group IPT for PLWHA in Northwest Ethiopia using the 
Ecological Validity and Culture Sensitivity model (111). I conducted focus group discussions 
among HIV counsellors (case managers), adherence supporters and service users to explore 
their perceptions about the causes, burden, severity of depression, and pathways that PLWHA 
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are using to receive mental health treatment (112). I also explored their views on the structure of 
group IPT, length of each session, group size and dynamics, preferred delivering agents and 
preferred intervention settings. These findings are incorporated into the adapted version of the 
WHO group IPT manual, which served as a guideline for training counsellors and for the 
intervention.  
The findings in Chapter 4 show that depression is viewed mainly as an outcome of interpersonal 
and psychosocial problems, and that these problems can be defined within IPT. The main 
recommendations drawn from the content adaptation of the WHO group IPT were: i) to include 
both men and women in forming IPT groups and with five to ten people per group; ii) to meet in 
private and quiet rooms; iii) a session length of between 1.5 to 2 hours conducted weekly; iv) 
membership of the IPT groups to be closed (not to include new members into the established IPT 
group after the first group sessions).  
Subsequent to the content adaptation, translation and language adaptation were conducted for 
the WHO group IPT manual (229) by incorporating the findings described above using a stepwise 
Participatory and Iterative Process Framework for Language Adaptation  (PIPFLA) approach 
(277). PIPFLA is a tool (framework) that guides how to undertake language adaptation for culture-
sensitive manualised psychological interventions. It includes several steps to conduct the 
adaptation to manuals and different intervention guidelines. The PIPFLA indicates that language 
adaptation for intervention manuals should be started by forward and backward translation 
followed by cultural adaptation involving stakeholders. Harmonisation and validation are also 
important steps of PIPFLA that finally help to use acceptable, appropriate and clear language for 
interventions. The PIPFLA framework allows the researcher to conduct a stepwise, descriptive 
and participatory language adaptation for a manualised intervention which is grounded in 
principles of good practice. It was a useful approach that helped to include appropriate, culturally 
acceptable and clear terminology into the manual through the participation of stakeholders. The 
process of language adaptation for the WHO group IPT manual involved translation, back 
translation, expert review and harmonisation steps. The recommendations drawn from the content 
adaptation were included into the manual, such as who the preferred counsellors are, the IPT 
group size and dynamics, the preferred intervention setting, and the intervention duration. 
Adaptation of the manual was made within the areas that the WHO recommended for adaptation. 
The core elements of group IPT and techniques of the intervention described in the original WHO 
guideline were maintained in the adapted manual as all of them were found to be valid to our 
study population The adapted manual was written in a simplified language to be used by non-
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specialist counsellors, and several modifications made to improve its cultural relevance. The 
adapted manual was also reviewed by stakeholders in a one-day adaptation workshop to validate 
the cultural relevance, clarity, applicability and acceptability of the language used in the manual. 
Several stakeholders participated in the workshop, including case managers, adherence 
supporters, ART nurses, mental health professionals and a psychologist. After the harmonisation 
of feedback obtained from the workshop, several copies of the manual were printed and used for 
training and the intervention.  
Although, the core principles of IPT are important areas for intervention, some authors argue that 
all of them may not be necessarily important (92). However, our study findings presented in 
Chapter 4 found that all the four problem areas are valid for PLWHA in Ethiopia.  Previously, 
group IPT was adapted and used by Bolton and colleagues in HIV-affected communities in 
Uganda (90, 92). Available global evidence showed that group IPT was cost-effective when used 
with a broad range of people with MDD in clinical settings (305). Bolton and colleagues indicated 
that group IPT could be more relevant to African cultures – because the view of oneself as being 
part of a family and a community is particularly strong in Africa (92). In the adaptation of the group 
IPT, Bolton and colleagues found that three of the four problem areas of IPT were associated with 
depression but that loneliness and/or social isolation were not applicable as a cause of depression 
in the HIV-affected community in Uganda (92). Their study participants were recruited in the HIV-
affected area, but their HIV status was not known so that stigma may not have been a concern. 
In the absence of stigma, loneliness or social isolation may not be viewed as a problem since the 
established social network and social support continue working in the community. In their field 
trial, Bolton and colleagues used 16 weekly group sessions and each session lasted for 90 
minutes (90). While the WHO does not provide reasons for recommending a limit of eight weekly 
sessions (229). these could include to i) maximise its acceptability, ii) increase its cost-
effectiveness, and iii) save time and other resources.    
The other important finding in Chapter 4 was to include both men and women in forming IPT 
groups which is believed to facilitate social support among group participants. This is in contrast 
to several group-based intervention trials from Uganda which matched group participants by 
separating men and women (92, 231). The other important finding indicated in chapter 4 was the 
recommendation on meeting place. Most PLWHA preferred the ART clinic settings rather than 
places in the community due to the fear of public stigma, concern about confidentiality, and easy 
access. But the studies conducted in Uganda used any meeting place available in the community 
and were more flexible in this regard (90). Confidentiality and stigma may not be an issue for 
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participants in Uganda, therefore, the meeting place may not be a concern for them, but it is a 
very important issue for PLWHA in Ethiopia.     
6.1.5. Acceptability and feasibility of group IPT 
Chapter 5 presented findings of the pilot study including the acceptability and feasibility of peer-
administered group IPT for depression among PLWHA. The overall evaluation of the pilot study 
indicated that the procedures and outcomes of group-based IPT were acceptable and feasible. 
The eight weekly group sessions of up to two hours duration were accepted. This is in agreement 
with the findings presented by Nakimuli-Mpungu and colleagues in the development of a culturally 
sensitive GSP intervention in Uganda, that adult PLWHA preferred group format counselling to 
individual-based counselling. The group-based interventions are thought to assist in expanding 
social networks, social support and coping skills (231). Nakimuli-Mpungu and colleagues have 
successfully implemented the GSP in HIV populations as a result of its high acceptability (287). 
Group-based IPT delivered by community health workers in a task shifting model was also found 
to be acceptable for PLWHA in South Africa (150). Petersen and colleagues adapted non-
specialist administered group-based IPT in 12 weekly sessions for PLWHA in South Africa (96) 
and they found the intervention conducive for delivery using a task shifting approach.  
As indicated in Chapter 5, the adapted group IPT delivered over eight weekly sessions provided 
encouraging results, which attest to the feasibility of peer-administered group-based IPT for 
PLWHA with depression in Ethiopia. Findings suggested that implementing group-based IPT in a 
more private and accessible setting encourages the participation of clients due to minimal 
exposure to stigma and favours maintaining confidentiality. It is always important to be flexible 
when choosing intervention settings and this should be done in consultation with the stakeholders 
and PLWHA. Trained peer counsellors were the most trusted and respected agents who 
contributed to the high acceptability and feasibility of peer-administered group IPT as shown in 
Chapter 4 of this thesis (109). Peers (case managers and adherence counsellors) have a close 
supporting relationship with PLWHA and are their sources of motivation (306).   
Physical accessibility was perceived to be an important barrier that can affect the acceptability 
and feasibility of the intervention when used for larger populations. Most PLWHA live in poverty  
(307) and may not afford travelling costs to get mental health treatment. Moreover, others who 
live in rural areas may not have easy access to transportation to attend sessions every week. In 
this case, either the participants should be funded for transportation costs or the intervention 
should be disseminated to every primary health care setting and integrated into other HIV 
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services. Conducting group sessions in villages within the community may reduce travelling and 
can increase participation in the intervention, if stigma can be minimised and confidentiality 
maintained to ensure acceptability. 
The lack of trained peer counsellors was also perceived to be a barrier to the intervention. 
Currently, there are 486 active case managers and adherence supporters in the Amhara regional 
state (in Northwest Ethiopia) working at ART clinics supporting PLWHA providing HIV counselling. 
In every referral ART clinic, an average of 15 case managers and adherence supporters are 
working along with health professionals to improve the lives of PLWHA in Ethiopia. Most of the 
case managers and adherence supporters received basic WHO mhGAP training that focused on 
detecting and managing common mental disorders. This highlights the availability of human 
resource potential that could assist in integrating peer-administered psychological interventions 
such as group IPT into the HIV care settings, especially given the encouraging results from the 
current study.     
6.1.6. Strategies contributing to the high acceptability and feasibility of group IPT 
In this section, I reflect on some of the processes of engagement that were conducted prior to 
and during the implementation of the intervention in collaboration with different stakeholders and 
that seem to have contributed to the positive outcomes of this study. These included i) a 
systematic and participatory cultural adaptation of group IPT; ii) stakeholder ownership and team 
motivation; iii) skill-focused training on group IPT; and iv) supervision and team organisation. I 
believe that these efforts contributed to enhance the acceptability and feasibility of a group IPT 
intervention among PLWHA in Ethiopia. I will present a brief description on each point below.     
The cultural adaptation of the group IPT intervention was conducted with the full participation of 
stakeholders whose recommendations were valued and taken into consideration during the 
adaptation of the WHO group IPT to the local context. The manual used simple language that is 
culturally appropriate and clear to service users, counsellors and supervisors. The opinion of each 
person was recognised when harmonising the manual and this assisted in establishing trust 
among the research team and service users. A selection of potential counsellors, determination 
of IPT group size and dynamics, number and duration of sessions, and time and date of meetings 
were made through collective decisions by stakeholders from the ART clinic.  
Creating stakeholder ownership and efforts to getting their motivation were done prior to launching 
the implementation. A sense of ownership was established as the stakeholders started 
understanding the commitment of the researchers on the project. A spirit of collaboration, trust 
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and teamwork were established among counsellors, supervisors and data collectors. The 
motivation created among counsellors was a great asset for the success of the intervention. 
Counsellors were the engines of the intervention who created a sense of belongingness within 
the team. Every counsellor was eager to see changes among group participants at the end of 
every session. The commitment of the counsellors to their given role greatly motivated the clients 
(group participants) to complete the intervention (93.5% of the participants completed the 
intervention).     
The skill-focused group IPT training provided to counsellors and supervisors was a fundamental 
asset in implementing the intervention successfully. The group IPT training was designed based 
on the WHO group IPT manual recommendations and in consultation with group IPT trainers. 
Ongoing adaptation of the training was done through daily reviews and discussion of the training 
by trainees and trainers. The aim of the training was mainly to teach the skills of facilitating IPT in 
group format, and the content of the training and the method of delivery were evaluated before 
the training days. The skill-focused training and the involvement of stakeholders in designing and 
conducting the group IPT training contributed to getting competent counsellors who had great 
motivation to help others.   
Supervision and good team organisation were central to the successful implementation of the 
intervention and were made possible by the commitment of the research team to the project. The 
team was organised based on the given roles, the roles of counsellors and supervisors were 
clearly stated, and everyone was supervised in his/her responsibilities. The counsellors were 
responsible for starting sessions on time, facilitating sessions successfully and completing 
session notes. The supervisors were responsible for coordinating and organising the overall 
process of the intervention, supervising, and evaluating the reliability of the intervention. I, the 
principal investigator (a mental health practitioner), also played a role in arranging logistics and 
organising the whole team. I provided consultation for any difficulties such as diagnosing severely 
ill clients, making referral decisions and linking clients who had other medical conditions to other 
treatment services. Other than these roles, I had no direct involvement in the decisions made by 
the counsellors and supervisors in relation to the intervention to avoid researcher bias.  
The implementation of psychological treatments usually needs trust-building and buy-in among 
stakeholders. This needs more effort, particularly in communities where psychological treatments 
are perceived to not be important (308) and with people with low mental health literacy (263). 
Internal challenges within the implementation team, such as resistance, and external barriers, 
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such as the presence of unsupportive policies, can affect the outcome of interventions. 
Inadequate funding, a lack of trained counsellors, limited supervision and a lack of collaboration 
can influence the acceptability and feasibility of treatments (309). Strong supervision, high 
commitment and coordination are important strategies for delivering psychological treatments 
effectively. More importantly, high motivation to help others, good communication skills and good 
organisational skills are highly needed for the successful implementation of group IPT. All these 
steps and time required to achieve effective buy-in and build mental health literacy require 
sufficient funding, but they pay off in the long term and should not be ignored.  
The unprecedented occurrence of COVID-19 would have affected the implementation of group 
IPT due to the nature of the infection that spreads in gatherings. Conducting group sessions using 
other approaches such as running group sessions virtually could be a good solution, although it 
is less likely to be applicable for people living in low-income settings, including in Ethiopia. Other 
alternatives should be found when such difficult conditions interfere with the implementation of 
group IPT. 
Generally, the findings of this thesis believed to be credible, dependable, transferable, 
trustworthy. The study was designed to answer specific research questions and implemented with 
active engagement of stakeholders using scientific guidelines and theoretical frameworks. Data 
were collected by using trained and independent research assistants using mixed data collection 
methods and validated instruments. Qualitative and quantitative data analysis were conducted 
guided by theoretical frameworks and using up-to-date analysis models. The results were 
interpreted in a way that is understandable to researchers and policy makers.    
6.2. Limitations  
There are several limitations that should be considered when interpreting the findings of this 
thesis. Specific limitations from Chapters 2 to 5 were addressed explicitly in each chapter’s 
limitations section. The general limitations of the thesis include: i) the diagnosis of MDD in Chapter 
3 was made by nurse research assistants which may lead to false positive or false negative 
diagnoses; ii) the findings used to adapt the WHO group IPT indicated in Chapter 4 may not be 
generalised to all PLWHA in Ethiopia; iii) the use of focus group discussions in Chapter 4 to 
explore perceived causes for depression have limited the collection of information on sensitive 
issues such as on intimate partner violence (IPV); iv) the significant reduction in depressive 
symptoms and improvement in PSS and QoL in Chapter 5 may not show the real effectiveness 
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of the intervention due to the absence of control groups. Each of these limitations is discussed 
along with their implications in detail below. 
First, the diagnosis of MDD in Chapter 3 was conducted by trained nurse research assistants 
which may introduce a false positive or false negative diagnosis of MDD. A false negative 
diagnosis may result in the missing of real cases in the intervention. Ideally, the diagnosis of MDD 
should have been conducted by a psychiatrist from the local population. However, psychiatrists 
are scarce in Ethiopia and the number of psychiatrists per 100,000 population was reported to be 
0.08 in 2017 (74). There were only two psychiatrists serving in the hospital in a part-time capacity 
during the data collection period. Therefore, using psychiatrists for data collection was not feasible 
and would not be realistic in a scale-up effort either. I am a mental health practitioner who is 
licensed to diagnose and prescribe medications. Thus, I provided training to nurses to administer 
the structured instrument of the MINI depression module by including several role-plays in the 
training. Nurses were chosen to administer the MINI because they had completed a psychiatry 
course during their nursing training and had received WHO mhGAP training. Moreover, I provided 
close supervision and assistance during the data collection. The use of trained nurses to diagnose 
MDD using the MINI has also been in practice in similar studies in Ethiopia (194). Although all 
necessary precautions were made when administering the MINI, the diagnosis conducted by 
nurses may still have introduced false diagnoses of MDD. Producing more psychiatrists takes 
more time and it is less likely that this gap can be filled in the next few years in Ethiopia. Preferably, 
this can be dealt with through the provision of adequate training to capacitate research assistants 
in diagnosing common mental disorders, including depression. 
Second, the findings that were used to adapt the WHO group IPT indicated in Chapter 4 may not 
be generalised to all PLWHA with different cultures in Ethiopia. Ethiopia is a diverse and multi-
ethnic country which contains more than 80 ethnic groups with more than 86 languages (310). I 
translated and adapted the WHO group IPT manual into the Amharic language which is spoken 
by more than 90% of people in the Amhara regional state in Northwest Ethiopia and serves as 
the working language for the Federal Democratic Republic of Ethiopia (FDRE). The adapted 
manual can be used by Amharic speakers who are familiar with the Amhara culture. Therefore, 
readers should consider that the cultural adaptation conducted for the WHO manual may not be 
generalisable to the larger HIV populations in Ethiopia. More research is needed to sufficiently 




Third, the use of focus group discussions in Chapter 4 to explore perceived causes for depression 
have limited the collection of information on sensitive issues. IPV, HIV/AIDS and mental health 
are three problems affecting a third of women of any age globally, and the most affected people 
are women from Africa (311). IPV is recognised as a major social problem that has been reported 
to have a strong association with depressive disorders (312, 313). A high prevalence of IPV has 
been reported as being common among HIV-affected people in Ethiopia (314). However, IPV or 
any other form of domestic violence and abuse were not elicited from any of the focus group 
participants in Chapter 4. The participants may not disclose sensitive issues including IPV during 
focus group discussions and IPV may remain hidden due to the use of focus group discussions 
in exploring perceived causes for depression. This can be managed using different data collection 
approaches in future: for example, including individual interviews or conducting separate focus 
group discussions with women alone can help to elicit information on sensitive issues including 
IPV. 
Fourth, the aim of Chapter 5 was to explore the acceptability and feasibility of group IPT for 
depression for PLWHA and some tentative effects of the intervention but without control groups. 
Therefore, the significant reduction in depressive symptoms and improvement in PSS and QoL in 
Chapter 5 may not be real effects of the intervention as there was no control group with which to 
compare the outcomes. But these initial results provide an indication of possible trends and could 
assist in calculating required sample sizes for full trial to test the effectiveness using a control 
group. Hence, future studies need to examine the effectiveness of group IPT in reducing 
depressive symptoms and in improving PSS and QoL for PLWHA using randomised controlled 
trials.    
6.3. Recommendations  
6.3.1. Recommendations for mental health researchers  
Despite the limitations discussed above, this study established a strong foundation in generating 
knowledge on depression treatment for PLWHA and in adapting group IPT for PLWHA in Ethiopia. 
The stepwise and evidence-based approaches used in this thesis provide good examples of how 
to adapt psychological interventions using implementation science which can serve as baseline 
evidence for future studies aimed at adapting similar interventions in Ethiopia.  
However, more research is needed to unfold the problems that cause depression in PLWHA, to 
identify evidence-based psychological treatments that can effectively address depression, and to 
explore approaches used to adapt evidence-based treatments into local contexts. The established 
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evidence on the effectiveness of psychological treatments has been limited to trials that included 
a limited number of psychological treatments. Some of these trials lack methodological rigor in 
drawing conclusions on whether a specific intervention is effective or not for PLWHA in LMICs 
(131). These findings call for researchers to conduct more randomised controlled trials to answer 
what type of treatment, in what context and what dose is effective for depressive symptoms for 
PLWHA. Such studies could also consider the suitability of IPT- versus CBT-focused interventions 
within an African context. Assessment of cost effectiveness should also be an important research 
area which is highly relevant to determine the economic feasibility of interventions. There is also 
a lack of evidence on how to adapt evidence-based psychological treatments for PLWHA in 
LMICs. The WHO drafted a protocol that can be used to adapt psychological treatments for 
different cultures, and future studies could improve the drafted protocol for standardised use in 
LMICs (113). This multi-step protocol can be used by researchers to adapt psychological 
treatments for several mental disorders including for depression in LMICs.  The WHO group IPT 
manual found to be an excellent guide written in clear and simple language that included all the 
important IPT components along with clear procedures. The manual is big in size and needs a 
significant effort to translate and adapt it. However, the main recommendations drawn from this 
thesis are that adaptations of group IPT should start with an understanding of the communities’ 
conceptualisation of depression, examining perceived causes, exploring treatment traditions.  
Recognising the traditional healing strategies and harmonising the new intervention into existing 
healing approaches can increase the acceptability and feasibility of the intervention. When 
adapting group IPT, researchers should give special attention for group dynamics, group size, 
intervention setting, contexts and session structures.  
The results of the pilot study presented in Chapter 5 showed significant change in reducing 
depressive symptoms and increasing social support and QoL within the immediate period after 
the intervention. This shows that group IPT has good potential as an effective psychological 
treatment for depression for PLWHA in Ethiopia. In addition, the findings presented in Chapter 5 
established the acceptable conditions of group IPT and how to make it feasible. IPT is not new to 
Ethiopia. IPT trainings have been provided by Ravitz and colleagues to physicians and health 
professionals in some parts of Ethiopia in collaboration with the Biaber project (247). Ravitz and 
colleagues suggested that medical education that involves IPT can contribute to narrowing the 
mental health treatment gap in Ethiopia through accessing basic psychological interventions 
(247). However, there has been no trial conducted to examine the effectiveness of IPT, 
particularly among PLWHA in Ethiopia. Research is required to examine the effectiveness of 
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group IPT using randomised controlled trials. It is also important to explore useful approaches to 
integrating group IPT into more ART clinic settings in primary, secondary and tertiary health care 
services in Ethiopia.  
6.3.2. Recommendations for HIV care providers  
The findings presented in this thesis have implications for recognising the magnitude of 
depression in the HIV population and for understanding the usefulness of psychological 
treatments, including group IPT, in managing depression and in improving the life of PLWHA. The 
findings presented in Chapter 3 show that one third of PLWHA had MDD, which is much higher 
when compared to other findings from SSA. This calls for the timely treatment of depression to 
facilitate clients’ engagement with HIV treatment and help to improve QoL of PLWHA (315). The 
role of the work force at ART clinics in Ethiopia, including health professionals and non-specialist 
HIV care providers, is highly important in the management of depression because treatments of 
depression can be provided by non-specialists who have received basic mental health training 
with strong supervision and support (78).  
The findings in Chapter 5 indicate that most HIV counsellors (case managers and adherence 
supporters) in Ethiopia received mhGAP training and can therefore contribute to the treatment of 
PLWHA with depression. Peer-counsellors were preferred by PLWHA to facilitate group sessions 
using a task shifting approach (Chapter 4). A task shifting approach seems a good strategy for 
addressing the shortage of highly trained human resources and can offer high quality and cost 
effective care to PLWHA (316). The Lancet global mental health series has strongly 
recommended the use of a task shifting approach to address the huge mental health treatment 
gap in LMICs (317) and in order to use available human resources efficiently (318). The WHO 
has also made important recommendations on the implementation of a task shifting approach, 
with particular emphasis on the need to train non-specialists, treat common mental disorders and 
retain the approach (319). Therefore, the stakeholders at the ART clinics need to follow evidence-
based implementation approaches and should recognise the role of case managers and 
adherence supporters in addressing depression if they have favourable working environments. 
Most importantly, the heads of ART clinics in Ethiopia need to provide private space for 
counsellors who help facilitate group sessions. It is also important to provide supervision and 
training on group IPT for peer-counsellors.  
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6.3.3. Recommendations for policy makers 
Policy makers need to understand the burden of depression and its impacts on the overall 
wellbeing of PLWHA. The mental health treatment gap in the general population is likely to be 
much higher in PLWHA in Ethiopia, and this suggests the need for mental health policy, political 
will, strong leadership and collaborative effort. Depression needs more emphasis due to its huge 
health-related and socio-economic impacts on PLWHA. Peer counsellors can feasibly facilitate 
group IPT interventions with a high level of acceptability, which is also supported by findings from 
LMICs (148). Peer counsellors can be selected from case-managers and adherence supporters. 
The number of case managers and adherence supporters is inadequate in Ethiopia (320). Hence, 
policy makers need to develop policies and strategies that can enable the delivery of task-shifted 
health care services in every ART clinic in Ethiopia. Producing more case managers and 
adherence supporters, and training them in group IPT, can contribute a lot to addressing 
depression in low-income settings.    
6.4. Conclusion  
This thesis sought to adapt and pilot group IPT for the treatment of depression for PLWHA, and 
to examine its acceptability and feasibility in ART clinics in Ethiopia. The thesis further examined 
the magnitude of MDD and its association with adherence to ART and QoL, as well as explored 
the perceived causes of depression among PLWHA. This thesis found that PLWHA are vulnerable 
to depression due to psychosocial adversities associated with the diagnosis of HIV/AIDS, such 
as problematic relationships, interpersonal conflict, divorce/separation, stigma, loneliness and 
poverty. This thesis identified different types of psychological treatments that can help reduce 
depressive symptoms, although their effectiveness varies. Psychological treatments that focus on 
addressing psychosocial problems were effective for PLWHA in LMICs. The findings presented 
in this thesis indicate that IPT can be therapeutic for depression for PLWHA in Ethiopia. Group 
IPT was found to be an appropriate, acceptable and feasible intervention that can help promote 
social support, establish therapeutic alliance, enable the learning of new social skills, and 
enhance motivation for change among intervention participants. The overall findings from the 
cultural adaptation of WHO group IPT indicate that this intervention was highly feasible and was 
perceived to be acceptable when delivered through eight weekly sessions of 1.5 to 2 hours.  
The Ethiopian health system strongly advocates for accessing mental health interventions using 
a task shifting model. A task shifting model enables the movement of tasks from highly skilled 
professionals to trained non-professionals. In this regard, peer counsellors can take over the roles 
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of psychologist and mental health professionals after receiving group IPT training and can 
contribute to making basic mental health interventions accessible to PLWHA. Peer counsellors 
were acceptable to PLWHA and found to be important agents for providing the group IPT 
intervention. The use of peer counsellors, with a strong supervisory and referral structure, seems 
a cost-effective approach that allows the efficient use of human resources in providing access to 
mental health care services for a larger number of PLWHA. Peer counsellors can speak the 
language of the community and deliver the adapted group IPT successfully.  
The integration of mental health care into HIV care services should be a priority in addressing 
depression. Integrated mental health services can increase access, improve client satisfaction, 
and help to provide all services at a time in one place, which reduces referrals. The integration of 
mental health services into primary health care has been promising in Ethiopia but needs a 
continuous supply of trained human resources and consistent availability of medications (321). In 
times of shortage of trained human resources, the introduction of peer-administered group IPT 
can help to narrow the huge mental health treatment gap using a task shifting approach. 
Nevertheless, psychological treatments need cultural adaptation, acceptability and feasibility 
assessments and testing of effectiveness prior to wider scale-up. In this regard, group IPT has 
shown good acceptability, feasibility and potential effectiveness in managing depressive 
symptoms among PLWHA. Thus, the next step for researchers should be taking the group IPT 
intervention through a full randomised controlled trial to examine its effectiveness in treating 
depression and improving PSS and overall QoL. Treating depression leads to better ART 
adherence and hence less reliance on second line ART medications. This, in turn, leads to better 
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Appendix D. Questionnaires, interview guides and checklists   
(Note: all Amharic translations are available on request from the author.) 
Module one: Structured questionnaires for survey study   
1. General Socio-demographic questions   
Instruction: The following questions asks about your personal socio-demographic condition. Therefore, 
please provide the most appropriate personal answers for each question.  
QNo Question  Response option  
1.1 Age  ____________ 
1.2 Gender  1. Female 
2. Male  
1.3 Marital status  1. Single 




1.4 Religion  1. Orthodox Christian 
2. Muslim 
3. Protestant  
4. Catholic 
5. Other_____________ 
1.5 Educational status  1. Illiterate  
2. Completed elementary school 
2. Completed high school 
3. University diploma and above 
1.6 How many children do you have? 1. None 
2. One 
3. Two 
4. Three and more 





4. Three and more 





4. Three and more 
1.9 What is your role in the 
household? 
1. Head of the household 
2. Spouse of household head 
3. Child of household head 
4. Sibling of household head 
5. Other _____________ 
1.10 
 
A. Employment status  1. Full time employed  
2. Pare time employed 
3. Self employed  
4. Student 
5. None employed 
6. Other _________ 





4. Own business 
5. No income 
6. Other _____ 
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C. Is your income secured for the 
next 12 months? 
1. Yes 
2. No 
2. Clinical questions 
Instruction: The following questions asks about health-related condition. Therefore, please provide the 
most appropriate answer regarding your health-related condition for each question. 
QNo Question  Response option  
2.1 Do you have any history of mental illness diagnosed by health 
professional in the last 12 months? 
1. Yes 
2. No 
A. What type of illness you have told by health professionals 1.Psychosis 
2. Depressive disorder 
3. Anxiety disorder 
4. Other-specify 
B. What type of treatment you got?  1. Anti-psychotic 
2. Anti-depressant 
3. Anxiolytic  
4. Other-specify 
C. For how long you took the treatment? Specify- 
D. Do you still attend your psychiatric follow up regularly? 1. Yes 
2. No 
2.2 Did you attend another follow up in another place for your problem 
in the last 12 months? 
1. Yes 
2. No 
2.3 Did you attend regular group sessions with peers for peer-support 
intervention in the last 12 months? 
1. Yes 
2. No 
A. If Yes, what type of group session? 1. HIV support group 
2. Adherence group 
3. Psychosocial counseling 
4. Other ________________ 
B. If Yes, for how long  _________________ 


















3. HRQOL (WHOQOL-HIV-Eth) 
Instruction: the following questions are asking about your wellbeing and emotional state. From the given 
alternatives, choose the one which you are greed for. 
QNo Question  Response options  
3.1 How would you rate your quality 
of life in terms of social and 
economic?   
1. Very 
poor   
2. Poor  3. Neither poor 
nor good 
4. Good  5. Very good 
3.2 How satisfied are you with your 












3.3 In the past two weeks, to what 
extent do you feel that physical 
pain prevents you from doing 
what you need to do? 





3.4 In the past two weeks, how 
much are you bothered by any 
physical problems related to 
your HIV infection?   
5. Not at all 4. A little 3. Moderate 




3.5 In the past two weeks, how 
much do you need any medical 
treatment to function in your 
daily life?  





3.6 In the past two weeks, how 
much do you enjoy life?  
1. Not at all 2. A little 3. Moderate 
amount    
4. Very 
much    
5. Extremely 
3.7 In the past two weeks, to what 
extent do you feel your life to be 
meaningful? 
1. Not at all    2. A little     3. Moderate 




3.8 In the past two weeks, to what 
extent are you bothered by 
people blaming you for your HIV 
status?  
5. Not at all    4. A little     3. Moderate 




3.9 In the past two weeks, how 
much do you fear the future?  





3.10 In the past two weeks, how 
much do you worry about 
death?  





3.11 In the past two weeks, how 
healthy is your physical 
environment? 
1. Not at all    2. A little     3. Moderate 
amount    
4. Very 
much    
5. Extremely 
3.12 In the past two weeks, do you 
have enough energy for 
everyday life? 
1. Not at all   2. A little   3. Moderately 4. Mostly 5. 
Completely 
3.13 In the past two weeks, how 
much worried are you about not 
being able to support your 
family? 
5. Not at all 4. A little   3. Moderately 2. Mostly 1. 
Completely 
3.14 In the past two weeks, to what 
extent do you have the 
opportunity for leisure activities? 
1. Not at all 2. Little 3. Moderately  4. Mostly  5. 
Completely  
3.15 In the past two weeks, how well 
are you able to get around?  
1. Not at all 2. Little 3. Moderately 4. Mostly 5. 
Completely 
3.16 In the past two weeks, how 
satisfied are you with your 
sleep? 
1. Very 










3.17 In the past two weeks, how 
satisfied are you with your ability 















3.18 In the past two weeks, how 
satisfied are you with your 
capacity for work?  
1. Very 
dissatisfied   
2. 
Dissatisfied   
3. Neither 
satisfied nor 





3.19 In the past two weeks, how 












3.20 In the past two weeks, how 
satisfied are you with your 












3.21 In the past two weeks, how 
satisfied are you with the 













3.22 In the past two weeks, how 
satisfied are you with the 












3.23 In the past two weeks, how 
satisfied are you with your 
access to health services?  
1. Very 










3.24 In the past two weeks, how 
satisfied are you with your 
transport? 
1. Very 










3.25 In the past two weeks, how 
satisfied are you with your 
relations to other people in your 
community? 
1. Very 










3.26 In the past two weeks, how 
satisfied are you with your 
access to adequate food and 
nutrition? 
1. Very 










3.27 In the past two weeks, how often 
do you have negative feelings 
such as blue mood, despair, 
anxiety, depression?  
5. Never 4. Seldom 3. Quite often 2. Very 
















4. Patient Heath Questionnaire Depression Module (PHQ-9) 
During the last two weeks, how often have you been bothered by any of the following problems? 
(Interviewers: Please repeat response options for each of the following questions). 
  Not at all Several days  
More than 
half the days 
Nearly 
every day  
4.1 Little interest or pleasure in doing things  0 1 2 3 
4.2 Feeling down, depressed, or hopeless   0 1 2 3 
4.3 Trouble falling or staying sleep, or sleeping too 
much 
 0 1 2 3 
4.4 Feeling tired or having little energy  0 1 2 3 
4.5 Poor appetite or eating too much   0 1 2 3 
4.6 Feeling bad about yourself - or that you’re a 
failure or have let yourself or your family down  
 0 1 2 3 
4.7 Trouble concentrating on things, such as 
reading the newspaper or watching television  
 0 1 2 3 
4.8 Moving or speaking so slowly that other people 
could have noticed. Or, the opposite - being so 
fidgety or restless that you have been moving 
around a lot more than usual  
 0 1 2 3 
4.9 Thoughts that you would be better off dead or 
of hurting yourself in some way  
 0 1 2 3 
 




Very difficult  Extremely 
difficult  
4.10 How difficult have these problems made it for 
you to do your work, take care of things at 
home, take care of yourself, or get along with 
other people? 



















5. MINI Depression module 
  No  Yes  
A1a Were you ever depressed or down, or did you feel sad, empty or worthless, most of 
the day, nearly every day, for two weeks?  
0 1 
A1b For the past two weeks, were you depressed or down, or did you feel sad, empty or 
hopeless, most of the day, nearly every day? 
0 1 
A2a Were you ever much less interested in most things or much less able to enjoy the 
things you used to enjoy most of the time, for two weeks?  
0 1 
A2b In the past two weeks, were you much less interested in most things or much less 
able to enjoy the things you used to enjoy, most of the time? 
0 1 
A3  Over that two-week period, when you felt depressed or uninterested?   0 1 
A3a Was your appetite decreased or increased nearly every day? Did your weight 
decrease or increase without trying intentionally (by 5% of body weight or  3.5kg for 
70 kg person in a month)?   
0 1 
A3b  Did you have trouble sleeping nearly every night over the past 2-week period 
(Difficulty falling asleep, waking in the middle of the night, early morning wakening or 
sleeping excessively)?  
0 1 
A3c Did you talk or move more slowly than normal or were you fidgety, restless or having 
trouble sitting still almost every day over the past 2-week period? Did anyone notice 
this? 
0 1 
A3d Did you feel tired or without energy almost every day over the past 2-week period?  0 1 
A3e Did you feel worthless or guilty almost every day over the past 2-week period?  0 1 
A3f Did you have difficulty concentrating or making decisions almost every day over the 
past 2-week period?  
0 1 
A3g Did you repeatedly consider hurting yourself, feel suicidal, or wish that you were dead 
over the past 2-week period? Did you attempt suicide or plan a suicide?  
0 1 
A3h Did you feel irritable?  0 1 
A4 Did these symptoms cause significant distress or problems at home, at work, socially, 
in your relationships, at school or in some other important way, and are they a change 
from your previous functioning over the past 2-week period?  
0 1 
A5 In between 2 episodes of depression, did you ever have an interval of at least 2 
months, without any significant depression or any significant loss of interest?  
0 1 
A6 How many episodes of depression did you have in your life time? (between each 
episode there must be at least 2 months without any significant depression)  
0 1 
 
B In the past month did you,   
B1 In the past month did you think that you would be better off dead or wish you were 
dead?  
No  Yes  
B2 In the past month did you want to harm yourself? No  Yes  
B3 In the past month did you think about suicide? No  Yes  
B4 In the past month did you have a suicide plan?  No  Yes  
B5 In the past month did you attempt suicide? No  Yes  
B6 In your life time, did you ever make a suicide attempt?  No  Yes  
 Is at least 1 of the above coded yes? No Yes  
 If yes, specify the level of suicide risk as follows; 
C1 or C2 or C6 = YES, indicates LOW suicide risk 
C3 or (C2+C6) = YES, indicates MODERATE suicide risk  





6. WHODAS 12 item questions  
 In the past 30 days, how much difficulty did you have in: 
QNo Question  None  Mild  Moderate Severe  Extreme 
6.1 Standing for long periods such as 30 
minutes? 
5 4 3 2 1 
6.2 Taking care of your household 
responsibilities? 
5 4 3 2 1 
6.3 Learning a new task, for example, learning 
how to get to a new place? 
5 4 3 2 1 
6.4 How much of a problem did you have joining 
in community activities (for example, 
festivities, religious or other activities) in the 
same way as anyone else can? 
5 4 3 2 1 
6.5 How much have you been emotionally 
affected by your health problems? 
5 4 3 2 1 
6.6 Concentrating on doing something for ten 
minutes? 
5 4 3 2 1 
6.7 Walking a long distance such as a kilometre 
[or equivalent]? 
5 4 3 2 1 
6.8 Washing your whole body? 5 4 3 2 1 
6.9 Getting dressed? 5 4 3 2 1 
6.10 Dealing with people you do not know? 5 4 3 2 1 
6.11 Maintaining a friendship? 5 4 3 2 1 
6.12 Your day-to-day work? 5 4 3 2 1 
 
6.13 Overall, in the past 30 days, how many days were these difficulties present?  
6.14 In the past 30 days, for how many days were you totally unable to carry out your usual activities 
or work because of any health condition? 
 
6.15 In the past 30 days, not counting the days that you were totally unable, for how many days did 
















7. Perceived social support  
Circle “1” if very strongly 
disagree 
Circle “2” if strongly disagree 
Circle “3” if mildly disagree 
Circle “4” if neutral 
Circle “5” if mildly agree 
Circle “6” if strongly agree 
Circle “7” if very strongly agree 
  
7.1 There is a special person who is around when I am in need.  1 2 3 4 5 6 7 
7.2 There is a special person with whom I can share my joys and 
sorrows. 
1 2 3 4 5 6 7 
7.3 My family really tries to help me. 1 2 3 4 5 6 7 
7.4 I get the emotional help and support I need from my family. 1 2 3 4 5 6 7 
7.5 I have a special person who is a real source of comfort to me. 1 2 3 4 5 6 7 
7.6 My friends really try to help me. 1 2 3 4 5 6 7 
7.7 I can count on my friends when things go wrong. 1 2 3 4 5 6 7 
7.8 I can talk about my problems with my family. 1 2 3 4 5 6 7 
7.9 I have friends with whom I can share my joys and sorrows. 1 2 3 4 5 6 7 
7.10 There is a special person in my life who cares about my feelings. 1 2 3 4 5 6 7 
7.11 My family is willing to help me make decisions. 1 2 3 4 5 6 7 
7.12 I can talk about my problems with my friends. 1 2 3 4 5 6 7 
8. The following questions were used to collect clinical data from clients’ medical record review  
8.1 A. When the diagnosis of HIV/AIDS done? _____________________ 
B. When clinical follow up started? _____________________ 
C. When ART treatment initiated? _____________________ 
D. For how long s/he has been taking ART treatment? _____________________ 
E. Total Number of medications s/he is taking _____________________ 
8.2 Does s/he experience medication side effect? 1. Yes 
2. No 
If yes, what side effect? _____________________ 




8.3 Does s/he attend her/his follow up regularly? 1. Yes 
2. No 
If No, what was the reason mention over the chart? ____________________ 
8.4 Is there other illness/disease s/he diagnosed in the last 12moths other 
than HIV/AIDS  
1. Yes 
2. No 
If Yes, mention  _____________________ 
What treatment s/he is getting? _____________________ 
8.5 A. Current CD4 count  _____________________ 
B. Last CD4 count  _____________________ 
C. Date last CD4 count done _____________________ 
8.6 A. Current viral load count  _____________________ 
B. Last viral load count  _____________________ 
C. Date last viral load done _____________________ 
8.7 WHO disease stage  _____________________ 
8.8 ART treatment regimen _____________________ 
8.9 Did the client has taken the prescribed medications correctly since the 
last follow up? 
1. Yes  
2. No  




Module two: Interview guide for adaptation of group IPT  
Interview guide for people living with HIV/AIDS (PWHA), case managers and adherence supporters  
Objective of questionnaire: Section one aimed to explore conceptualization of depressive symptoms by People Living 
with HIV/AIDS (PWHA) and adherence counsellors who are attending their clinical follow up in the ART clinic in 
Felegehiwot Hospital. Section B aimed to identify preferred treatment strategy to help depressed PWHA in Felegehiwot 
referral hospital.    
Section A. Exploring depression using explanatory model of illness among PLWHA.   
Let’s listen a case presentation about stories of Selam then we will discuss about her story later (the case will be 
displayed on a projector). After listening the stories of Selam (“Now, let’s discuss how you understood Selam’s 
story”).  
 
1. Can you explain to me what Selam’s problems are? (Probe for understanding e.g., is it understood as 
witchcraft, stress etc, if it is any of these things, how do they work eg how does the witchcraft work, how 
does the stress work?, etc ). 
2. What are the different words that you and other people use to describe Selam’s problem? Probing (What 
other symptoms do people have who are depressed and how do these symptoms affect her life? How long 
do these symptoms usually last?)  
3. What do you think causes these feelings? (For example, is it specific events or situations that trigger or start 
the symptoms, or is it people’s beliefs, or other things) 
4. How common are depressive symptoms in PWHA? Are PWHA more likely to be depressed than other 
people? If so, why? 
5. Where do they seek help?  
Section B. Exploring treatment preferences using ecological validity and culture sensitivity model 
1. What are the best treatment options available to help depressed PWHA in Felegehiwot hospital?  
2. What additional support do you think they need? 
3. What do you know about psychological treatments?  
Now let me tell you about Group Interpersonal Therapy (Group IPT). Group IPT is one of psychological treatments 
used to treat depressive symptoms. It focuses to alleviate depressive symptoms triggered by one or more of these four 
problems: 1) grief/loss of beloved one’s, 2) Dispute/disagreement, 3) Life change including divorce, separation, 
migration, job loss, and 4) loneliness/separation. Depressed people will meet in group to share their personal problems 
that are causing their depressive symptoms, to share coping skills and to set goals to solve difficult situations. Therefore, 
depressive symptoms can be treated when those triggering factors solved using Group IPT.  
Based on the above description of Group IPT, let’s discuss the following ideas. 
4. Do you know about it before and if yes what are your thoughts about expanding it for larger population 
Ethiopia?  
• Think of its acceptability and appropriateness.  
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• Is it feasible in this context and if not, how can we make it feasible? 
You’ve told me about what types of treatments you think may work for PWHA with depressive symptoms. Let’s talk 
about how the treatment should be provided. For example, who should provide it, where it should take place, how 
often, and so on.  
Probes:  
• What time of day and week 
• Where?  
• How long the sessions should be and how many sessions 
• Who should conduct the therapy as counselor? (gender, age, qualification, locality, relationship/ community 
relations). 
• Group or individual 
Let’s think about any problems in running such therapy sessions.  
Probes:  
• What would make it acceptable to people 
• Would it be convenient for people? 
• How can any problems be overcome? 
Section C. Case vignette  
Selam is 30 years old housewife. She has been feeling unusually sad and miserable for the last few weeks. 
She has lost interest in everything and she is not getting pleasure at all. Even though she feels tired all the 
time, she has trouble sleeping nearly every night. Selam does not feel like eating and has lost weight. She 
cannot keep her mind on housework and puts off making decisions. Even day-to-day tasks seem too much 
for her such as cooking, baking, house cleaning and other activities. Once she told her husband that she is 
feeling helpless, hopeless, guilty with unknown reasons so that she prefers to die in whatever means. This 











Module three: Fidelity assessment checklists 
The following questions were used to assess fidelity of group IPT intervention. 
Note: These forms can be used as a reminder of the different tasks to complete in each session, as a self-assessment 
tool for facilitators or by peers or a supervisor as part of ongoing learning and supervision.  
3.1. Pre-group phase (Individual session) 
Group member ID: ___________ 
Session # and date: ___________ 
Facilitators Name: ________________________________________ 
Supervisors Name: ________________________________________ 
( ) Audio ( ) Live supervision ( ) Verbal report only 
Please rate using the following key terms: 




Not applicable to 
session 
Couldn’t assess in 
supervision  
1 2 3 4 5 6 
 
Introduces self and project to person  1 2 3 4 5 6 
Reviews person’s depression symptoms by administering a depression rating scale  1 2 3 4 5 6 
Explains that depression is a common but very impairing condition and discusses 
person’s impairment 
1 2 3 4 5 6 
Gives hope that depression is treatable 1 2 3 4 5 6 
Assigns person the sick role  1 2 3 4 5 6 
Links beginning of depression to interpersonal problem(s)  1 2 3 4 5 6 
Conducts interpersonal inventory  1 2 3 4 5 6 
Selects and agrees with the person on 1 or 2 IPT problem areas  1 2 3 4 5 6 
Agrees with person on interpersonal goals  1 2 3 4 5 6 
Discusses number of sessions, attendance and group rule  1 2 3 4 5 6 
Demonstrates knowledge of Group IPT model  1 2 3 4 5 6 
Works at establishing a good relationship with prospective group member  1 2 3 4 5 6 
Demonstrates good understanding of person’s problem and its context  1 2 3 4 5 6 
Has a collaborative style  1 2 3 4 5 6 
 
Individual session: supervisor's recommendations to facilitator: _________________________________ 
Strengths: ___________________________________________________________________________ 
Difficulties: __________________________________________________________________________ 







3.2. Initial group phase (Group session 1) 
Group ID: __________________  
Session # and date: _____________ 
Facilitator: _________  
Supervisor: __________________________ 
( ) Audio ( ) Live supervision ( ) Verbal report only 
Please rate using the following key: 




Not applicable  Couldn’t assess in 
supervision  
1 2 3 4 5 6 
 
Introduces self and project to group  1 2 3 4 5 6 
Conducts group icebreaker activities (each member introduces the person next to 
them, etc.)  
1 2 3 4 5 6 
Discusses purpose of the group  1 2 3 4 5 6 
Explains that depression is a common but very impairing condition, and asks each 
person about impairment, while removing guilt  
1 2 3 4 5 6 
Encourages each group member to talk about depression symptoms, related life 
problems and goals  
1 2 3 4 5 6 
Outlines group rules (confidentiality, attendance, etc.)  1 2 3 4 5 6 
Demonstrates knowledge of Group IPT model  1 2 3 4 5 6 
Works at establishing rapport and group cohesion  1 2 3 4 5 6 
Shares time fairly amongst group members  1 2 3 4 5 6 
Is able to keep group focused  1 2 3 4 5 6 
Session 1: Supervisor's recommendations to facilitator: _______________________________________ 
Strengths: ___________________________________________________________________________ 
Difficulties: __________________________________________________________________________ 










3.3. Middle group phase (group sessions 2–7) 
Group ID: __________________    Session # and date: _____________ Facilitator: _________  
Supervisor: __________________________ 
( ) Audio ( ) Live supervision ( ) Verbal report only 
Please rate using the following key:  




Not applicable to 
session 
Couldn’t assess in 
supervision  
1 2 3 4 5 6 
 
Welcomes group, reviews each member’s depression symptoms for past week with 
the depression rating scale and obtains depression score  
1 2 3 4 5 6 
Comments on improvement or worsening of depression and gives each group 
member hope  
1 2 3 4 5 6 
Connects improvement or worsening of depression to past week’s interpersonal 
events and links these events to the IPT problem area(s)  
1 2 3 4 5 6 
Focuses on each group member’s identified IPT problem area(s)  1 2 3 4 5 6 
When group member deals with grief, facilitator enables discussion of the 
circumstances of the loss  
1 2 3 4 5 6 
When group member deals with grief, facilitator reviews their relationship with the 
deceased person  
1 2 3 4 5 6 
When group member deals with grief, facilitator helps with reconnection with the world 
and future plans  
1 2 3 4 5 6 
When group member discusses disputes, facilitator clarifies their expectations about 
the situation that triggered dispute  
1 2 3 4 5 6 
When group member discusses disputes, facilitator identifies problematic 
communications  
1 2 3 4 5 6 
When group member discusses life changes, facilitator helps them find positives and 
negatives about old role  
1 2 3 4 5 6 
When group member discusses life changes, facilitator helps them find positives and 
negatives or opportunities in the new role  
1 2 3 4 5 6 
When group member discusses life changes, facilitator helps them develop skills to 
better manage the new role  
1 2 3 4 5 6 
When group member is socially isolated, facilitator helps them to acquire skills to 
engage in social interactions  
1 2 3 4 5 6 
Analyses interpersonal situations in detail to find out what happened (communication 
analysis)  
1 2 3 4 5 6 
Helps group members practise new communication strategies  1 2 3 4 5 6 
Encourages group members to help each other to generate options to deal with 
problems  
1 2 3 4 5 6 
When group members have no options, facilitator encourages them to find advocates 
and others with more power to help  
1 2 3 4 5 6 
Encourages group members to use role-play to rehearse desirable interactions  1 2 3 4 5 6 
Demonstrates knowledge of Group IPT model 1 2 3 4 5 6 
Works at establishing good relationships and group cohesion  1 2 3 4 5 6 
Shares time fairly amongst group members  1 2 3 4 5 6 
Is able to keep group focused  1 2 3 4 5 6 
 
Sessions 2–7 Supervisor's recommendations to facilitator: _____________________________________ 
Strengths: ___________________________________________________________________________ 
Difficulties: __________________________________________________________________________ 
Plans for improvement (rehearse, assign reading, etc.) ________________________________________
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3.4. Termination group phase (group session 8) 
Group ID: __________________  
Session # and date: _____________ 
Facilitator: _________  
Supervisor: __________________________ 
( ) Audio ( ) Live supervision ( ) Verbal report only 
Please rate using the following key: 







in supervision  
1 2 3 4 5 6 
 
Reviews each group member’s depression from start of the treatment to now and 
comments on progress  
1 2 3 4 5 6 
Discusses warning symptoms of depression (How would you know that you are 
getting depressed again?) 
1 2 3 4 5 6 
Identifies successful strategies used in treatment  1 2 3 4 5 6 
Reviews group members’ interpersonal goals, successes and efforts to change  1 2 3 4 5 6 
Discusses generalization of strategies to future situations for group members  1 2 3 4 5 6 
Discusses his/her own and group members’ feelings about ending treatment 1 2 3 4 5 6 
Assesses need for further treatment  1 2 3 4 5 6 
Discusses possibility of recurrence of depression and plan for managing recurrence  1 2 3 4 5 6 
Demonstrates knowledge of Group IPT model  1 2 3 4 5 6 
Works at maintaining relationships with and amongst group members  1 2 3 4 5 6 
Shares time fairly amongst group members  1 2 3 4 5 6 















Module four: Intervention evaluation checklist    









All information discussed 
was relevant to me. 
1  2 3  4  5 6  
The sessions were long 
enough to discuss topics.  
1 2 3 4 5 6 
I was feeling comfortable 
with sessions. 
1 2 3 4 5 6 
 Chances were provided 
for me to ask questions. 
1 2 3 4 5 6 
Discussion point were 
easy to understand.   
1 2 3 4 5 6 
I feel relaxed and ready to 
listen and to talk. 
1 2 3 4 5 6 
The sessions helped me 
to work on my problems. 
1 2 3 4 5 6 
The homework helped me 
to solve my problems. 
1 2 3 4 5 6 
The facilitator was 
prepared for the sessions. 
1 2 3 4 5 6 
The facilitators know the 
content of the intervention. 
1 2 3 4 5 6 
The facilitators were good 
at managing the group. 
1 2 3 4 5 6 
The facilitator made the 
sessions interesting. 
1 2 3 4 5 6 
The facilitators 
communicate clearly. 
1 2 3 4 5 6 
The facilitators encourage 
participation.  
1 2 3 4 5 6 
The facilitation space was 
suitable for group session. 
1 2 3 4 5 6 
The session location was 
easy to find 
1 2 3 4 5 6 
I need such intervention 
for others too. 
1 2 3 4 5 6 
The intervention was 
relevant to manage my 
problems. 
1 2 3 4 5 6 
The experience I found 
from others helped me to 
resolve my problems. 
1 2 3 4 5 6 
I am satisfied with the 
intervention 
1 2 3 4 5 6 
I am satisfied with the 
facilitator 
1 2 3 4 5 6 
I am satisfied with the 
group session 









Module five: Group IPT competency assessment for counsellors   
Counsellors competence for group IPT was assessed at the completion of the training using the following 
questions. 
1. Please name the four types of triggers of depression in IPT define each one. 
2. What are the phases of Group IPT? (Just mention them.) 
3. Describe the tasks that need to take place in the pre-group phase. 
4. Describe the goals and steps of the initial group phase. 
5. Describe how a typical session starts in the middle phase. 
6. In the middle phase, what are the strategies for working with grief? 
7. What are the stages of a dispute? (Please describe each.) 
8. What are the strategies for managing disputes? 
9. What are the strategies for life changes? 
10. What are the strategies for loneliness/social isolation? 
11. What is communication analysis? Can you give an example? 
12. Describe 2 other techniques that you use in Group IPT (across strategies). Please explain. 
13. Describe 1 way to involve group members in group discussions, and give examples. 
14. What is something you can do to distribute your time fairly among the group members? 
15. What happens during the termination phase?  
Note: Test scoring instructions are as follows: every question gets 2 points if answered adequately, 1 point if something 
important is missing and 0 points if the answer is incorrect. Usually the facilitator should be able to answer 70% of the 










Appendix E. Sample of consent forms  
 
  
Alan J. Flisher Centre for Public Mental Health 
Department of Psychiatry and Mental Health 
University of Cape Town 
 46 Sawkins Road, Rondebosch, 7700 
Cape Town, South Africa 
Tel. +27 21 685 0120  
Fax +27 21 685 1223 
 
 
Informed consent form for survey of quality of life, depressive symptoms and ART adherence status 
– Survey in Objective 2.  
This informed consent is for people with HIV/AIDS in a research titled “Depression and HIV/AIDS: adapting 
and piloting group interpersonal therapy for treatment of depressive symptoms among people with 
HIV/AIDS in Northwest Ethiopia”  
Hello. My name is Biksegn Asrat. I am an AMARI PhD fellow at the Alan J. Flisher Centre for Public Mental 
Health in the University of Cape Town, South Africa. You are being asked to participate in an interview as 
part of a study that I am conducting. Before you agree to take part, you should understand what it involves. 
This letter is to help you decide if you want to participate in this study. Participation is voluntary, and you 
should agree to take part only if you are happy with all it entails.  
The overall aim of this research project is to explore the problems that people living with HIV/AIDS are 
facing, and to identify clients who have depressive symptoms. Later part of the study aimed to treat 
depressive symptoms using group interpersonal therapy. Depressive symptoms and not taking ART 
medications are affecting the wellbeing of many people with HIV/AIDS. Therefore, interventions are needed 
to treat depressive symptoms and to promote ART medication adherence.  
The objective of this interview is to identify people who have depressive symptoms among ART follow up 
clients at Bahir Dar Felegehiwot referral hospital. You have been approached to participate in this study 
because you are one of the clients attending ART follow up at Bahir Dar Felegehiwot referral hospital. The 
interview will help us to generate evidence and you will know your mental health status at the end of the 
interview. Your usual HIV care will not be negatively impacted in any way if you choose not to participate 
in the study.   
What is being asked of you? 
If you agree to take part in this study, you will be one of 395 clients participating. You will be asked to give 
answers for prepared structured questions about your background, general health and emotional /or 
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psychological status. You also will be asked about your social support status, your ART follow up status, 
and your habits. The interview could take 30 to 45 minutes. Additionally, I need to know your previous CD4 
count, viral load and other medical information. Therefore, if you agree for the interview, then I will look at 
your medical record to see your previous general health status. The information that you provide will help 
me to know whether you need treatment or not. Furthermore, it will allow me to know what is really affecting 
the wellbeing of your mental health.    
Potential risks and discomforts of participating in this study 
There is only minimal risk to participating in this survey study. There are two anticipated potential risks for 
participants: (1) improper disclosure of confidential information; and (2) unpleasant feeling associated with 
issues raised during the interview. There is a risk of leaking confidential information out of the group 
members. However, the probability of improper disclosure of confidentiality by research staffs is low 
because all the research staffs received intensive training about how to handle confidentiality. In addition, 
your name will not be written in the questionnaire, and the data will be accessed by the principal investigator 
only. As mentioned above, some questions may provoke unpleasant feeling, but you will not be pressured 
to give answer for such questions. You can ask the data collector to skip the specific question that has high 
discomfort for you. 
Potential benefits of participating in this study 
Your participation in the study will help you to know your mental health status such as: presence of 
depressive symptoms, the quality of your living standard, your social relationship and the status of your 
social support. Once after you understood your mental health status, then I will assist you what kind of 
treatment you should get. If you are identified having depressive symptoms you will have a chance to get 
free psychological treatment from us. If you have severe form of depression, then I will refer you to a 
specialized care. Otherwise, there is no available fund to be paid for your participation in this interview.  
Confidentiality and privacy 
All study staffs will receive intensive training in participants confidentiality procedures and there are serious 
sanctions (including dismissal) if confidentiality is broken. Any information that you will give me will remain 
confidential. The questionnaire and the informed consent is labelled by secret numbers (codes). You will 
be asked to put your name and signature on the informed consent only. The questionnaire will not have 
your name and it will be stored in a locked cabinet which is accessed by the primary researcher only. The 
data will be entered into a computer software and it will be saved in a password secured folder on the 
primary researchers’ computer. The questionnaire and the consent form will be destroyed within 2 years 
after the compilation of this study. The University of Cape Town (UCT) Human Research Ethics committee 
(HREC) will however have access to all data. We will use the information you provide us to write and publish 
papers in academic journals, but this data will not be identified by name. Your name will not appear 
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anywhere in any published material and your identity will remain anonymous as codes will be used. 
However, confidentiality will need to be broken if you pose a danger to yourself or others.     
Rights of participants 
Your participation is entirely voluntary and there is no penalty for refusing to participate. If you decided to 
participate, you may choose to stop your participation at any time. You are free not to provide answer for 
specific questions. There will be no consequence at all. However, your participation is highly needed for 
this research project. You have the right to know how confidentiality will be maintained. If you believe 
confidentiality will be broken, then you can leave from participation at any time. This study will be conducted 
according to the ethical guidelines and principles of the International Declaration of Helsinki.   
Who is funding the study? 
The study is being conducted through the Alan J. Flisher centre for Public Mental Health (UCT) and the 
African Mental Health Research Initiative (AMARI). It is funded by AMARI consortium whose overall goal is 
to build and support research in mental, neurological and substance use in Africa. For more information 
you can visit: https://amari-africa.org/biksegn-asrat/  
Reimbursement 
There is no reimbursement for this interview. However, refreshment will be provided at the end of the 
interview.  
Who to contact with question 
If you have any questions, concerns or complaints about your rights as a participant, please contact 
Biksegn Asrat at any time using the following addresses. He is available on (+251) 923229274 in Ethiopia, 
(+277) 30544676 in South Africa or via email biksegnasrat1@gmail.com or ASRBIK001@myuct.ac.za  
Country supervisor of this study is Dr Fentie Ambaw. Therefore, you can call him through his address 
whenever you have complaints. Mobile: (+251) 911 81 70 07, Office: (+251) 588 209834, E-mail: 
fentiea.getahun@gmail.com / fentiea@bdu.edu.et   
The primary supervisor of this research is Associate Prof Marguerite Schnider, Office: +27 21 406 6308; 
Cell: +27 73 253 5080, email work: marguerite.schneider@uct.ac.za Skype: marguerite8242. You are 
welcome to contact her if you have any additional queries. 
If you have any concerns or complaints please you can call the chairperson of the HREC, Prof Marc 




Please let us know if you have any questions before checking this consent form. Please check each item 
to show that you agree to what is required (leave blank if you do not agree): 
Agree   
 I agree to take part in the interview which has been fully explained to me.  
 I understand that my participation in this interview is completely voluntary, and there will 
be no penalty if I choose not to participate. 
 
Signing this consent form indicates that you have read this consent form (or have had it read to you), that 
your questions have been answered to your satisfaction, and that you voluntarily agree to participate in this 
study. You will receive a copy of this signed consent form. 
-------------------------------------------------------------------------------------------------------------- 
Participants (Name and signature)                                                                      Date 
--------------------------------------------------------------------------------------------------------------- 
Person obtaining consent (signature and printed Name)                                    Date  
--------------------------------------------------------------------------------------------------------------- 
Witness (signature and printed Name)                                                                Date  
*A witness is required if the research participant cannot read (e.g. blind or illiterate) or if it is required by the 
study plan. The witness should participate in all of the discussions with regards to the participant research 
during the consent process. By signing this consent form, the witness guarantees that all the information 
with in the consent has been explained to the participant, and that the consent seemed to have been 















Appendix F. Standard operating procedure (SOP) 
Step 1: Checking eligibility of participants for the study 
Step2: Informed consent administration 
Step 3: Interviewing 
Step 4: Score PHQ-9 (Case if 5 or None if 4) 
Step 5: Refer participants with PHQ score of 5 to the intervention facilitators (counsellors) 
Step 6: Facilitators will invite the participant for group IPT after individual counselling session 
Step 7: Informed consent administration for group IPT intervention   
Step 8: Check suicide risk  
Step 9: Refer if there is suicidal or homicidal behaviour  
 
 
Figure 17. Diagrammatical illustration of the standard operating procedure that used in the 
recruitment of participants into the intervention 
 
Objective IV: Group IPT 
intervention (step 8 and 9)  
Consent administration to 
recruite for Group IPT 
intervention (step 7)
Identifying participants with 
Depressive symptoms (step 4, 5 
and 6)
Objective 1: Survey of 
depressive symptoms (step 3) 
Consent adminstration (step 1 


















Appendix G. Stepwise adaptation framework for the WHO group IPT manual 
 
Figure 18. Participatory and Iterative Process Framework for Language Adaptation (PIPFLA) that 



























Appendix H. Counsellors weekly notes sample form 
 
Group members name: _______________________ 
Counsellors name: ___________________________ 
Group number: ______________________________ 
 
Date: __________________ 
Depression score at baseline: ______________ 
 
 














Plan for next week (including goals): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Homework:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
